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RÉSUMÉ
Le dioxyde de carbone (CO2) est un résidu naturel du métabolisme cellulaire, la troi-
sième substance la plus abondante du sang, et un important agent vasoactif. À la moindre
variation de la teneur en CO2 du sang, la résistance du système vasculaire cérébral et
la perfusion tissulaire cérébrale subissent des changements globaux. Bien que les mé-
canismes exacts qui sous-tendent cet effet restent à être élucidés, le phénomène a été
largement exploité dans les études de réactivité vasculaire cérébrale (RVC). Une voie
prometteuse pour l’évaluation de la fonction vasculaire cérébrale est la cartographie de
la RVC de manière non-invasive grâce à l’utilisation de l’Imagerie par Résonance Ma-
gnétique fonctionnelle (IRMf). Des mesures quantitatives et non-invasives de de la RVC
peuvent être obtenus avec l’utilisation de différentes techniques telles que la manipu-
lation du contenu artériel en CO2 (PaCO2) combinée à la technique de marquage de
spin artériel (Arterial Spin Labeling, ASL), qui permet de mesurer les changements de
la perfusion cérébrale provoqués par les stimuli vasculaires. Toutefois, les préoccupa-
tions liées à la sensibilité et la fiabilité des mesures de la RVC limitent de nos jours
l’adoption plus large de ces méthodes modernes de IRMf. J’ai considéré qu’une analyse
approfondie ainsi que l’amélioration des méthodes disponibles pourraient apporter une
contribution précieuse dans le domaine du génie biomédical, de même qu’aider à faire
progresser le développement de nouveaux outils d’imagerie de diagnostique. Dans cette
thèse je présente une série d’études où j’examine l’impact des méthodes alternatives de
stimulation/imagerie vasculaire sur les mesures de la RVC et les moyens d’améliorer
la sensibilité et la fiabilité de telles méthodes. J’ai aussi inclus dans cette thèse un ma-
nuscrit théorique où j’examine la possible contribution d’un facteur méconnu dans le
phénomène de la RVC : les variations de la pression osmotique du sang induites par les
produits de la dissolution du CO2.
Outre l’introduction générale (Chapitre 1) et les conclusions (Chapitre 6), cette thèse
comporte 4 autres chapitres, au long des quels cinq différentes études sont présentées
sous forme d’articles scientifiques qui ont été acceptés à des fins de publication dans
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différentes revues scientifiques. Chaque chapitre débute par sa propre introduction, qui
consiste en une description plus détaillée du contexte motivant le(s) manuscrit(s) asso-
cié(s) et un bref résumé des résultats transmis. Un compte rendu détaillé des méthodes
et des résultats peut être trouvé dans le(s) dit(s) manuscrit(s). Dans l’étude qui compose
le Chapitre 2, je compare la sensibilité des deux techniques ASL de pointe et je dé-
montre que la dernière implémentation de l’ASL continue, la pCASL, offre des mesures
plus robustes de la RVC en comparaison à d’autres méthodes pulsés plus âgées. Dans
le Chapitre 3, je compare les mesures de la RVC obtenues par pCASL avec l’utilisation
de quatre méthodes respiratoires différentes pour manipuler le CO2 artérielle (PaCO2)
et je démontre que les résultats peuvent varier de manière significative lorsque les ma-
nipulations ne sont pas conçues pour fonctionner dans l’intervalle linéaire de la courbe
dose-réponse du CO2. Le Chapitre 4 comprend deux études complémentaires visant à
déterminer le niveau de reproductibilité qui peut être obtenu en utilisant des méthodes
plus récentes pour la mesure de la RVC. La première étude a abouti à la mise au point
technique d’un appareil qui permet des manipulations respiratoires du CO2 de manière
simple, sécuritaire et robuste. La méthode respiratoire améliorée a été utilisée dans la
seconde étude – de neuro-imagerie – où la sensibilité et la reproductibilité de la RVC,
mesurée par pCASL, ont été examinées. La technique d’imagerie pCASL a pu détecter
des réponses de perfusion induites par la variation du CO2 dans environ 90% du cortex
cérébral humain et la reproductibilité de ces mesures était comparable à celle d’autres
mesures hémodynamiques déjà adoptées dans la pratique clinique. Enfin, dans le Cha-
pitre 5, je présente un modèle mathématique qui décrit la RVC en termes de changements
du PaCO2 liés à l’osmolarité du sang. Les réponses prédites par ce modèle correspondent
étroitement aux changements hémodynamiques mesurés avec pCASL ; suggérant une
contribution supplémentaire à la réactivité du système vasculaire cérébral en lien avec le
CO2.
Mots clés: Reactivité de la vasculature cérébrale, dyoxide de carbone, IRM fonc-
tionnelle, Arterial Spin Labeling, perfusion cérébrale, pression osmotique du sang.
ABSTRACT
Carbon dioxide (CO2) is a natural byproduct of cellular metabolism, the third most abun-
dant substance of blood, and a potent vasoactive agent. The resistance of cerebral vas-
culature and perfusion of the brain tissue respond to the slightest change in blood CO2
content. The physiology of such an effect remains elusive, yet the phenomenon has been
widely exploited in studies of the cerebral vascular function. A promising avenue for
the assessment of brain’s vascular function is to measure the cerebrovascular reactiv-
ity to CO2 (CVR) non-invasively using functional MRI. Quantitative and non-invasive
mapping of CVR can be obtained using respiratory manipulations in arterial CO2 and
Arterial Spin Labeling (ASL) to measure the perfusion changes associated with the vas-
cular stimulus. However, concerns related to the sensitivity and reliability of CVR mea-
sures by ASL still limit their broader adoption. I considered that a thorough analysis and
amelioration of available methods could bring a valuable contribution in the domain of
biomedical engineering, helping to advance new diagnostic imaging tools. In this thesis
I present a series of studies where I exam the impact of alternative manipulation/ASL
methods on CVR measures, and ways to improve the sensitivity and reliability of these
measures. I have also included in this thesis a theoretical paper, where I exam the pos-
sible contribution of an unappreciated factor in the CVR phenomenon: the changes in
blood osmotic pressure induced by the products of CO2 dissolution.
Apart from a general introduction (Chapter 1) and conclusion (Chapter 6), this thesis
comprises 4 other chapters, in which five different research studies are presented in the
form of articles accepted for publication in scientific journals. Each of these chapters
begins with its own specific introduction, which consists of a description of the back-
ground motivating the study and a brief summary of conveyed findings. A detailed
account of methods and results can be found in the accompanying manuscript(s). The
study composing Chapter 2 compares the sensitivity of two state-of-the-art ASL tech-
niques and show that a recent implementation of continuous ASL, pCASL, affords more
robust measures of CVR than older pulsed methods. The study described in Chapter 3
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compares pCASL CVR measures obtained using 4 different respiratory methods to ma-
nipulate arterial CO2 (PaCO2) and shows that results can differ significantly when ma-
nipulations are not designed to operate at the linear range of the CO2 dose-response
curve. Chapter 4 encompasses two complementary studies seeking to determine the
degree of reproducibility that can be attained measuring CVR using the most recent
methods. The first study resulted in the technical development of a breathing apparatus
allowing simple, safe and robust respiratory CO2 manipulations. The improved respira-
tory method was used in the second – neuroimaging – study, in which I and co-authors
investigate the sensitivity and reproducibility of pCASL measuring CVR. The pCASL
imaging technique was able to detect CO2-induced perfusion responses in about 90% of
the human brain cortex and the reproducibility of its measures was comparable to other
hemodynamic measures already adopted in the clinical practice. Finally, in Chapter 5
I present a mathematical model that describes CVR in terms of PaCO2-related changes
in blood osmolarity. The responses predicted by this model correspond closely to the
hemodynamic changes measured with pCASL, suggesting an additional contribution to
the reactivity of cerebral vasculature to CO2.
Keywords: Cerebrovascular reactivity, carbon dioxide, functional MRI, Arterial
Spin Labeling, cerebral perfusion, blood osmotic pressure.
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CHAPTER 1
INTRODUCTION
The brain is a highly metabolic organ demanding a constant and substantial blood
supply [66]. It is estimated that about 15% of the cardiac output flows to the cerebral
vasculature. Approximately 80% of that supply flows within two highly pressurized
pair of arteries, known as the internal carotids, which are originated nearly mid way be-
tween the brain and the heart. The remaining 20% reaches the brain through downstream
branches of the vertebral arteries. The ultimate destination of arterial blood delivery is
the capillary bed, which consists of a vast array of microscopic vessels, possessing a
single layer of endothelial cells devoid of smooth muscle, that rest embedded within the
brain [211, 232]. Given the ubiquity of their presence, capillaries are generally consid-
ered an integral constituent of the organ’s tissue. They provide porosity to the brain,
allowing blood to perfuse it. It is at the capillary level that intravascular blood is in
its most intimate contact with the organ’s surrounding tissue, and where most of the
necessary exchange between blood and the brain takes place. At the distal side of the
capillary bed, the venular tree passively collects the outflowing blood at a very low and
steady hydrostatic pressure.
The cerebral vascular system counts on stringent auto-regulatory mechanisms that
grant stability to the brain’s perfusion [397]. It has been observed that, in normal con-
ditions, global perfusion of the brain remains unchanged for a wide range of systemic
arterial pressures [133]. Cerebral vasculature regulates its resistance (dilating or con-
tracting) in order to preserve the organ’s normal perfusion against variations in the body’s
systemic pressure. The rate of perfusion in the cerebral tissue is not regulated by the pres-
sure exerted on the organ, but rather, on the resistance of its vessels. Another interesting
feature of cerebrovascular function is that, cerebral perfusion pressure remains fairly
constant for a wide range of different flow/perfusion rates [314]. The brain function
is secured by intricate and multi-level mechanisms of resistance regulation (involving
neuro- and myogenic reflexes) that allow cerebral perfusion to change as required while
2maintaining cerebral blood pressure under strict control.
To properly function the brain depends on a fit and responsive vasculature. Charac-
terization of cerebrovascular function, i.e. its ability to dilate and contract, is gaining
increasing interest due to its probable role in age related cognitive decline and in a num-
ber of neurological conditions [111, 259, 297]. For instance, arterial stiffness and deficits
in cerebral perfusion have been associated with the development of vascular dementia
and Alzheimer’s Disease (AD) [104, 395]. It has been speculated that deficiencies in the
auto-regulatory mechanisms controlling cerebral resistance would impair normal cogni-
tive processes and possibly damage the brain tissue [118, 166]. Measurements of the
vasculature response to a stimulus may provide a useful index of the integrity of such
mechanisms, aiding the understanding, diagnostics, prognosis and treatment evaluation
of different cerebral diseases.
Carbon dioxide (CO2) is the natural byproduct of oxidative metabolism and the most
abundant of the blood’s constituents after water and NaCl. It also occurs to be one of the
most potent vasoactive agents [218]. Although the exact mechanisms remain to be elu-
cidated, it has been widely observed that the cerebral vasculature promptly responds to
experimental changes in the arterial CO2 content (or PaCO2) [116, 193, 215]. Whereas
for increasing levels of PaCO2 – known as hypercapnia – the resistance of cerebral vas-
culature drops, yielding a global increase in cerebral perfusion, for lower PaCO2 levels
– known as hypocapnia – there is an increase in vascular resistance and decrease in per-
fusion. Here the terms hyper- and hypocapnia are used to denote benign and transitory
changes in arterial CO2, not a clinical condition; and we consider that mild to moderate
changes in blood CO2 do not exert a significant influence on brain metabolism, only on
its vasculature. The phenomenon has been exploited in the development of functional
MRI (fMRI) applications for non-invasive measures of cerebrovascular function, or reac-
tivity (CVR) [67, 104, 184, 224, 297]. In this type of fMRI, perfusion-weighted images
are continuously acquired during a respiratory manipulation inducing PaCO2 changes.
Analysis of the fMRI signal issues a map of the cerebral perfusion response to CO2,
which is usually normalized by the amplitude of the CO2 change and termed CVR map.
As depicted by fMRI, perfusion responses (i.e. control of vascular tone) can be lo-
3calized to regions on the scale of millimeters [299] and possibly less [148]. While it is
possible to estimate a global index of CVR measuring changes in the flow velocity of
main arteries feeding the brain [1, 325], fMRI-based methods allow an in-depth spatial
characterization of CVR [343]. Furthermore, certain techniques allow measuring the
amount of blood that, having reached the capillary bed, exchanges with the tissue, i.e.
tissue perfusion, the prime parameter characterizing blood supply in the organ. In addi-
tion to providing an exquisite measurement of the cerebrovascular function, combined
fMRI measures of tissue perfusion and blood oxygenation during hypercapnia can be
used to estimate the cerebral metabolic rate of O2 consumption (CMRO2) [156, 158], an
important parameter in functional studies of the whole brain. Brain metabolism can also
be assessed by Positron Emission Tomography (PET), but PET measures of CMRO2
require the injection of radioactive tracers. Other than emitting ionizing radiation, such
tracers have extremely short half-lives, which further limits the applicability of the PET
method. A non-invasive and more readily available estimate of CMRO2 based on fMRI-
CVR methods, can greatly contribute to brain research and the neuroradiology practice.
Although indisputably valuable, the broader adoption of CVR measures are still ham-
pered by limitations of current methods, which are introduced below.
fMRI methods
A primary concern in the imaging assessment of CVR is the sensitivity and speci-
ficity of the imaging method.
The MRI techniques permitting the specific and non-invasive measure of cerebral
perfusion are collectively known as Arterial Spin Labeling (ASL) [75, 396, 403, 408].
The ASL method does not depend on the injection of external agents to obtain the perfu-
sion contrast in its images: to create the perfusion contrast, ASL uses spatially-selective
inversion to make blood water temporarily function as an endogenous contrast agent.
The ASL – or perfusion-weighted – image is in fact the result of a subtraction between
two images: a labeled and a control one. These two images are virtually the same except
for the additional label signal in one of them, which accounts for the ASL perfusion con-
trast. The ASL labeling is accomplished by preparatory MR pulses that excite the spins
4of inflowing blood prior to entering the image region. Image readout is played when
the magnetically labeled blood has had time to perfuse the brain tissue and exchange
water with the surrounding parenchyma, thereby generating a water-labeled image. The
control image is acquired under (nearly) the same experimental conditions except that
inflowing spins do not receive the label during the labeling phase. The difference signal
in the subtracted control-labeled image corresponds to the amount of brain water that
has been renewed during the imaging time (i.e. perfusion of the tissue) and is thus a
relatively small fraction (<2%) of the raw image signal. At this signal level, thermal
and physiological noise severely impact the statistical significance of the perfusion mea-
sure, and the low signal-to-noise ratio (SNR) of current readout methods still poses a
challenge for the sensitivity of ASL.
In measurements of CVR, however, it is the control over the spin labeling that raises
more important concerns [404]. Irrespective of the ASL technique, the large shifts in
global perfusion elicited by PaCO2 manipulations can compromise efficiency and timing
control of the label, yielding ASL perfusion measures that inaccurately underestimate
CVR.
In Chapter 2 of this thesis, I examine the performance of two state-of-the-art ASL
methods in measuring perfusion changes induced by a carefully controlled mild hyper-
capnic challenge. One is a typical implementation of the pulsed type (PASL), wherein a
large volume of inflowing blood is instantaneously labeled using a short radio-frequency
pulse; the other is a recently introduced variant of the continuous method (CASL),
named pseudo-continuous ASL (pCASL), wherein blood flowing through a labeling
plane at the level of carotids and vertebral arteries is continuously inverted using phase-
modulated radio-frequency energy. My findings will justify the choice of pulse sequence
for the the remainder of experimental acquisition composing Chapters 3 and 4 of this
thesis.
Functional stimulus
Another aspect to consider in the measurement of cerebrovascular reactivity, is the
vasoactive stimulus used to induce the vascular response, namely the PaCO2 manipula-
tion.
5Hypercapnia is caused whenever the rate of CO2 production exceeds the rate of its
elimination. That can be achieved, for instance, by supplying someone with air mix-
tures containing higher amounts of CO2 than what is normally found in atmospheric air
(which is virtually zero). A common strategy is to administer a CO2 mixture of fixed
composition for inhalation, also known as hypercapnic induction by “fixed inspired CO2
dose” (FI) [110, 188]. The FI method is relatively simple but, because the actual degree
of hypercapnia achieved depends on several biometric and physiological parameters, the
cerebral blood flow response may vary between subjects. This may not be a concern
since end tidal (expiratory) partial pressure of CO2 (PET CO2) – a surrogate for PaCO2
[421] – can be readily monitored in subjects and be used to normalize CVR measures
[245]. However, in experiments requiring a predeterminate vascular stimulus – such as
those reported in Chapter 2 of this thesis – the variable PET CO2 output might represent
a problem. The modest changes in blood oxygen levels during the FI CO2 manipulation
may also render the method unsuitable for experiments requiring a stringent control over
this variable.
Over the last ten years, interest has emerged in systems for the prospective and in-
dependent targeting of specific PET CO2 and PET O2 values. Perhaps the most advanced
example is the Thornhill Research Inc. (TRI) RespirAct [306, 341, 348]. Others in-
clude the simple contrivance for clamping PET CO2 and PET O2 despite rapid changes
in ventilation described by Banzett et al. [18] and the system for dynamic forcing of
PET CO2 and PET O2 described by Wise et al. [400]. All of the latter methods involve
continuous adjustments of the inspired gas composition, based either on feed-back from
real-time monitoring of end-tidal values or physiological (feed-forward) modeling of gas
exchange.
We will focus here on the TRI RespirAct system, since it is the closest to commer-
cial availability and was the system employed for experiments reported in this thesis.
The RespirAct uses a prospective control approach: prior to the experiment, based on a
comprehensive model of gases storage-exchange in the body compartments, the system
computes the composition of gas mixtures to be inspired in order to achieve a desirable
end tidal output and then delivers gas mixtures with variable compositions according to a
6predetermined schedule. The system is supplied with 4 gas mixtures of different O2 and
CO2 composition enabling a variety of different respiratory challenge schemes. To en-
sure control over administered gases, the gas delivery is achieved using a special breath-
ing circuit that is usually sealed to the subjects’ face using adhesive tape. Also, subjects
need to be instructed to empty the gas supply reservoir of the circuit at every breath.
Despite the versatility and robustness of this gas method, availability of the RespirAct
system has been restricted to research sites due to its cost and limited production as an
investigational device.
Hypercapnia can also be induced without any gas administration, by simply per-
forming a breath-hold (BH), i.e. suspending elimination of endogenously produced CO2
[187, 269, 340]. Although the simplest of the hypercapnic manipulations, BH meth-
ods pose several concerns such as its applicability in subjects who may be unable to
follow instructions, the short duration of the manipulation, the impossibility of measur-
ing expired CO2 levels during the breath-hold, and potential confounds associated with
concurrent hypoxia (the breath-hold also interrupts reposition of O2) .
The above-mentioned methods represent a wide variety of trade-offs between sim-
plicity and rigor. Although the TRI RespirAct system has been compared favorably
against fixed-inspiration methods, it is possible that simple enhancements to FI methods
(such as paced breathing and careful monitoring of end-tidal values) may render these
competitive with prospective targeting systems such as the RespirAct. There also re-
mains a widespread interest in the BH methods due to their simplicity and availability.
A thorough analysis of these alternate methods should allow researchers and clinicians
to select the most appropriate technique for a given application.
In Chapter 3 of this thesis I compare CVR measures obtained using the BH, the FI
and the RespirAct methods, in an experimental set of well controlled conditions.
Measurement reproducibility
The clinical adoption of CVR methods hinges on the reproducibility of related mea-
sures as well as on the availability of imaging/stimulation techniques.
Because of their simplicity and few confounds, fixed-inspired (FI) approaches con-
7tinue to be the most widely adopted method to induce blood gas changes. In addition, as
will be demonstrated in Chapter 3 of this thesis, the FI method can provide robust mea-
sures of CVR. These make the FI method a good candidate to integrate CVR imaging
methods for clinical use. Nevertheless, the respiratory apparatus commonly utilized to
deliver gas mixtures still limit the reproducibility of FI respiratory stimuli and related
fMRI responses.
The study in Chapter 2 shows that the pCASL perfusion imaging technique is more
sensitive and accurate than PASL in measuring CVR, thus constituting a more suitable
imaging method for this type of application. Also, the scientific community seems to
have converged to a consensus that pCASL is the technique with the most potential
to promote the clinical adoption of ASL perfusion imaging in a broader sense [7] –
the method has quickly popularized and become available in most scanner platforms.
Pseudo-CASL has already been tested in different applications and a recent report shows
that its measures of resting perfusion are more reliable than those obtained with PASL
[61]. The degree of reproducibility of pCASL measures in applications involving mod-
ulations in blood gases, however, remained to be determined.
In the first study of Chapter 4 I propose refinements to the FI method that improve
reproducibility of its respiratory manipulations. In the second study I examine the re-
producibility of pCASL measures in a gas-based application exploiting the improved FI
approach.
CVR signal modeling and interpretation
The magnitude of CO2-induced perfusion responses is usually computed by linear
modeling of the perfusion signal based on basis functions that can be summed to repre-
sent the anticipated time-domain MRI signal [107, 128, 347]. The basis function (also
referred to as regressor) representing the CO2 response may consist of the monitored
values of PET CO2 for instance. Alternatively, the design of the respiratory paradigm
(representing the periods of increased/decreased PaCO2) can be convolved with a hemo-
dynamic response function (HRF) corresponding to the impulse response function in a
linear system. This HRF usually consists of a gamma variate function, derived from
8an empirical observation of responses to brief neuronal stimulation [34, 123, 407], but
HRFs specific to respiratory responses have also been proposed [27]. Although both of
the above mentioned modeling methods can afford robust estimates of the magnitude of
CO2-responses, they do not account for the physiology underling the CVR phenomenon.
In fact, the underpinnings of CO2 reactivity remains elusive [419]. Several physio-
logical parameters have been shown to impact on the vascular response to blood CO2;
however, the exact mechanisms and interactions between them, are still uncertain. Pi-
oneer investigators of CVR once formulated a thorough quantitative description of the
phenomenon but the responses predicted by the model were found to be slower than the
responses observed experimentally, and the authors concluded that a faster mechanism
should be involved [130]. In that study, as in others [373], the osmotic effects induced by
CO2 dissolution have not been contemplated. When dissolved in blood, CO2 increases
HCO−3 concentration and blood osmotic pressure [32], to which the cerebral and other
vasculature are also quite reactive [43, 112, 140, 362]. It is possible that the vascular
reactivity to CO2 includes the participation of blood HCO−3 and osmolarity.
In Chapter 5 of this thesis I investigate the role of osmotic forces in the vascular
reactivity to CO2. I present a mathematical model relating PaCO2 to blood osmolarity,
linking the latter to cerebral perfusion changes, and show that the predicted responses
are in close agreement with the CO2-induced hemodynamic changes observed using
ASL. The proposed model can be regarded as a physiologically meaningful CO2-HRF. It
relates vascular reactivity to gaugeable physico-chemical phenomena; and explains how
physiological parameters such as resting blood volume and blood-brain-barrier (BBB)
permeability may be reflected in the ASL perfusion signal.
CHAPTER 2
PULSED AND CONTINUOUS ASL IN CVR
The objective of this study was to compare the performance of pCASL and PICORE
Q2TIPS PASL in measuring global perfusion responses elicited by mild hypercapnia in
a clinical 3T scanner.
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2.1 Arterial Spin Labeling
Arterial Spin Labeling is a class of MRI techniques allowing dynamic, quantitative
and non-invasive imaging of tissue perfusion [7, 77, 87, 294, 399, 403]. Unlike contrast-
enhanced imaging techniques, ASL does not require an exogenous contrast agent to
generate its perfusion-weighted image. In ASL, the perfusion tracer consists of arterial
blood water that has been temporarily labeled by radio-frequency (RF) pulses. The RF
labeling pulses invert the magnetic polarity of blood water spins right before they flow
into the image region, resulting in a small flow-dependent contrast. If this image is then
subtracted from a control image, acquired under the same conditions except without the
labeling pre-pulses, the resultant difference image will include only the flow-dependent
signal. The intensity of this image is a function of the amount of tagged blood perfusing
the region of interest in the interval between labeling and image readout [48, 51, 75, 384,
404, 410].
This approach provides a specific measurement of perfusion, unlike the more widely
applied blood oxygenation level-dependent (BOLD) MR contrast mechanism [198, 228].
Although more sensitive than ASL in detecting hemodynamic changes, BOLD provides
an ambiguous measure that depends on different physiological parameters such as blood
flow, blood volume and rate of oxygen extraction/consumption [49, 157]. Other than a
vascular component, the BOLD signal has a contribution from cellular respiration. ASL
may be employed in place of BOLD when it is desirable to focus on purely vascular re-
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sponses, such as studies of a pathology which may have separate vascular and metabolic
components. Recent applications of ASL include characterization of cerebral vascula-
ture function by a measure of the hemodynamic response to changes in the arterial con-
tent of CO2 (PaCO2) [9, 188, 274]. In this modality of functional MRI, the functional
stimulus consists of experimental hypercapnia (increased levels of PaCO2), a vascular
stimulus inducing global increases in cerebral perfusion. The resulting functional maps
depict the spatial distribution of the cerebral vasculature reactivity (CVR) to CO2, an
index that may be used to estimate the brain’s vascular health. These CVR measures can
also serve to ‘calibrate’ the BOLD signal, i.e. to factor out the contribution of flow and
volume from the latter signal, allowing estimates of cerebral metabolic rate of oxygen
consumption (CMRO2) [44, 106, 158]. While CMRO2 estimates can be obtained with
other nuclear medicine imaging techniques, fMRI methods provide a measure that is
absolutely non-invasive. Functional MRI of the cerebral reactivity to CO2 may become
an important tool in the clinical assessment of both vascular and metabolic functions in
the brain; however, limitations in the ASL methods still pose a challenge to their broad
adoption.
ASL methods can be classified into pulsed and continuous types, or PASL and CASL
respectively. While in PASL the magnetic labeling, or inversion, of spins is achieved
instantly (<30 ms) using a magnetic pulse, in CASL spins are gradually inverted by a
continuous (typically 1-2 s) MR stimulation.
2.2 Continuous ASL
In CASL, a slice selective gradient defines a labeling plane intersecting the major
arteries of the neck while a low amplitude RF irradiation is continually (1-2 s) applied
to invert the spins that flow through that plane (Figure 2.1 right) [298, 308, 396]. From
entering to leaving the labeling plane the inflowing spins undergo what is denominated
a flow-driven adiabatic inversion [246]. Efficiency of this adiabatic inversion is a func-
tion of sequence parameters (viz. gradient strength and energy of the RF radiation) and
velocity of flowing spins [277]. During the labeling period, tagged spins travel from the
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PASL pCASL
Figure 2.1: PASL and pCASL labeling schemes. In PICORE PASL an inversion pulse (red)
is applied at the level of the neck to label a fixed volume of blood. After the inversion, at TI1,
saturation pulses are applied to the label slab to impose a fixed duration to the bolus tag. Image
(yellow) is acquired at TI2 when the entire bolus should have been delivered to the tissue. In
pCASL a long train of low-energy RF pulses (red) is applied below the imaging region, also at
the level of the neck. The blood spins passing through the labeling plane during the labeling
period undergo an adiabatic inversion, continually accumulating in the tissue. Image readout
(yellow) is played after a delay to allow complete delivery of tagged blood.
labeling to the imaging plane, gradually accumulating in the parenchymal tissue there.
The image is acquired after a delay, which is intended to minimize contribution of large
arteries to the perfusion signal and ensure that the perfusion quantification is accurate
[4, 265]. At the moment of acquisition, accumulation of spins in the parenchymal tissue
should have peaked and label signal be exhibiting a decay 1.
As mentioned above, efficiency of continuous labeling depends on the flow velocity
of spins crossing the labeling plane [404], which vary along the labeling period due to
the pulsatile nature of arterial flow [409]. Although sensitive to physiological variations
in arterial flow, CASL labeling efficiency is in fact estimated as the average efficiency
along the whole period of labeling, which will vary little from acquisition to acquisition;
at least under normal conditions. On the other hand, during hypercapnia, when flow
1. Labeled spins start to decay immediately after the label, however, as they accumulate in the
parenchyma, the labeled image signal increases despite the T1 decay. The label signal begins to decay
when blood delivery is complete.
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velocity in the main arteries can be significantly increased, drops in the mean label effi-
ciency of CASL might yield underestimated measures of perfusion – a concern for the
assessment of CVR.
A major concern that is common to virtually all ASL methods is the control over
off-resonance effects: the spurious effects of the labeling irradiation on the spins per-
taining to the image region [406]. The control is usually achieved by duplicating the
off-resonance effects of labeling on the control image so that the effect is cancelled in
the subtracted image. In CASL however, such control becomes impracticable in multi-
slice acquisitions due to the geometry of the labeling [74]. Off-resonance effects can be
minimized by performing the labeling with a dedicated coil of narrow radiation aper-
ture, placed directly over the region of the neck where flowing spins are to be labeled
[361, 424]. Nonetheless, the dual coil approach requires special hardware, has a strong
dependency on the labeling geometry and adds to the distance between the label and
imaging plane (which reduces the labeled image signal). An alternate method for the
control of CASL off-resonance effects in multi-slice imaging includes the amplitude
modulation (AM) of the labeling RF [5, 387]; however, the latter approach is excep-
tionally energy demanding and its labeling efficiency is usually limited due to safety
constraints for RF power deposition (particularly at high magnetic fields). Another ob-
stacle for the implementation of CASL methods is the limited support for the continuous
mode of RF irradiation offered by standard MRI hardware. Clinical scanners are opti-
mized for pulsed RF operation, often precluding the use of heavy duty cycles implicated
in CASL.
A recently introduced variant of CASL, named pseudo-continuous ASL (pCASL)
[72, 408], emulates the continuous labeling method by replacing the continuous RF ir-
radiation with a train of short pulses of approximately 500 µs duration; and creates the
control image based on the re-inversion of spins instead of mimicking the label pulse in
a distal plane. While more compatible with standard clinical MR hardware, this strategy
offers control over off-resonance effects in multi-slice imaging and also higher labeling
efficiency than the original continuous method.
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2.3 Pulsed ASL
In PASL, the labeling is achieved using a short and strong RF pulse (10-30 ms) that
instantaneously inverts a large volume of blood spins [403]. As opposed to CASL, PASL
labeling is insensitive to the velocity of spins, reaching a nearly optimum (∼95%) inver-
sion efficiency that is not affected by flow velocity [404]. Among the several different
PASL geometries, PICORE (Proximal Inversion of magnetization with a Control for
Off-Resonance Effects) is probably the most widely adopted scheme and the one which
most resembles the CASL approaches (Figure 2.1 left) [403]. As the name implies, in
PICORE PASL the labeling is applied proximal to the imaging plane, i.e. at the level
of the carotids and vertebral arteries. Slice selective gradients define a labeling band of
10-20 cm thickness, placed parallel to and nearly 1 cm below the imaging band. The gap
between the labeling and imaging bands is intended to preserve the spins in the imag-
ing band from spurious excitation due to imperfections in the spatial profile of labeling
pulses. Labeling is then followed by a delay to give time for the whole volume of tagged
blood to leave the labeling plane, cross the gap and arrive at the imaging region before
the readout (the interval is known as Time of Inversion, TI). For the acquisition of the
control image, the labeling pulse is repeated with a shift in its center frequency and in
the absence of the accompanying band selective gradient, which allows duplicating (con-
trolling for) the off-resonance effect of the labeled image without the effective labeling
of spins 2.
The signal of a PASL subtracted image – similarly to CASL – is proportional to the
amount of tagged blood that has accumulated in the tissue during the period between the
labeling and imaging readout. Put differently, the volume of tagged blood contributing to
the PASL signal is proportional to the blood flow (volume by unit time) multiplied by a
duration (time). However, the bolus of labeled blood created by the PASL labeling pulse
has a fixed volume, making it impossible to determine flow differences. Accurate flow
quantification is possible by acquiring a series of subtracted perfusion images at variable
inversion time delays from the inversion pulse and fitting the tag inflow curve with a
2. The spurious excitation of off-resonance spins in the imaging band (off-resonance effect) is further
mitigated by complementary fat saturation applied to the imaging band just prior to the labeling pulses.
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kinetic model of the bolus time dependence. Nonetheless, such variable TI techniques
are time consuming [248] and may not be an option, particularly in cases involving vas-
cular stimulation by hypercapnia. One approach to control for the label duration – hence
avoiding inaccuracies associated with changes in the latter parameter when estimating
flow with a single TI subtracted image – is to impose a fixed duration to the bolus by
saturating the MR signal in the tag region at a fixed time after the labeling pulse. This
is the essence of techniques such as Quantitative Imaging of Perfusion with a Single
Subtraction (QUIPSS) version II [405] and its variant Q2TIPS [241]. In Q2TIPS the
saturation consists of a series of saturation pulses applied to a thin slice at the distal end
of the tag band (proximal to the image band). These methods will ensure a fixed label
duration as long as the trailing edge of the tagged blood bolus does not exit the initial
tagging region before the saturating pulses are applied.
The initial, and most widely adopted, implementation of the QUIPSS II method used
an interval TI1 between the inversion and the onset of saturation pulses of 700 ms, with
a label band thickness of 100 mm [176, 389, 405]. The interval TI2 between the inver-
sion pulse and the excitation pulse for the first slice was 1400 ms. This study showed
that, at global CBF rates observed during rest or during moderate focal activation such
as that produced by finger tapping, the trailing edge of a 100 mm label bolus would take
longer than 700 ms to exit the initial tagging region (meaning that the QUIPSS II satura-
tion would control the tag duration). However, during global flow increases, which are
known to have a large impact on the flow velocity in the major arteries feeding the brain
[20, 303], it is quite possible that the trailing edge of the label bolus will clear the tag
region prior to TI1, rendering any QUIPSS II saturation pulses ineffective and creating a
situation that may underestimate flow. This concern can be mitigated to some extent by
using a thicker label slab (i.e. 150-200 mm), but in general there may always be some
level of global flow above which the control of label duration by spatially selective satu-
ration becomes ineffective. A comparison of results obtained with different tag widths is
shown in the Appendix I. It should be noted that wide tag bands accentuate the spurious
effect caused by imperfections in the label band profile; longer pulses or larger gaps may
be necessary to compensate for that, both of which tend to reduce SNR.
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2.4 Pulsed vs. Continuous ASL in measuring CO2-induced CVR
PASL has long been the predominant form of ASL, possibly due to simpler imple-
mentation and broader compatibility with available MRI hardware. CASL, which has
been actually the earliest ASL method proposed, offers several theoretical advantages
but its adoption has been limited due to the complexity of controlling for off-resonance
effects in multi-slice scans and the high transmitted RF power demanded. The recent in-
troduction of pCASL methods, which emulates the continuous irradiation with a pulsed-
like strategy, has allowed the more widespread adoption of the CASL approach [7].
A possible advantage of CASL, and variants such as pCASL, for quantification of
flow changes during hypercapnia (i.e. CVR) is that it provides an implicit control over
the label duration (the time-width of the label equals the labeling time). Such techniques
also offer an increase in the SNR of individual flow subtraction images, albeit at the
expense of a slightly lower imaging rate (which reduces statistical power). A potential
confound in CASL methods (including pCASL) is that the labeling efficiency may suf-
fer from B0 inhomogeneities [175]; and vary if there are large changes in arterial flow
such as in CVR measures [13]. However, because of the use of a short gap between
RF pulses in the pCASL implementation, the label efficiency is relatively insensitive to
potential field inhomogeneity effects at the typical labeling location for a range of flow
velocities. Dai et al. showed that pCASL label efficiency is at least 80% as long as field
inhomogeneity is within 3 ppm at 3T [72]. This value was estimated based on theoretical
calculations by Wu et al. [408] in which the flow velocity was varied from 20 to 80 cm/s,
and further verified experimentally in a recent study using phase-contrast MRI as the ref-
erence [13]. Dependency of labeling efficiency on flow velocity still poses a challenge
to CVR measures using CASL and variants.
A number of groups have published ASL measures of the increase in perfusion pro-
duced by hypercapnia. At the time of the present study, most other studies had used
pulsed ASL, whereas only two had used CASL or variants. Table 2.I summarizes stud-
ies (from 2000 to 2010) reporting measures of CVR using ASL and respective differ-
ences in in terms of instrumentation and vascular stimulus used (based on references
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[8, 13, 47, 60, 139, 188, 225, 256, 274, 293, 353]). CVR measures had been usually
reported using a massive average over grey-matter (GM) although some groups have
also been interested in measuring CVR in the visual cortex (VC) for other purposes (of-
ten to investigate the relationship between CVR and visually-evoked fMRI responses).
“Present data” refers to results obtained in this Chapter’s study. The type and sub-type
of labeling approach adopted, i.e. whether the labeling was pulsed or continuous, what
was the specific type of geometry and whether the sequence included any control for
label duration, are indicated in the second and third column: “ASL type” and “Vari-
ant.” As it can be seen, in that period, only two studies had reported CVR using the
continuous approach. The vast majority of studies used PASL PICORE with QUIPSS II
control for label duration. Next columns show, differences regarding sequence parame-
ters such as “slab” thickness and inversion times (“TI1” and “TI2”) in PASL; and label
duration in CASL (“duration”). Methods also differed with respect to the stimulus, i.e.
the hypercapnic “Manipulation”. Gas manipulations had been carried out mostly using
fixed-inspired method, and lately the RespirAct apparatus. The doses administered for
inhalation (“CO2 dose”) and elicited changes in end-tidal CO2 levels (∆PET CO2) are
also reported. And finally, the population studied (all healthy subjects), ASL CBF mea-
sures (“%∆CBF”) and computed “CVR” are given in the 3 right most columns. CVR
values shown in italics were not reported in the actual study; they have been computed
from reported changes in CBF and PET CO2.
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Paper ASL Type ASL variant PASL CASL Manipulation CO2 dose ∆PETCO2 Field Population ∆CBF CVR
slab 
(cm)
TI1 
(ms)
TI2 
(ms)
duration   
(s)
            
(%)
         
(mmHg)
            
(T)
          
(%∆)
                 
(Δ%CBF/mmHg)
Measured in GM
Stefanovic 2006 PASL PICORE / QUIPSS II 15 500 1100 – Fixed-inspired 5.0 8.0 1.5 adult 20 3
Stefanovic 2006 PASL PICORE / QUIPSS II 15 500 1100 – Fixed-inspired 10.0 21.0 1.5 adult 70 3
Nöth 2006 PASL PICORE / QUIPSS II 10 600 1300 – Rebreathing – 6.0 1.5 adult 24 4
Stefanovic 2006 PASL PICORE / QUIPSS II 15 500 1100 – Fixed-inspired 7.5 13.0 1.5 adult 50 4
Kastrup 2001 PASL FAIR – – 1200 – Fixed-inspired 5.0 13.0 1.5 adult 87 7
Kastrup 2001 PASL FAIR – – 1200 – Breath-Hold – – 1.5 adult 62 7
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – Fixed-inspired 10.0 11.3 3.0 adult 18 2
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – Fixed-inspired 5.0 3.3 3.0 adult 11 3
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – RespirAct – 4.7 3.0 adult 16 3
Present data PASL PICORE / QUIPSS II 16 700 1400 – RespirAct – 4.8 3.0 adult 14 3
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – Fixed-inspired 7.5 5.2 3.0 adult 13 3
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – RespirAct – 7.0 3.0 adult 20 3
Mark 2010 PASL PICORE / QUIPSS II 10 700 1300 – RespirAct – 10.0 3.0 adult 29 3
Chen 2010 PASL PICORE / QUIPSS II 15 700 1300 – RespirAct – -3.0 3.0 adult – 4
Chen 2010 PASL PICORE / QUIPSS II 15 700 1300 – RespirAct – -6.0 3.0 adult – 4
Chen 2010 PASL PICORE / QUIPSS II 15 700 1300 – RespirAct – 4.5 3.0 adult – 5
Nöth 2006 PASL PICORE / QUIPSS II 10 600 1300 – Rebreathing – 6.3 3.0 adult 29 5
Bulte 2009 PASL PICORE / QUIPSS II 10 700 1400 – Fixed-inspired 4.0 6.5 3.0 adult 30 5
Nöth 2008 PASL PICORE / QUIPSS II 10 600 1300 – Rebreathing – 5.7 3.0 adult 32 6
Chen 2010 PASL PICORE / QUIPSS II 15 700 1300 – RespirAct – 9.0 3.0 adult – 7
Hajjar 2010 CASL – – – – – Fixed-inspired 5.0 3.0 elderly – 1
Present data CASL pCASL – – – 1.5 RespirAct – 4.6 3.0 adult 20 4
Measured in VC
Present data PASL PICORE / QUIPSS II 16 700 1400 – RespirAct – 4.8 3.0 adult 25 5
Perthen 2008 PASL PICORE / QUIPSS II 10 600 1500 – Fixed-inspired 5.0 8.4 3.0 adult 47 6
Ances 2008 PASL PICORE / QUIPSS II 20 700 1500 – Fixed-inspired 5.0 6.5 3.0 adult 47 7
Leontiev 2007 PASL PICORE / QUIPSS II 20 700 1400 – Fixed-inspired 5.0 9.3 3.0 adult 81 9
Ances 2008 PASL PICORE / QUIPSS II 20 700 1500 – Fixed-inspired 5.0 8.1 3.0 elderly 79 10
Aslan 2010 CASL pCASL – – – 1.7 Fixed-inspired 5.0 8.9 3.0 adult 40 5
Present data CASL pCASL – – – 1.5 RespirAct – 4.6 3.0 adult 35 8
Table 2.I: ASL measures of CVR in the literature (2000-2010).
18
Although the reported CASL measures lay within the range determined with PASL,
the wide variation in gas manipulations used and small number of CASL publications
made it difficult to establish whether there was any systematic difference in apparent
reactivity. Considerably more data was available on resting blood flow measured using
both PASL and CASL methods, and the average baseline perfusion values indicated that
under resting conditions the two methods were comparable (Table 2.II, based on refer-
ences [23, 52, 57, 121, 154, 274, 275, 285, 298, 361, 384, 387, 412, 416]). While a num-
ber of recent studies had compared the sensitivity and quantitative results provided by
pulsed and continuous ASL sequences for both baseline flow and in neuronal activation
paradigms, there had been no systematic comparison of the performance of these two
types of ASL during hypercapnic manipulations. The objective of the following study
was therefore to provide such a comparison using a controlled hypercapnic manipulation
to ensure a high degree of reproducibility in the end-tidal CO2 values attained.
For the experiments in this study 10 healthy subjects, aged 18-35 were scanned in
a 3T MRI clinical system using a 32 channel head coil. We compared pCASL and PI-
CORE Q2TIPS (a type of PASL) using the commonly adopted TI1/TI2 of 700/1400 ms,
and a considerably thicker labeling slab of 16 cm. Hypercapnic manipulation was con-
ducted utilizing the TRI RespirAct system, which was set to produce controlled 5 mmHg
increases in the subjects’ end tidal CO2, two times along a 10 minute scan. Results of
this study have been published in the Journal of Magnetic Resonance Imaging. I and
co-authors have concluded that pCASL performs better than PASL in measuring global
perfusion changes associated with a mild hypercapnic challenge.
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Paper ASL Variant Field Population CBF in GM
(T)  (ml/100g/min)
PASL
Nöth 2006 PICORE / QUIPSS II 1.5 adult 48
Campbell 2006 QUASAR / QUIPSS II 1.5 elderly 57
Campbell 2006 QUASAR / QUIPSS II 1.5 adult 67
Wang 2002 FAIR 1.5 adult 74
Cavucola 2009 PICORE / QUIPSS II 3.0 - 52
Nöth 2006 PICORE / QUIPSS II 3.0 adult 55
Nöth 2008 PICORE / QUIPSS II 3.0 adult 56
Present data PICORE / QUIPSS II 3.0 adult 56
Ho 2010 QUASAR / QUIPSS II 3.0 adult 57
Cavucola 2009 FAIR 3.0 - 58
Glodzik 2010 FAIR 3.0 elderly 60
Cavucola 2009 QUASAR / QUIPSS II 3.0 - 61
Wang 2002 FAIR 4.0 adult 59
CASL
Biagi 2007 - 1.5 adult 58
Parkes 2004 - 1.5 adult 58
Ye 2000 - 1.5 adult 68
Parkes 2004 - 1.5 adult 68
Wang 2002 - 1.5 adult 70
Biagi 2007 - 1.5 teen 79
Biagi 2007 - 1.5 children 97
Pohmann 2010 pCASL 3.0 adult 37
Xu 2009 pCASL 3.0 elderly 43
Xu 2009 pCASL 3.0 adult 48
Wang 2005 - 3.0 adult 50
Talagala 2004 separate coil 3.0 adult 56
Present data pCASL 3.0 adult 57
Table 2.II: ASL measures of resting perfusion (2000-2010). This table brings a summary of
the studies reporting ASL measures of CBF during resting conditions. ASL measures differed
basically with respect to instrumentation: PASL and CASL variants (“ASL Variants”) and mag-
netic field strength (“Field”). CBF measures in GM are shown in the right most column.
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2.5 Stuty manuscript
Comparison of Pulsed and Pseudocontinuous Arterial Spin-Labeling for Measur-
ing CO2-Induced Cerebrovascular Reactivity
Authors: Felipe B. Tancredi, Claudine J. Gauthier, Cécile Madjar, Divya S. Bolar, Joseph
A. Fisher, Danny J. J. Wang and Richard D. Hoge
Status: Published in the Journal of Magnetic Resonance Imaging vol. 36, p. 312-321,
2012. DOI 10.1002/jmri.23658
Purpose: To compare the performance of pulsed and pseudocontinuous arterial spin-
labeling (PASL and pCASL) methods in measuring CO2-induced cerebrovascular re-
activity (CVR). Materials and Methods: Subjects were scanned using both ASL se-
quences during a controlled hypercapnia procedure and visual stimulation. CVR was
computed as the percent CO2-induced increase in cerebral blood flow (∆%CBF) per
mmHg increase in end-tidal PCO2. Visually evoked responses were expressed as ∆%CBF.
Resting CBF and temporal signal-to-noise ratio were also computed. Regionally aver-
aged values for the different quantities were compared in grey matter (GM) and visual
cortex (VC) using t-tests. Results: Both PASL and pCASL yielded comparable respec-
tive values for resting CBF (56±3 and 56±4 mL/min/100g) and visually evoked re-
sponses (75±5% and 81±4%). Values of CVR determined using pCASL (GM 4.4±0.2,
VC 8±1 ∆%CBF/mmHg), however, were significantly higher than those measured using
PASL (GM 3.0±0.6, VC 5±1 ∆%CBF/mmHg) in both GM and VC. The percentage of
GM voxels in which statistically significant hypercapnia responses were detected was
also higher for pCASL (27±5% vs. 16±3% for PASL). Conclusion: pCASL may be
less prone to underestimation of CO2-induced flow changes due to improved label tim-
ing control.
Key Words: ASL, Hypercapnia, Cerebrovascular Reactivity
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INTRODUCTION
Hypercapnia is known to elicit a global increase in cerebral blood flow (CBF) [85,
190], a phenomenon that has been exploited in various magnetic resonance imaging
(MRI) applications including measures of cerebrovascular reactivity (CVR) [186, 256]
and calibrated MRI for estimation of task-induced cerebral metabolic rate of oxygen
(CMRO2) changes [9, 158]. These techniques rely on arterial spin-labeling (ASL), which
provides dynamic and noninvasive images of CBF.
Pulsed ASL (PASL) has long been the predominant form of ASL, due possibly to
simpler implementation and broader compatibility with available MRI hardware. The
continuous approach (CASL), which was the earliest ASL method proposed [75], offers
several theoretical advantages but its adoption has been limited due to the complexity
of controlling for off-resonance effects in multislice scans and the high transmitted ra-
diofrequency (RF) power demanded. The recent introduction of pseudocontinuous ASL
(pCASL) methods, which emulate the continuous irradiation with concatenated series of
short RF pulses [408], has allowed the more widespread adoption of the CASL approach.
A major factor affecting the amplitude of the ASL subtraction signal is the dynamics
of label timing [4, 265, 414]. In PASL, techniques such as QUIPSS I and II [405], and
variants such as Q2TIPS [241], have been adopted to impose a fixed duration to the label
passage and hence avoid inaccuracies associated with changes in the latter parameter.
Label duration is controlled as long as the trailing edge of the tagged blood bolus does
not exit the initial tagging region before the saturating pulses are applied. During global
flow increases, which are known to have a large impact on the flow velocity in the major
arteries feeding the brain [258], it is possible that the trailing edge of the label bolus will
clear the tag region earlier, rendering QUIPSS saturation pulses ineffective and creating
a situation that underestimates flow.
A potential advantage of CASL (and variants such as pCASL) for quantification of
flow changes during hypercapnia is that it provides an implicit control over the label
duration. CASL also offers an inherently higher flow contrast, resulting in increased
temporal signal-to-noise ratio (SNR) of individual flow subtraction images, albeit at the
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expense of a slightly lower imaging rate (reducing statistical power). The longer min-
imum TR value typically associated with CASL techniques is less of a limitation for
hypercapnic manipulations, which tend to use relatively long block designs. A potential
confound is that CASL’s labeling efficiency may be altered by changes in the arterial
flow velocity [13, 298, 404].
A number of recent studies have compared the sensitivity and quantitative results
provided by PASL and CASL for both baseline flow and the local responses observed
in neuronal activation paradigms [61, 384, 404, 408], but there has been no systematic
comparison of the performance of these two types of ASL during hypercapnic manipu-
lations, and in fact very few hypercapnia studies to date have used CASL.
The aim of this study was to compare the performance of two ASL sequences in
measuring global CBF responses elicited by mild hypercapnia: one using the widely
adopted PICORE Q2TIPS pulsed labeling approach, and one using pseudocontinuous
labeling. The local flow responses stimulated by a visual paradigm were also examined.
MATERIAL AND METHODS
Ten healthy subjects were recruited for the study (two females, eight males, ages 24-
33). All subjects gave informed consent and the protocol was approved by the Research
Ethics Committee of our institution.
Functional MRI Protocol
Each functional imaging run consisted of three blocks of baseline alternated with two
blocks of stimulation, each lasting 120 seconds. In two runs the manipulation consisted
of a step increase in end-tidal PCO2 (PET CO2), while in the other two runs a visual
stimulus was used. The order of the conditions was randomly varied between subjects.
Visual Stimulation
The visual stimulus was a black-and-white radial checkerboard, contrast reversing
at 16 Hz. The stimulus was presented using an LCD projector (EMP-8300, Epson,
Toronto, ON, Canada) onto a translucent screen viewed by subjects through a mirror
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integrated into the Siemens head coil. The visual baseline was a uniform grey screen
with the same spatial mean luminance as the checkerboard pattern. Subjects breathed
atmospheric composition medical air throughout visual stimulation runs.
Hypercapnic Manipulation
PET CO2 and end-tidal PO2 (PET O2) were independently targeted via the admin-
istration of gases containing mixtures of O2, CO2, and N2 to a sequential gas-delivery
breathing circuit [341] by a computer-controlled gas blender [306] (RespirAct, Thornhill
Research, Toronto, ON, Canada). The RespirAct was programmed to maintain a con-
stant PET CO2 of 40 mmHg and PET O2 at 100 mmHg at baseline, and iso-oxic (PET O2
maintained at 100 mmHg) increase in PET CO2 by 5 mmHg for the hypercapnic stimu-
lus. PET CO2 and PET O2 were monitored continuously by the RespirAct and as a safety
measure pulse rate and arterial O2 saturation were also monitored using a pulse-oximeter
(InVivo Instruments, Orlando, FL).
The same grey screen and fixation marker used as the baseline condition in the visual
stimulation protocol was maintained throughout the hypercapnia runs.
MRI Acquisition
Imaging was performed on a 3 T scanner (TIM Trio, Siemens Medical Solutions,
Erlangen, Germany) using a 32-channel receive-only head coil. A T1-weighted anatom-
ical acquisition (MPRAGE with TR/TE/α = 2300/3ms/90◦ 64x64 matrix and 1 mm3
resolution) was followed by four functional scanning runs.
Each of the stimulation paradigms (hypercapnia and visual) were carried out with
both types of ASL scan (PASL and pCASL). Pulsed ASL was performed using the
PICORE labeling geometry [403] with a tag width of 160 mm and a 10 mm gap. The
Q2TIPS method [241] was used with TI1/TI2 = 700/1400 ms and stop time 1350 ms.
Other sequence parameters were TR/TE/α = 2000/10ms/90◦
In the pCASL acquisitions, labeling was performed over a 1.5-second period using
a series of 25◦ Hanning window-shaped RF pulses of 500 µs duration and separated by
360 µs gaps. These were applied along with a 6 mT/m gradient and the labeling plane
was placed 100 mm below the center of the imaged volume. A postlabeling delay of
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900 ms was used, while other sequence parameters were TR/TE/α = 3000/10ms/90◦.
For both types of ASL the same gradient-echo EPI with fat saturation was used
(slices 6 mm thick, 1 mm gap, 4 mm in-plane resolution, 64x64 matrix and bandwidth
of 3 kHz/pixel), using a partial k-space acquisition factor of 7/8 and GRAPPA parallel
imaging (acceleration factor of two [131]). In the PASL scans six slices were acquired,
while 16 slices were imaged in the pCASL acquisitions. The different numbers of slices
were due to implementation details of the respective ASL sequences; care was taken in
subsequent analyses to control for this. The stack of oblique axial slices were positioned
to maximize coverage of the occipital lobe and oriented along a plane passing through
the trunk and splenium of the corpus callosum.
Image Analysis
All MRI data were analyzed using the Neurolens software package (www.neurolens.org).
Image series were first motion-corrected [69], spatially smoothed (6 mm full-width at
half-maximum [FWHM] 3D Gaussian kernel), and intensity normalized. The flow-
weighted signal was then isolated using linear surround subtraction. Voxel-wise CBF
response amplitudes for each condition (visual stimulation or hypercapnia, henceforth
referred to as “visual” or “CO2” conditions) were then estimated by fitting the time-
course data with a general linear model (GLM) consisting of a block response term
(convolved with a single-gamma hemodynamic response function: HRF time-to-peak =
5.4 sec, FWHM = 5.2 sec) [123] plus a third-order polynomial to model resting flow
and drift. Global CBF responses to hypercapnia were estimated by defining a grey mat-
ter (GM) region of interest (ROI) mask for each subject. These ROIs were generated
through segmentation of the MPRAGE acquisition and resampled to the spatial resolu-
tion of the ASL scans 3.
To estimate CBF responses in visual cortex (VC) evoked by the visual and hypercap-
nic stimuli, ROIs were defined based on activation maps for the visual stimulation data
(circular bias was avoided through steps described below). For both ASL types a VC ROI
was first derived from the visual activation map by thresholding the T-maps at P < 0.001
3. A more detailed description of this procedure is given in next Chapter’s manuscript.
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and manually removing activated regions outside the occipital lobe. Visual stimulation
responses achieved very high significance in most subjects with both techniques, permit-
ting a more stringent threshold P value (0.001) than was later used to assess the detection
power for hypercapnic responses (P < 0.05). The large visual response meant that the
statistical detection of visual responses was substantially “overpowered,” making the
visual ROI largely insensitive to the exact threshold used (mitigating concerns about
potential circularity in this approach).
The threshold T-values were determined as described in [407], which takes into ac-
count the brain volume imaged and effective spatial resolution to correct for multiple
comparisons. This resulted in slightly different threshold values for different subjects
and scan techniques, but these were all very close to an average threshold value of 5.6.
To remove the impact of total volume coverage on thresholding, this average threshold
value was used in all 18 functional scans.
Since VC masks based on activation masks from a specific technique (referred to
as “technique-specific VC”) are likely to emphasize voxels with large responses in the
respective method, we also generated VC masks that were the “union,” or “intersection”,
of the technique-specific VCs (referred to as union and intersection VC ROIs, respec-
tively). Technique-specific VC ROIs were utilized to compare the results that would be
obtained in studies based entirely on one of the two ASL types. To rule out possible bias
from ROI differences, we also performed comparisons using common VC ROIs, i.e. the
union or intersection VC ROIs.
To determine response amplitudes during visual stimulation and hypercapnia, the av-
erage GLM “effect-size” (based on the fit parameters, or β ’s) within the ROI was used as
the response amplitude, which was then divided by the ROI-averaged baseline (constant)
term from the same model fit (β0) and multiplied by 100 to convert to percent change.
ROI-averaged time series were similarly expressed in percent change by normalizing the
signal to the constant fit term after removing drift terms from the GLM fit.
We computed the mean PET CO2 values for the different conditions (normocapnia
and hypercapnia) and the true PET CO2 increase as the difference between them (tran-
sition phases were excluded). The ROI-average CVR was computed by dividing the
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average percent change in CBF within the ROI by the PET CO2 increase in mmHg.
We also computed the ROI-averaged temporal SNR (tSNR) for baseline flow and
T-values for both baseline flow and functional responses from the model fit. The number
of voxels for which the T-value exceeded a threshold corresponding to P < 0.05 was
also determined for the different conditions. The tSNR was defined as the baseline CBF
signal amplitude (from the constant term of the GLM model fit), divided by the root-
mean-square value of the residual error between the measured signal at each voxel and
the modeled signal. The use of GLM residuals, as opposed to simple mean and standard
deviation values, provides stability measures, which we feel are more closely linked to
statistical detection power.
A T-value for the estimate of baseline CBF was also computed (i.e. testing the hy-
pothesis that resting CBF was different from zero) as the constant term of the GLM
model fit divided by the residual standard error (equivalent to the residual standard de-
viation adjusted for the number of images, and hence degrees of freedom, in the series).
Similarly, T-values were computed for the response amplitudes during visual stimulation
and hypercapnia. As a metric of the sensitivity of the two ASL methods for detection
of resting flow and visual or hypercapnic responses, we first determined the number of
voxels for which the T-value for the condition in question exceeded a threshold corre-
sponding to P < 0.05 (corrected). The number of detected voxels was then divided by
the total number of voxels in a given ROI (either GM or VC).
Maps of absolute flow – baseline and response to hypercapnia – were also generated
using Eq. 1 in Ref. [385] for PASL and Eq. 1 in Ref. [386] for pCASL. For PASL, the
following parameter values were used: blood-brain partition coefficient = 0.9, labeling
efficiency = 0.95, blood T1 = 1.49 seconds, GM T1 = 1.4 seconds. The same parameters
were used for pCASL, except that a labeling efficiency of 0.80 [408] was assumed.
Baseline values were subsequently averaged within GM.
As the final analysis step, group averages were computed for percent effect-sizes,
the ASL time series, CVR, tSNR, T-value, absolute baseline flow, and detection rate.
Results are always shown as the group mean ± standard error (SE).
Based on the above averages, we tested the hypothesis that PASL estimates of CVR
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are systematically lower than those obtained using pCASL by comparing measures from
the respective techniques in a one-tailed Student’s t-test. tSNR, T-values, and voxel
counting were also compared using a one-tailed t-test. The resting flow values from the
two methods were compared using a two-tailed t-test.
For qualitative comparisons, unthresholded maps of absolute CBF, tSNR, and vari-
ous response measures such as effect-size, T-value, and ∆CBF were overlaid on high-
resolution anatomic T1 scans. Unthresholded maps were used because this provided the
truest depiction of sensitivity and specificity in the data (thresholding can introduce an
“iceberg effect,” in which slightly subthreshold peaks or regions are obscured).
RESULTS
Data from one subject could not be used due to excessive artifacts in one of the PASL
series.
Functional Response Signals
Figure 2.2 shows ROI average time courses recorded using the two ASL methods
during visual stimulation and hypercapnia. For hypercapnia, signals are shown for both
GM and VC ROIs. It is qualitatively evident that the pCASL signals exhibit consistently
better stability. Both techniques yield clearly discernible visual responses.
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Figure 2.2: ASL signal time courses. ASL signal time courses. Evoked CBF response signals
for PASL (left) and pCASL (right) during visual stimulation and hypercapnia. ROI average
signals are shown for hypercapnia in ROIs throughout all GM and also restricted to VC. Shaded
regions in the plots indicate the 2-minute blocks of stimulation.
Baseline and CO2 Response Maps
Both PASL and pCASL maps of baseline blood flow, shown in rows 2 and 3 of
Fig. 2.3, provided a clear delineation of cortical anatomy – comparable to segmented
GM masks shown in top row of the same figure – revealing the expected perfusion con-
trast between grey and white matter. Baseline CBF values measured in GM were 56±3
and 56±4 mL/min/100g for PASL and pCASL, respectively. Maps of the baseline tSNR
(4th and 5th rows) were computed by dividing the baseline blood flow signal (i.e. the
effect size from the contrast selecting for the constant term in the linear model) by the
residual standard deviation. The tSNR of PASL in GM was generally lower and more
heterogeneous than that of pCASL. The bottom two rows of Fig. 2.3 show maps of the T-
value for the resting flow signal, in which the baseline effect was divided by the residual
standard error (taking into account the different imaging rates) instead of the standard de-
viation. This indicates that the improved per-image tSNR of pCASL and higher imaging
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rate of PASL balance each other [13], resulting in roughly equivalent overall statistical
power for detection of baseline flow in both cases.
Figure 2.3: GM masks and baseline flow maps. The top row shows automatically segmented
GM masks (red color scale) for all subjects. Subsequent rows show baseline flow maps, at the
corresponding locations, acquired using PASL and pCASL (in alternating rows). Rows two and
three show maps of absolute flow in units of mL/min/100g. Rows four and five show the SNR
(β0 divided by the GLM residual SD) for resting blood flow during the hypercapnia runs. Rows
six and seven show corresponding maps of T-statistic (β0 divided by GLM residual SE).
T-maps computed for the response to hypercapnia (Fig. 2.4, rows 1 and 2) generally
exhibited large variations in sensitivity over cortical GM for both techniques. However,
this is likely due to spatial variations in the tSNR. Inspection of the raw effect-size maps
for this response reveals more homogeneous apparent flow responses throughout cortical
GM (rows 3 and 4), particularly for the pCASL sequence (statistical inference is not pos-
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sible with these maps, but they are a more direct reflection of the response amplitude).
Maps of absolute DCBF (bottom two rows) exhibited similar patterns to the effect-size
maps.
Figure 2.4: Hypercapnia response maps. Rows one and two show maps of T statistic for
the CBF response to hypercapnia as measured using PASL and pCASL, respectively. The color
mapping for T statistic values has been adjusted so that the transition from yellow to orange,
indicated by the star, corresponds to P < 0.001 (corrected). Rows three and four show maps of
the GLM effect sizes of the CBF response. Rows five and six show the size of the flow change,
given in mL/min/100g.
Visual Response Maps and ROIs
In spite of the differences observed between subjects and pulse sequences for CO2
responses, both PASL and pCASL resulted in similar maps of visual activation, demon-
strating good sensitivity and specificity as indicated in the statistical maps shown in the
top two rows of Fig. 2.5. These maps allowed calculation of visual ROIs for use in the
other quantitative analyses shown below. The ROIs thus computed were of generally
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comparable extent and position for both methods.
Figure 2.5: Visual response maps and VC masks. Rows one and two show maps of T statistic
for the CBF response to visual stimulation for PASL and pCASL data, respectively. The color
mapping for T statistic values has been adjusted so that the transition from yellow to orange,
indicated by the star, corresponds to P < 0.001 (corrected). Rows three and four show ROIs
encompassing VC in the different subjects, based on the visual activation data from the respective
ASL sequences (green for PASL, red for pCASL).
Temporal SNR of Baseline CBF
Group average tSNR for GM and VC is shown as bar graphs in Fig. 2.6A. The
tSNR values computed for pCASL were generally higher than those found for PASL, a
difference that achieved statistical significance (P < 0.01) in the GM ROI. Respective
tSNR values for PASL and pCASL in GM were 1.9±0.1 and 2.4±0.2; those in VC were
2.4±0.1 and 2.7±0.2.
In spite of the higher tSNR of pCASL (Fig. 2.6A), the increased imaging rate of
PASL resulted in equivalent statistical power in the two types of image series, leading to
similar detection rates for resting blood flow in GM voxels, as shown in Fig. 2.6B. The
respective percent detection rates for resting CBF in GM voxels with PASL and pCASL
were 93±2 and 95±1. Resting CBF detection rates within the VC mask (i.e. the fraction
of voxels within the VC that exhibited baseline flow signal significantly different from
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0) were 98.1±0.8 (PASL) and 97.5±0.9 (pCASL). Average T-values for resting CBF in
GM were 23±2 (PASL) and 25±2 (pCASL); T-values in VC were 29±2 (PASL) and
26±3 (pCASL).
Figure 2.6: Temporal SNR and sensitivity for baseline flow. a: tSNR for baseline CBF
(mea±SE) computed in GM and VC. b: Percent of GM and VC voxels with statistically sig-
nificant baseline flow signal.
Functional Flow Changes
The ability to impose targeted changes in PET CO2 allowed us a high degree of re-
producibility of the stimulus. Nonetheless, while individual results demonstrated con-
trol within a tolerance of ±2 mmHg in different individuals and scans, the range of
CVR measures in GM was much larger in PASL than in pCASL ([0.7-6.1] vs. [3.0-5.2]
∆%/mmHg, respectively).
Figure 2.7 shows percent flow increases in response to hypercapnia and visual stim-
ulation obtained using the two ASL sequences in different ROIs (converted, in the case
of hypercapnia, to a CVR index by dividing by the increase in PET CO2). Both methods
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show comparable values for the visually evoked flow increases, with the exception of
values averaged over the union VC ROI, which were significantly different. For the hy-
percapnic responses, PASL resulted in apparent CVR values that were systematically and
significantly (P < 0.05) smaller than those measured using pCASL. This was observed
using ROIs covering both all GM and VC. Comparisons were repeated using different
criteria for the VC ROIs (i.e. technique-specific, intersection, and union VC ROIs) and
these were found to provide consistent results in all cases.
Figure 2.7: CBF responses to hypercapnia and visual stimulation. a: CVR to hypercap-
nia measured in GM and VC ROIs. b: ∆%CBF values for visual stimulation in VC. c: CVR
measured in VC as delineated using alternate ROI selection criteria: 1) technique-specific (this
approach is used in A); 2) intersection; and 3) union.
Results for individual subjects and group averages are summarized in Table 2.III.
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Table 2.III: Individual Baseline Flow and Responses. ∆PET CO2 is the increase in end-tidal CO2 during the hypercapnia scan. Columns
2 and 5 show baseline flow values measured in gray matter (GM) and in the visual cortex (VC) ROIs, respectively. ROI-averaged percent
changes, i.e. flow responses, are shown in columns 3, 6, and 8. Columns 4 and 7 show cerebrovascular reactivity (CVR) values, computed
as the flow response per mmHg of ∆PET CO2.
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Figure 2.8A shows the average T-values for the hypercapnic response in GM and
VC, while Fig. 2.8B shows the corresponding detection rates (the two measures convey
related but not identical information about the distribution and extent of the apparent
response). The average T-value provided by pCASL for CO2 response in GM was greater
(P < 0.03) than that measured with PASL. The PASL average T-value was 2.0±0.3,
while that obtained with pCASL was 2.9±0.4. PASL and pCASL average T-values of
CO2 response in VC were: 3.9±0.6 and 5.2±0.6. The difference between the latter
values was only marginally significant (P < 0.08) with both values higher (P < 0.05
and P < 0.005) than the correspondingT-values computed in GM. The pCASL sequence
detected GM responses to hypercapnia at a significantly higher rate (27±5%) than PASL
(16±3% detection). In VC the corresponding detection rates for the CO2 response were
56±7 and 42±9.
Figure 2.8: Average T-values and detection power for hypercapnic responses. a: Average
T statistic values (mean±SE) for the CBF response to hypercapnia measured in GM and VC. b:
Percent of GM and VC voxels showing statistically significant response to the stimulus.
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Visual responses measured by PASL and pCASL in V1 were similar. Although the
extent and amplitude of the pCASL response tended to be larger, the differences did
not achieve statistical significance. The visual detection counts for PASL and pCASL,
respectively, were 290±60 and 400±100 voxels (counts instead of percentage rates are
used here because no independent segmentation of VC was available as in the case of
GM). The visually evoked percent change in CBF measured by PASL was 75±5%, while
that measured by pCASL was 81±4%. Average T-values in V1 for the visual activation
were 9.6±0.8 for PASL and 9.7±0.9 for pCASL. ROI average values quoted here are
for technique-specific VC ROIs.
While the visually evoked flow response may be stronger than the response to a mild
hypercapnic stimulus, the response is local, limited to the VC. The VC, although exten-
sive, is just a fraction of the total volume of the brain, and so is the brain’s total flow
increase with respect to the local flow increase. We found that the GM averaged flow
percent change during visual stimulations were 5±2% and 7±3% for PASL and pCASL,
respectively. These two figures correspond to ≈40% of the flow changes in GM as com-
puted to the hypercapnic stimulus.
DISCUSSION
In this study we compared the performance of pulsed and pseudocontinuous ASL
sequences for measuring global CBF responses elicited by mild hypercapnia. We also
compared results obtained for resting cerebral blood flow and focal visual stimulation.
A number of differences were noted, which may be due to the different temporal char-
acteristics of the two labeling approaches.
Early implementations of the QUIPSS II method [403] used an interval TI1 between
the inversion and the onset of saturation pulses of 700 ms, with a label slab thickness
of 100 mm (the limited thickness probably due to use of a transmit-receive head coil
for inversion). This initial report showed that, at global CBF rates observed during
rest or during moderate focal activation such as that produced by finger tapping, the
trailing edge of a 100-mm label bolus would take longer than 700 ms to exit the initial
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tagging region (meaning that the QUIPSS II saturation would control the tag duration).
However, during global flow increases, which are known to have a large impact on the
flow velocity in the major arteries feeding the brain, it is quite possible that the trailing
edge of the label bolus will clear the tag region prior to TI1, rendering any QUIPSS II
saturation pulses ineffective and creating a situation that may underestimate flow. This
concern can be mitigated to some extent by using a thicker label slab (i.e. 150-200 mm)
as done in the present study, but in general there may always be some level of global
flow above which the control of label duration by spatially selective saturation becomes
ineffective.
In CASL, the control over the label duration is implicit, thus relieving the latter
concern. Such techniques also offer an increase in the tSNR of individual flow subtrac-
tion images, although the imaging rate is typically somewhat lower; and a reduction in
variability due to pulsatile changes in flow velocity during the cardiac cycle. A poten-
tial confound in CASL methods (including pCASL) is that the labeling efficiency may
suffer from field inhomogeneities, and vary if there are large changes in arterial flow.
However, because of the use of a short gap (360 ms) between RF pulses in our pCASL
implementation, the label efficiency is relatively insensitive to potential field inhomo-
geneity effects at the labeling location. Dai et al. showed that efficiency is at least 80%
as long as field inhomogeneity is within 3 ppm at 3T. This value was estimated based
on theoretical calculations by Wu et al. in which the flow velocity was varied from 20
to 80 cm/s, and further verified experimentally in a recent study using phase-contrast
MRI as the reference.
Our results in indicate that the intrinsic per-image tSNR of the continuous method re-
mains higher (Fig. 2.3, 4th and 5th rows; Fig. 2.6A). The increased imaging rate of PASL,
however, compensates for this, as shown by the maps of T-value (Fig. 2.3, last two rows)
and the number of voxels after thresholding of T-maps (Fig. 2.6B). Indeed, PASL and
pCASL provide maps (Fig. 2.3, 2nd and 3rd rows) and absolute values of baseline flow
that are virtually indistinguishable (Table 2.III), indicating that both methods are good
candidates for imaging and quantifying resting CBF in healthy volunteers. Neverthe-
less, different results might be obtained in the case of abnormally slow flow rates, as
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these could exacerbate T1 label decay, which is more prevalent in pulsed methods.
The most notable differences between the two ASL methods were found in the de-
piction of the hypercapnia responses. Inspection of the T-maps for the CO2 manipu-
lation (Fig. 2.4, first two rows) reveals that the anticipated pattern of GM response is
poorly demonstrated for most subjects in both PASL and pCASL. This is surprising,
since BOLD data during comparable manipulations consistently indicates a very strong
hemodynamic response throughout GM. However, the effect-size maps give a more di-
rect indication of the response amplitude (middle two rows) than the T-maps, in which
there is a division by the residual standard error. It is likely that the spatial patterns seen
in the T-maps are largely driven by the spatial patterns of noise, which tend to obscure
the globally uniform GM flow response. When the effect-size maps are considered, it
is apparent that pCASL provides a more reliable depiction of the global GM response
(note lack of PASL response in large areas of cortical GM in subjects 2, 3, 4, and 7). Al-
though the effect-size maps provide a qualitative depiction of the response pattern, they
are closely related to maps of absolute change, which can be computed using the ap-
proach described above for resting CBF. Quantitative maps of ∆CBF (bottom two rows)
are computed in this way and the response measured by pCASL appears to demonstrate
a more uniform depiction of GM flow increases.
The meanT-value for hypercapnic response within the GM and visual ROI masks was
consistently higher for pCASL, achieving statistical significance for the average over
the GM mask (Fig. 2.8A). This corresponded with increased voxel detection rates by
pCASL for hypercapnia, as shown in Fig. 2.8B. This latter bar graph shows the percent-
age of voxels within the GM and VC masks in which the ASL T-values for hypercapnic
response exceeded a threshold corresponding to P < 0.05 (corrected). Since it can be
assumed that, in reality, all GM voxels underwent increased blood flow in the healthy
volunteers imaged in this study, the low detection rates indicate that thresholded T-maps
of hypercapnic CBF response are likely to be unreliable for the assessment of CVR,
regardless of ASL technique.
Figure 2.7 shows estimated CVR values as measured with PASL and pCASL. The
estimated CVR values provided by pCASL are significantly higher than those measured
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with PASL in both regions GM and VC. This difference was apparent regardless of the
ROI prescription method used (technique-specific, intersection, or union). In contrast,
the visually evoked responses were not significantly different, except when averaged
over the union of activated areas detected by both methods. This is probably due to
both the large amplitude of the visually evoked response and the fact that pulsed ASL
tag dynamics are less affected by focal than by global flow changes. It should be noted
that, in spite of the large peak amplitude of the visual flow response, when averaged over
all GM it represents a substantially smaller increase in whole-brain blood flow (7±3%
via pCASL) than hypercapnia (20±1). The difference found for the union ROI can be
explained by the fact that pCASL tended to yield visually evoked changes over a more
extensive region than did PASL.
Although similar responses were observed for focal flow increases, our results show
a systematic reduction in the apparent CO2-induced flow increase measured with PASL
relative to values obtained with pCASL. The demonstration that PASL and pCASL yield
virtually indistinguishable values for resting CBF, as well as for visually evoked flow
responses, reinforces our suspicion that global physiological manipulations like mild
hypercapnia pose a special challenge for PASL methods. Our results suggest that typical
implementations of PASL may fail to control tag timing at high CBF rates, thereby
underestimating CBF responses.
In conclusion, the use of pCASL instead of PASL may help improve the sensitivity
and accuracy of MRI measurements relying on global manipulation such as measure-
ments of CVR and CMRO2.
The lack of a “gold standard” measure of CVR prevents us from ruling out the pos-
sibility that pCASL is also affected by sources of systematic error during hypercapnia,
such as reductions in labeling efficiency as postulated by Aslan et al. [13] (who postu-
lated a 36% underestimation of the CBF change during a 9 mmHg increase in PET CO2,
which could imply an underestimation of CBF change in our 5 mmHg manipulation by
up to 20%). Further study using methods such as phase-contrast flow quantification is
clearly warranted. Another promising avenue of investigation is the use of pulsed or
continuous ASL methods with variable delay times[155], which allow measurement of
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the tag inflow curve and, by fitting with kinetic models, quantitative estimation of CBF.
These may help refining and validating single-subtraction versions of ASL techniques.
CHAPTER 3
CO2 MANIPULATIONS
The specific objective of this study was to compare CVR measures obtained using a
variety of approaches to manipulate CO2 levels, including breath-hold and two different
gas administration methods.
]
3.1 Blood and respiratory gases
One of the primary functions of the vascular system is to permit the many tissues of
the body to exchange gases with the environment [138]. The blood that is pumped by the
left ventricle of the heart circulates through the arterial vascular tree carrying O2 to be
consumed in oxidative metabolism in the tissues. The blood about to perfuse the tissues
is rich in O2 and called arterial blood. At the same time it delivers O2, the perfusing
blood removes byproducts of metabolism from the tissue, mostly CO2. Following these
exchanges, blood leaves the tissue low in O2 and high in CO2, being named venous
blood. Blood re-arterialization, i.e. O2 replenishment and CO2 elimination, takes place
at the lungs, two organs allowing a protected interface between blood and the external
environment – the blood-air-barrier (BAB) – through which gases can passively diffuse.
In the lungs, most of the incoming blood consists of the venous blood resulting from the
systemic gas exchanges, that is pumped by the right ventricular chamber of the heart.
The blood that leaves the lungs is arterial blood that will flow back to the heart and refill
its left chambers for recirculation.
The rate of gas exchange between blood and air, i.e. arterialization of venous blood,
depends on the pressure gradients across the BAB, and these are determined by the
composition of inspired air and minute volume (the volume inspired per unit time) [242].
When breathing air with atmospheric composition at rest, a ventilatory rate between 6
to 12 breaths per minute is necessary to keep an adequate gradient across the BAB.
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When such gradients are disturbed, either by changes in minute volume or in inspired
concentrations, blood will leave the lungs and perfuse the body with different amounts
of O2 and CO2 than those normally occurring: if loaded with higher amounts of CO2 the
arterial blood is denoted hypercapnic; if depleted of CO2, it is denoted hypocapnic.
There has been increasing interest in assessing cerebrovascular function using fMRI
measures of the perfusion changes induced by manipulations in arterial CO2 content
[93]. The CO2 manipulation in these type of applications often consists of hypercap-
nia induced by the administration of CO2-enriched gas mixtures [256] or breath hold-
ing [269], although some groups have also been interested in drug-induced hypercapnia
[336], and others in hyperventilation maneuvers inducing hypocapnia [347].
3.2 Administration of inspired gases in fixed concentrations
The “fixed inspired CO2” manipulation method (FI) consists of administering CO2-
enriched gas mixtures of fixed composition for inhalation [188]. The mixture is usu-
ally composed of 5% of CO2 balanced with air, which, while keeping inspired O2 at
95% of its normal levels, shifts partial pressure of inspired CO2 from 0 mmHg to 38
mmHg. This causes a steep decrease in the gradient of CO2 diffusion across the BAB,
reducing the ability of the blood to clear this gas and yielding hypercapnia 1. With the
incomplete arterialization of venous blood, PaCO2 raises in a continuous fashion, as re-
vealed by end-tidal PCO2 (PET CO2) monitored samples. This process depends on sev-
eral physical/physiological parameters (minute volume, baseline levels of arterial and
venous PCO2, the size of CO2 compartments such as lungs, blood and muscular tis-
sue, etc) but that can be modeled as an exponential growth of just two distinct phases.
This approximation provides robust estimates of PaCO2 increases. Because in CVR
measures the changes in cerebral perfusion can be normalized to the latter quantity, the
variable PaCO2 outputs produced by the FI methods are less of a concern. However,
1. For highly concentrated mixtures (≥7%) it is possible that the the gradient of CO2 across BAB
reverses, leading to a situation where blood will absorb CO2 for a certain period until venous CO2 levels
surmount the inspired concentration and re-reverse the gradient. The discussion will be limited to 5%-CO2
mixtures.
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in experiments depending on a stable plateau of hypercapnia for more prolonged ac-
quisition [149] or in those requiring specific hypercapnic challenges [30], the variable,
unrestrained, PaCO2 output might represent a limitation. Also, there may be an increase
in minute volume and PaO2 associated to CO2-induced air hunger [400]. The possible
increases in PaO2 during the manipulation might influence CO2 reactivity measures and
represent an additional limitation of the method.
To summarize, in FI methods the gas input is fixed whereas the resulting PaCO2/PaO2
output is uncertain. Even though FI is the most commonly employed method of hy-
percapnic manipulation there are some concerns about its applicability in experimental
settings requiring a stringent control over the latter variables.
3.3 Prospective targeting of CO2 and O2 levels
The targeting of specific end-tidal levels is possible using feed-back computer con-
trolled gas mixing systems that can quickly adjust inspired doses according to monitored
values of respiratory gases [206, 400]. However, these systems may be bulky, difficult
to replicate and operate at high flow rates. Alternatively, the RespirAct marketed by
Thornhill Research Inc is a compact gas administration system that produces controlled
modulations in respiratory gases using a prospective, feed-forward approach, which min-
imizes gas consumption [306, 348].
The RespirAct system is supplied with 4 gas mixtures 2 of different composition:
one with 100% O2 ; one with 21% O2 / 79% N2 ; one with 10% O2 / 90% N2 ; and
one with 20% CO2 / 10% O2 / 70% N2 3. The gas delivery circuit accompanying the
system allows controlling the volume of inspired gas (as long as the subject empties the
bag with delivered mixtures at each breath). Based on demographic, physical and esti-
mated physiological input data the system computes the sequence of gas compositions
and volumes to be administered in order to achieve a desired hypercapnic output. Most
likely, the system estimates the size of the lungs’ different compartments (i.e. inspira-
2. The system needs all four connections to properly operate. A fifth gas mixture is required for
calibration
3. As a safety measure, the system does not use any mixture with less than 10% O2 .
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tory and functional residual capacities), the arterio-venous CO2 difference and the body
CO2 storages, to determine the PET CO2 respiratory response function 4 and with that
information generates the input that should give rise to the prescribed output. To pro-
duce a step change in PET CO2, for instance, the RespirAct system delivers particularly
highly concentrations of CO2 at the beginning of hypercapnic blocks to force a rapid
transition of CO2 levels in the lungs (< 3 breaths); then, by gradually decreasing the
amount of CO2 delivered during the block it keeps PET CO2 steady, maintaining a sta-
ble hypercapnic level [18]. Perhaps more importantly, the possibility of independently
targeting PET CO2 and PET O2 allows reproducing sharply defined hypercapnic plateaus
while avoiding incidental changes in PET O2 [172].
The Respiract method is indisputably valuable for certain applications and for a more
sophisticated characterization of the cerebral vasculature. However, the method adds
complexity to the gas manipulation. Other than requiring the proprietary TRI RespirAct
device, a RespirAct experiment involves 5 gas mixtures and disposable delivery circuits
that are usually more expensive than the medical masks used in FI methods. The method
also requires more time for preparation. Furthermore, it consists of a gas administra-
tion technique that relies on compliance by the subject. As previously mentioned, the
RespirAct system delivers a volume×dose for inhalation and to ensure an effective ma-
nipulation subjects need to empty the fresh gas reservoir at every breath. Lastly, the
mask is fit on to the subjects’ face using adhesive tape to seal the edges, which can be
uncomfortable, difficult for individuals with facial hair, and makes the mask harder for a
subject to remove rapidly if they so desire. It may be possible to determine CVR using
simpler means.
3.4 Breathing maneuvers
A very simple an readily available means to induce hypercapnia is to perform a
breath-hold (BH) [159, 187, 269]. By suspending elimination of CO2, PaCO2 will natu-
rally rise, following an logistic growth that (probably) resembles the one observed dur-
4. i.e. its theoretical model would be able to estimate the bi- or multi-exponential PET CO2 response
issuing from a FI step change in inspired CO2
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ing the FI manipulation. Since the breath-hold imposes a general suspension of gas
exchange across the BAB, it also results in a significant decrease in PaO2, an effect that
might confound estimates of CO2 reactivity. Besides, accurate estimates of the respira-
tory responses are challenging. These can be obtained from the difference between two
end-tidal points, one sampled immediately before and one immediately after the breath
hold [269]. For that, subjects are asked to perform the breath-hold at some point during
the expiratory phase and then, at the end of the breath-hold, give a small forced exhale.
However, when the forced exhale is not sufficient to allow the sampling of alveoli gases,
respiratory responses are underestimated. Other concerns related to the method include:
1) the short duration and small magnitude of the stimulus, which might render the de-
tection of vascular responses difficult as the ASL signal is very noise; 2) the possible
discomfort associated with apnea; and 3) difficulty complying with instructions.
As an alternative to breath hold, some groups have explored CO2 manipulations
based on hyperventilation and hypocapnia 5 [347, 382]. Hypocapnia can be sustained for
prolonged periods without much discomfort and PET CO2 levels are continually available
during hyperventilation. More importantly, the method is widely available. Nonetheless,
the comparison between CVR measures obtained with hyper- and hypocapnic methods
should be done with care. The perfusion changes measured with hypocapnic methods
reflect the constriction reflex of cerebral vasculature, rather than the dilation seen in hy-
percapnic manipulations. The CO2 vascular response is dose dependent and it has been
observed that perfusion changes are more prominent in hypercapnia than in hypocapnic
regimens [60]. Such non-linear behavior – as in many other physiological processes –
can be described by a logistic function [20, 314], which defines an interval of relative lin-
earity, beyond which responses tend to attenuate and plateau. It would be quite valuable
to identify the interval of PET CO2 levels to which changes in perfusion are equivalent, as
it would permit a more effective comparison between CVR measures based on different
methodologies.
5. Hyperventilation increases minute volume and the gradients of diffusion cross the BAB, which
accelerates the CO2 washout and cause hypocapnia.
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3.5 Respiratory and vascular responses
The CO2 manipulation methods described here represent a wide variety of trade-offs
between simplicity and theoretical rigor. As CVR measures are likely to gain increasing
importance in multi-site studies of aging and disease-related neurophysiological effects,
a thorough analysis of such respiratory manipulations was deemed fundamental.
The study in this Chapter has been devised to determine whether CVR measures
obtained with BH, FI and the Respiract hypercapnic methods would be comparable and
whether any difference in subjects’ tolerability and/or compliance would be observed. To
verify to which extent vasoconstriction reactivity measures differ from CVR measures of
vasodilation, a hyperventilation maneuver has been included in the comparison. Linear
modeling of respiratory traces allowed robust estimates of PET CO2 responses in each of
the different manipulations. Given the varied stimulation profiles, individual PET CO2
models were used as response regressors in the linear modeling of fMRI signals. To help
identifying the linear regions of perfusion change, CO2-perfusion data from the differ-
ent manipulations were put together and fitted with a sigmoidal dose-response model.
Sample consisted of ten young healthy subjects and CVR maps for the different manip-
ulations were obtained with the pCASL method. Results of this study have been pub-
lished as a full research article in the Journal of Cerebral Blood Flow and Metabolism.
Whereas hypocapnia-based CVR measures differed significantly from hypercapnia-base
ones, it has been found that the three hypercapnia induction methods yield comparable
CVR measures when these are expressed as the relative change in perfusion per mmHg
increase in PET CO2. When CVR was expressed as the absolute change in perfusion
per mmHg increase in PET CO2, Respiract related measures differed from FI and BH.
These two operated in the linear region of the CO2 dose-response curve, manipulating
PET CO2 between 30 and 45 mmHg. Regarding discomfort and difficulty ratings, differ-
ences were not statistically significant; however, the authors noted that results in older
groups or those affected by disease could be different.
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Stimulation of cerebral vasculature using hypercapnia has been widely used to study
cerebral vascular reactivity (CVR), which can be expressed as the quantitative change
in cerebral blood flow (CBF) per mmHg change in end-tidal partial pressure of CO2
(PET CO2). We investigate whether different respiratory manipulations, with arterial spin
labeling used to measure CBF, lead to consistent measures of CVR. The approaches in-
cluded: (1) an automated system delivering variable concentrations of inspired CO2 for
prospective targeting of PET CO2), (2) administration of a fixed concentration of CO2
leading to subject-dependent changes in PET CO2), (3) a breath-hold (BH) paradigm
with physiologic modeling of CO2 accumulation, and (4) a maneuver combining breath-
hold and hyperventilation. When CVR was expressed as the percent change in CBF per
mmHg change in PET CO2), methods 1 to 3 gave consistent results. The CVR values
using method 4 were significantly lower. When CVR was expressed in terms of the ab-
solute change in CBF (mL/100g per minute per mmHg), greater discrepancies became
apparent: methods 2 and 3 gave lower absolute CVR values compared with method 1,
and the value obtained with method 4 was dramatically lower. Our findings indicate that
care must be taken to ensure that CVR is measured over the linear range of the CBF-CO2
dose-response curve, avoiding hypocapnic conditions.
Key Words: Arterial Spin Labeling, Cerebral Vascular Reactivity, functional MRI, Hy-
percapnia
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INTRODUCTION
Measurements of the cerebral blood flow (CBF) response to a stimulus may provide a
useful index of cerebral vascular function, aiding in the study and diagnosis of different
cerebral diseases with a vascular component [121, 340, 392]. Hypercapnia (increased
levels of blood CO2.) is known to cause global increases in CBF [193], a phenomenon
that has been exploited in the development of functional magnetic resonance imaging
(fMRI) measures of cerebral vascular reactivity (CVR) [187, 318, 319]. To measure
CVR, perfusion-weighted images are acquired during a respiratory manipulation that
induces hypercapnia, with analysis of the resultant image series yielding a map of the
CBF response to CO2. The fMRI technique providing the most quantitative measure of
CBF is arterial spin labeling (ASL) [6, 76, 396]. Cerebral vascular reactivity can thus
be expressed as the percentage or absolute change in CBF per mmHg change in the end-
tidal partial pressure of CO2 (PET CO2, a surrogate for arterial PCO2). In addition to
providing a direct depiction of cerebral vascular function, the ASL and BOLD responses
to a hypercapnic manipulation can be input to biophysical models allowing estimation
of the cerebral metabolic rate of O2 [9, 158], a key indicator of cerebral function.
A number of approaches have been explored for the induction of hypercapnia to
measure CVR with fMRI methods. One of the most commonly adopted methods has
been to administer a mixture of gases with a fixed concentration of CO2 (typically 5%
to 7% by volume) diluted in atmospheric composition air [157, 318, 418]. Because this
approach uses a fixed concentration of inspired CO2 during all phases of the hypercapnic
episode and for all experimental participants, we refer to this method as ‘fixed inspired’,
or FI. Methods based on administration of gas mixtures require the participant to wear
a breathing mask or mouthpiece by which the inspired gases are delivered, as well as
a system for controlling flow rates and alternating between normal air and the CO2/air
mixture. When FI CO2 mixtures are used, the actual PET CO2 levels induced during
air breathing and administration of the CO2 mixture will depend on the subject’s body
mass, basal metabolic rate, and minute ventilation. Moreover, accelerated breathing dur-
ing hypercapnia can lead to incidental hyperoxia, which exerts a mild vasoconstrictive
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influence. These effects may confound CVR measurements made using the FI method.
To address the latter concerns, several groups have devised methods for prospectively
targeting specific PET CO2 and PET O2 levels during different phases of hypercapnia in-
duction. Early methods [18, 345, 346] focused on maintenance of constant partial pres-
sures using sequential rebreathing approaches, wherein subjects receive an externally
administered gas up to a certain flow rate, beyond which they rebreathe expired gas.
Feedback approaches have also been explored [400], although these require extremely
high flow rates (e.g. 70L/min). Slessarev et al. [341] have extended the sequential re-
breathing approach to incorporate physiologic modeling of CO2 fluxes in the body to
make predictive, breath-by-breath adjustments of inspired gases to achieve prospective
and independent control of end-tidal PCO2 and PO2 at lower flow rates.
One of the simplest methods used to induce hypercapnia is to have subjects hold
their breath [185], resulting in accumulation of CO2 in the blood and resultant increases
in CBF. This can be performed with minimal equipment and set-up time, although it
is limited to subjects who are able to understand and comply with the breath-holding
instructions. This procedure also necessarily leads to a degree of hypoxia, which may
confound the imaging responses observed. Moreover, since the quantitative expression
of CVR requires knowledge of the change in PET CO2, which is usually measured from
exhaled gas that is not available during a breath-hold, applicability has been limited. The
latter difficulty has been overcome by having subjects execute a small, forced exhalation
at the end of the breath-hold that is used to measure PET CO2 at the end of the maneuver
[269].
To date, there have been few studies comparing PET CO2-normalized estimates of
CVR obtained using different respiratory manipulations, and none that have included
both gas administration and breath-holding methods. A recent study by Mark et al.
[256] showed that a commercial implementation of the sequential rebreathing system
with feed-forward modeling described by Slessarev et al. reduced the variability of CVR
estimates compared with measurements made in the same individuals using fixed con-
centrations of inspired gases (the FI approach). The latter study also showed reduced
fluctuations in PET O2 during hypercapnic manipulations when the sequential rebreath-
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ing approach was used.
Given that PET CO2 is necessarily monitored in any quantitative CVR study, an im-
portant question is whether retrospective normalization of flow responses produced by
an uncontrolled PET CO2 excursion will give equivalent results to a similar normal-
ization applied to data acquired during PET CO2 changes that have been prospectively
controlled. To the extent that percent changes in CBF might be a linear function of
PET CO2, the two approaches should be equivalent. If the ranges of PET CO2 covered by
different techniques span different domains of a non linear dose-response relationship
[20, 144, 168, 314], however, then the apparent CVR values could differ considerably.
Addressing this question was the primary aim of the present study.
MATERIAL AND METHODS
For this study, we scanned 10 healthy subjects (ages between 18 and 35) measuring
CBF changes during 4 types of respiratory manipulation in the following order: (1) au-
tomated prospective control (PC); (2) administration of fixed concentrations of inspired
gases (FI); (3) breath hold (BH); and (4) breath-holds combined with hyperventilation
(HV). To control for minute ventilation, an audio metronome was used to pace the sub-
jects’ breathing. Figure 3.1 shows timing diagrams for the different manipulations. All
subjects underwent the manipulations in a pre-session 1 week before the scanning and
gave informed consent for their participation. The protocol was approved by the Comité
mixte d’éthique de la recherche du Regroupement Neuroimagerie Québec.
Subjects were imaged using a 3T scanner (Siemens TIM TRIO, Siemens Medical
Solutions, Erlangen, Germany) using the vendor’s 32-channel head coil. Although the
BH and HV methods did not require a face mask, the FI and PC methods were each
implemented using a different type of mask. The scan session was therefore divided
into three phases: PC, FI, and a final phase with the mask removed for BH and HV.
Subjects were withdrawn from the MRI scanner for placement of the appropriate mask
and monitoring equipment between phases. Each phase consisted of a simple localizer
sequence, a high-resolution anatomic acquisition (MPRAGE with 1 mm3 resolution)
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Figure 3.1: The four respiratory manipulations. In the prospective control (PC) method, the
inspired gas mixture is continually modulated, allowing near step changes in PET CO2 (resem-
bling the square blocks shown). In fixed inspired (FI), gas mixtures with fixed composition are
administered during different blocks, inducing hypercapnia during periods of CO2 enrichment
(the square blocks here represent the inspired concentration of CO2, not PET CO2). The breath
hold (BH) method developed by the Cardiff group consists of 20-second breath-holds alternated
with paced breathing (PB). The hyperventilation (HV) method uses these same short breath-holds
though differently organized as to resemble the two-block design adopted in the gas manipula-
tions. Ventilatory rate is also 50% higher than in the PB used in the other manipulations. In this
figure, BH is used to denote the BH method as well as to indicate breath-hold events. PET CO2,
end-tidal partial pressure of CO2.
of ∼5 minutes duration, and the functional scans with ∼10 minutes duration each. For
the functional scans, we used pseudo-Continuous ASL [72, 364], with a labeling time
of 1.5 seconds, delay of 0.9 seconds, and repetition time/echo time of 3,000/10 ms.
Slice prescription was 11 slices with 7mm×4mm×4mm voxel resolution and 1 mm gap.
Readout consisted of a GRE-EPI scheme with GRAPPA acceleration factor 2 and 7/8
partial Fourier reconstruction. Total time of the experiment was 1 hour and 30 minutes.
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During all functional acquisitions, subjects were paced in their breathing using me-
tronome beeps played over headphones. Subjects breathed at a constant rate, unless they
were performing a breath-hold. Instructions to perform the breath-hold consisted of a
beep with different tone. During the breath-hold, the metronome beeps were paused. In
the case of HV, an additional beep tone was used to signal intermittent breaths during the
series of breath-holds. The ventilatory rate was set to 16 breaths per minute, comparable
to the average of rates during normocapnia and hypercapnia reported by Mark et al.
[256] for unpaced breathing. In the HV maneuver, the ventilatory rate was increased to
24 breaths per minute, deliberately inducing hypocapnia during these periods.
In the PC phase, the hypercapnic manipulation was conducted using a commercial
implementation (RespirAct, Thornhill Research, Toronto, Canada) of the sequential re-
breathing system with feed-forward modeling described by Slessarev et al [341]. In
this system, a physiologic model is used to compute a sequence of inspired gas con-
centrations that will result in the desired sequence of end-tidal O2 and CO2 values in
a given subject. We programmed the RespirAct to increase PET CO2 by 7 mmHg from
the subjects’ baseline PET CO2 during two intervals of 2 minutes:20 seconds (2 min-
utes:20 seconds apart) while keeping end-tidal levels of O2 unchanged throughout the
manipulation. An individuals baseline PET CO2 was determined based on measurements
obtained during anatomic scans while the subject was breathing air through the respira-
tory apparatus. Subjects were asked to follow the metronome at 16 breaths per minute
during this phase and to ensure that the fresh gas bag of the breathing circuit was emptied
at every breath (necessary to ensure accurate targeting of end-tidal gas levels).
In the FI phase, subjects were fitted with a non rebreathing face mask (Hudson
RCI, CA, USA) and paced to breathe at 16 breaths per minute. Plastic tubing and a Y-
connector were used to connect flow meters for medical air and CO2-5% (balanced with
air) tanks to the circuit leading to the mask. The CO2 mixture was administered in two
intervals of 2 minutes:20 seconds duration, separated by intervals of 2 minutes:20 sec-
onds during which medical air flowed through the circuit.
In the last phase, subjects performed the breath-holding routines. First, in the BH
manipulation, subjects were asked 12 times to hold their breath for 20 seconds (see Fig-
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ure 1, bottom left panel). Breath-holds alternated with 30 seconds of paced breathing, in
which subjects were asked to follow the metronome at 16 breaths per minute. Increases
in PET CO2 were estimated by comparing the end-tidal levels from the beginning with the
end of the breath-hold. To sample PET CO2 just before resumption of breathing, subjects
were instructed to give a small forced exhalation at the end of each breath-hold, as de-
scribed in Murphy et al [269]. In the HV manipulation, there were two equal sets of six
breath-holds, each with an approximate 2 minutes:20 seconds duration, and separated
by 2 minutes:20 seconds of paced breathing. In each set, 20-second periods of breath
holding were punctuated by single breaths (exhale-inhale) that lasted ∼3 seconds. Such
compounded breath-hold blocks were interleaved with hyperventilation, during which
subjects were asked to follow the metronome at 24 breaths per minute. This sequence is
described in Figure 1, bottom right panel.
At the end of the session, subjects were asked to rate their discomfort during the
different respiratory manipulations according to the 7-step scale proposed by Banzett et
al [17].
Respiratory levels of CO2 (and O2) were continuously monitored using a nasal can-
nula and a gas sampler/analyzer (Biopac MP150, BIOPAC Systems Inc., CA, USA),
as well as comparable analyzers incorporated into the RespirAct during PC scans. The
baseline levels and the amplitude of the hypercapnic response associated with each ma-
nipulation were obtained through linear modeling of the end-tidal points in the capno-
graph (Figure 2). Each hypercapnic stimulus was treated as an independent event block,
except in HV, where the 12 breath-holds were aggregated into 2 blocks. In each manip-
ulation, biexponential functions were used to model transition periods at the beginning
and end of blocks. The model also incorporated a first-order drift term; and an offset that
represented the baseline end-tidal level during that run (which is partly dependent on the
rate of paced breathing). The resting ‘normal’ PET CO2 levels were obtained from the
evaluation of capnograph recordings obtained while subjects breathed air during unpaced
breathing (e.g. during the anatomic scans that preceded the FI and BH manipulations).
The PET CO2 and PET O2 values were compared during conditions, and against the
normal resting levels during unpaced breathing, using a paired t-test.
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Image analysis was performed primarily using the NeuroLens software package
(www.neurolens.org). The ASL image series were first motion corrected. The flow
series were then obtained using surround subtraction of the raw ASL images. Next, the
ASL difference signal (representing CBF) was fit with a general linear model consisting
of the modeled values of PET CO2 normalized to have unit amplitude, plus a third-order
polynomial representing drift terms and constant offset. This fitting procedure provided
maps of the estimated baseline flow signal and related increases.
To determine responses in different tissue regions, these ASL signal estimates were
averaged within an ROI that consisted of a grey-matter probability mask. This mask was
computed based on the high-resolution anatomic acquisitions, which were segmented for
grey matter using FSL’s FAST program [426] and resampled to match the spatial sam-
pling of the functional series. Average ROI responses were computed as the weighted
sum of ASL parameter estimates from the general linear model fit multiplied by the grey-
matter probability within each voxel, to control for partial volume effects with white
matter and cerebrospinal fluid (which are assumed to exhibit little or no ASL difference
signal). Average parameter estimates were converted from raw MR signal units to ab-
solute CBF using the approach described in Wang et al [386]. To exclude functional
responses associated with the auditory metronome used, temporal lobe regions (contain-
ing auditory cortex) were not included in the ROI maps. In addition to the ROI analyses,
group average maps of the various ASL parameters (resting CBF, absolute CO2-induced
flow change, percent CO2-induced flow change) were computed by coregistration of
individual maps into the MNI 152 stereotactic space.
The coupling between flow and CO2, i.e. the CO2 dose-response curve, was further
explored by plotting the ASL vs. PET CO2 in the following manner: grey-matter-averaged
CBF and monitored PET CO2 traces for PC, FI, and HV were binned into 30-second in-
tervals, excluding the first 20 seconds after transitions. The BH data were binned in a
different manner, using 30-second and 20-second intervals according to the stimulus de-
sign. The quantities were averaged within these temporal bins, and used to plot absolute
CBF as a function of PET CO2 during each time bin. Data points from the different types
of manipulation were color coded and displayed on the same axes. Data were fit using
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the sigmoidal model adopted by Reivich [314]:
CBF = a+ b
1+c.e−d.logPCO2
RESULTS
End-Tidal Monitoring
Figure 3.2 shows examples of respiratory CO2 traces associated with each manipula-
tion and respective models of the PET CO2 responses. The numerical values (mean±SE)
shown on each plot correspond to the group average change in PET CO2 at the end of the
manipulation (where the change is typically maximal). These estimates are also shown
in a bar graph in Figure 3.3B. The group average changes in PET CO2 produced by the
different manipulations ranged from 6.6±0.3 mmHg (PC) to 18±1 mmHg (HV), and dif-
ferences between respective changes were generally statistically significant at P < 0.05,
with the exception of the pair FI and HV, for which P > 0.2.
Baseline PET CO2 levels are shown in Figure 3.3A. The baseline levels of PET CO2
associated with all four manipulations were significantly different than the ‘normal’ rest-
ing values, observed when subjects breathed spontaneously. Whereas FI, BH, and HV
had baseline PET CO2 levels that were lower than the resting values, the PC manipulation
had levels that were higher. Although PC accurately attained the target PET CO2 values,
the targeted baseline values were chosen to be slightly higher than the spontaneously
arising PET CO2 due to our observation that values much below 40 mmHg were difficult
to achieve with the RespirAct at the desired breathing rates. We suspect that this is due
to the incorporation of a rebreathing circuit in this system.
The baseline PET CO2 levels were, as expected, lowest in HV, where ventilatory rate
was 50% higher than in the rest of the manipulations. Fixed inspired and BH did not
differ significantly from each other, although both had baseline PET CO2 levels that were
considerably lower than the spontaneously arising value.
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Figure 3.2: PET CO2 increases obtained with the modeling of end-tidal CO2 samples. The
group mean±SE change is displayed over representative traces of the four different manipula-
tions. Left to right: PC and FI on the top, and BH and HV on the bottom. In each plot, the gray
oscillating trace represents the continuous sampling of CO2, and the black trace the model fitted
to the PET CO2 points. The horizontal dotted lines correspond to the spontaneously arising rest-
ing PET CO2. In the gas methods, the dashed traces connect the minimum of tidal PCO2 points,
indicating the inspired gas concentration.
Incidental changes in O2 (Figure 3.3D) were all significantly different from zero. In
PC and FI, changes were minimal and virtually indistinguishable. Baseline levels of
PET O2 (Figure 3.3C) were above spontaneous resting levels except for PC. As would be
expected, peak baseline levels for PET O2 were observed for HV, which drove PET O2 to
142±2. During manipulations including breath-hold (BH and HV), PET O2 fell by up to
26±2 mmHg, reaching a lower value of 92±6 mmHg in the HV manipulation.
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Figure 3.3: Comparison of group average PET CO2 and PET O2 levels during the four dif-
ferent manipulations. Baseline levels on the left and size of the induced changes on the right.
The black horizontal lines in the baseline plots indicate the group average value for the sponta-
neously arising end-tidal gas levels. Except for the pairs indicated, t-tests pointed to significant
differences in both baseline and evoked change values between the various methods. The group
average baseline values determined for all methods also differed significantly from the sponta-
neously observed end-tidal values.
Arterial Spin Labeling Flow Signal
Examples of the linear modeling of the ASL signal are shown in Figure 3.4 for the
average grey-matter signal in a single subject. Absolute ASL flow changes and baseline
levels for each manipulation are shown as bar graphs in Figure 3.5A and B, respectively.
Differences in the measured flow responses were only significant (though marginally,
with P = 0.16) between FI and HV. Note that the flow change in response to breath-
holds in HV is the lowest, despite the fact that this manipulation gave the largest change
in PET CO2.
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Figure 3.4: Arterial spin labeling (ASL) flow signal changes in grey matter during hyper-
capnia from a single representative subject. Linear modeling fits of PET CO2 traces (black) are
plotted over corresponding ASL signals (grey) for the four different manipulations. Left to right:
PC and FI on the top, and BH and HV on the bottom. CBF, cerebral blood flow.
Absolute levels for baseline flow were generally correlated with baseline PET CO2
levels, with the PC manipulation having considerably higher baseline PET CO2 and CBF
values than the other manipulations, among whom the differences were not statistically
significant.
When expressed as the percent change in CBF per unit of change in PET CO2, PC, FI,
and BH yielded comparable CVR estimates that did not differ by a statistically signifi-
cant amount (Figure 3.5C). The HV manipulation, however, gave a significantly lower
value of relative CVR (the term ‘relative CVR’ will be used to indicate ∆%CBF/PET CO2).
When expressed in terms of the absolute change in CBF (mL/100g per minute) per
mmHg change in PET CO2 (‘absolute’ CVR), however, there were significant differences
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in the values given by the different methods (Figure 3.5D). In general, the absolute CVR
values were correlated with the resting PET CO2 associated with each manipulation.
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Figure 3.5: Group average values of the arterial spin labeling (ASL) flow signal in grey
matter. (A) Baseline flow; (B) absolute flow increases. In (D), the CO2-induced increases are
normalized by the PET O2 increases and expressed as an absolute cerebral vascular reactivity
(CVR) ratio. The percent change in ASL signal per mmHg increase in CO2 in (C). In the bottom
graphs, we indicate where the t-tests did not point to significant differences (differences between
PC and FI/BH were only marginally significant with P < 0.1). In panel A, significant differences
(P < 0.05) are indicated by an asterisk symbol.
Group average maps of the baseline blood flow and reactivity to CO2 are shown in
Figure 3.6. Maps for both baseline CBF and CO2-induced response reveal peak values
in grey matter, as expected. Maps based on percent change (bottom row) are somewhat
noisier, reflecting the vulnerability of ratio images to low signal-to-noise ratio in the de-
nominator.
60
Figure 3.6: Group average cerebral blood flow (CBF) maps. Baseline signal (1st row), CO2-
induced response (2nd row) and cerebral vascular reactivity (CVR), computed as absolute units
of flow per mmHg increase in CO2 (3rd row) and as the percent increase with respect to baseline
(4th row). BH, breath hold; FI, fixed inspired; PC, prospective control; HV, hyperventilation.
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The images displayed are non oblique axial slices that pass through the upper oc-
cipital lobe, above the calcarine sulcus. We suspect that the low baseline CBF in these
areas is due partly to sulcal anatomy that results in a relatively lower partial volume of
grey matter and hence the appearance of lower CBF. The short postlabel delay used may
also result in incomplete clearance of macrovascular signals in some arterial territories.
We cannot rule out the possibility that anterior and middle cerebral artery territories
are showing macrovessel enhancement that is absent or reduced in the posterior cere-
bral artery territory (occipital lobe). Another potential source of error is the residual N/2
ghosting we have noticed in some subjects’ data which could be biasing the average CBF
in that particular area. Yet, regardless of its source, this small measurement error seems
to equally affect the four different baseline maps, i.e. it is not specific to any respiratory
manipulation.
CO2 Dose-Response Curve
The ASL vs. PET CO2 paired data (Figure 3.7) were generally well described by the
sigmoidal model, with most of the non linearity observed toward the lower range of
PET CO2 values at which CBF appeared to plateau some minimal threshold value. The
CBF-PET CO2 pairs associated with the PC manipulation typically fell at the upper end
of these curves while data points associated with the HV manipulation gave the lowest
PET CO2 values and consequently lay along the lower CBF plateau.
Comfort of Participants During Breathing Manipulations
Subjective ratings of air hunger provided by subjects for the different manipulations
were 2.8±0.4 for PC, 2.3±0.3 for FI, 2.4±0.3 for BH, and 2.5±0.4 for HV. No signifi-
cant differences at P < 0.05 were detected.
DISCUSSION
Although having a small offset, PET CO2 and arterial PCO2 (PaCO2) are strongly
correlated. This offset might slightly differ across manipulations, but it is reasonable
to assume that during each manipulation the offset is constant. Being so, for the com-
parison of CVR, which depends on the normalization of the CBF response by the size
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Figure 3.7: Arterial spin labeling (ASL) flow vs. CO2 dose-response curves in nine subjects.
BH, breath hold; FI, fixed inspired; PC, prospective control; HV, hyperventilation.
of the hypercapnic stimuli, ∆PET CO2 can be used in place of ∆PaCO2 with no loss of
generality. We believe that, under the conditions of this study, PET CO2 is an accurate
surrogate for PaCO2.
Measures of CVR obtained using a variety of respiratory manipulation methods were
found to be comparable when CVR was expressed as the percent change in CBF per
mmHg change in PET CO2. When CVR was expressed in terms of the absolute flow
change, however, significant differences were noted. In general, the absolute change in
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CBF was correlated with the baseline level of PET CO2, indicating that the non linear
dose-response curve describing the CBF-PET CO2 relationship had an important role in
determining reactivity. The variance of the induced change in PET CO2 was lowest for
the PC method, although the variance of other methods was also relatively low, possibly
due to the use of a metronome to pace breathing in all cases.
A notable finding was that, for all manipulations except PC, subjects exhibited end-
tidal CO2 values considerably lower than the ‘spontaneous’ baseline observed when they
breathed without pacing using no mask or the non rebreathing mask. This is very likely
due to the rather high breathing rate of 16 to 24 breaths per minute imposed by the
metronome pacing, a conclusion that is also supported by the finding of slightly hyper-
oxic baselines PET O2 values for all manipulations except PC. Prospective control was
notable for a baseline PET CO2 value that was somewhat higher than the spontaneous
value, reflecting constraints on the PET CO2 values that could be targeted.
To the extent that the change in CBF is a linear function of change in PET CO2, the ex-
act baseline and change values for the latter are not critical. However, our data revealed
that moderate hypocapnia can bring the cerebral vasculature into a non linear regime
that approaches the ‘threshold’ dose for CO2 below which further decreases in PET CO2
have minimal effect on CBF. In this lower range of CO2 levels, absolute CVR is consid-
erably reduced compared with the CO2 reactivity seen around 40 mmHg. Although this
effect is corrected somewhat for all but the most severe hypocapnic baselines (HV) when
‘relative’ CVR (∆%CBF/PET CO2) is computed, our findings suggest that CVR studies
should be conducted with baseline PET CO2 values that are solidly within the linear range
(30 to 45 mmHg). This can be achieved using a PC system like the RespirAct, or by im-
posing lower rates of paced breathing during other manipulations. These findings are
consistent with those of previous studies reporting significant differences between CVR
to hypocapnic and hypercapnic stimuli [40, 59].
In terms of the relative advantages and disadvantages of the different methods, the
following conclusions can be summarized:
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Prospective Control
Use of the RespirAct device resulted in the PET CO2 values that were the most con-
sistently in the linear range of the CBF vs. PET CO2 relationships for our participants,
because of the higher range of PET CO2 values attained in these experiments. Changes
in PET O2 during the hypercapnic manipulations were negligible (as these were prospec-
tively targeted by the device to be zero).
Administration of Fixed Inspired Gases
While this approach gave robust changes in PET CO2 values and imaging signals, the
baseline PET CO2 values were somewhat lower than those obtained with the PC method,
encroaching on the non linear region of the dose-response curve. This resulted in group
average values for absolute CVR, which were also somewhat lower than those obtained
using the PC method. Relative CVR values (∆%CBF/PET CO2) obtained with FI were
also slightly lower than those given by PC, although the difference was not statistically
significant. Changes in PET O2 during hypercapnic manipulations were negligible, likely
due to the use of paced breathing in this manipulation (avoiding accelerated breathing
and resultant hyperoxia).
Breath Hold
Because these experiments used the same baseline breathing rate as FI, the baseline
PET CO2 was similarly depressed relative to the spontaneous baseline. Consequently, the
resultant values of absolute and relative CVR were also lower than those given by the
PC method (although they were very similar to those given by FI). PET O2 decreased
significantly during this manipulation, as expected due to the interruption of oxygen
uptake. Such mild hypoxia could contribute a slight vasodilatory input, which would
tend to exaggerate CVR measures. While the latter effect could explain the tendency of
BH measures of CVR to be higher than those for FI, the difference is fairly small and
not statistically significant.
Hyperventilation
As expected, the higher breathing rate of 24 breaths per minute used on this manip-
ulation gave the lowest baseline PET CO2 and consequently the lowest CVR values due
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to the proximity of CO2 values with the lower plateau of the dose-response curve. The
long cumulative reduction in minute ventilation during the breath-hold phases also re-
sulted in the highest degree of hypercapnia and hypoxia. The CVR values obtained with
this approach were thus far lower than those of the other methods, for both absolute and
relative expressions.
In terms of overall performance, the PC method appears to have provided the most
linear estimate of CVR with the least contamination from hyperoxia of all of the meth-
ods. However, the same level of linearity could likely be achieved in the FI and BH
methods with small adjustments, particularly the pacing of participants at slower breath-
ing rates. For future studies where the control over minute ventilation is a concern,
we would advocate the use of paced breathing at lower rates, e.g. 8 to 12 breaths per
minute. Methods including significant hypocapnia (< 30 mmHg) should be avoided, as
these will necessarily give CVR values biased by the non linearity of the CBF-PET CO2
dose-response curve. All methods were well tolerated by our cohort of young healthy
participants, although results in older groups or those affected by disease could be dif-
ferent.
In conclusion, we noted that variability of CVR between methods was reduced when
CVR was expressed in terms of the percent change in CBF rather than the absolute
change. Values of CVR expressed in terms of the absolute change in CBF per unit
of change in PET CO2 depended strongly on the range of PET CO2 levels considered,
indicating that the non linearity of the CBF-PET CO2 dose-response curve exerts signif-
icant influence on the observed CBF reactivity. In particular, manipulations involving
a hypocapnic baseline should be avoided as these may fall within the sublinear region
of the dose-response curve. To facilitate interpretation and comparison of results, we
recommend that future studies reporting ASL-based CVR values indicate baseline and
hypercapnic flow values along with percentage changes. It is equally important to spec-
ify the baseline and hypercapnic levels of end-tidal CO2 during such experiments.
CHAPTER 4
REPRODUCIBILITY OF CVR MEASURES
The objective of the studies composing this section was to determine the degree of
reproducibility of pCASL measures in applications based on blood gas manipulations
when using the fixed inspired method.
]
4.1 CVR methods
Pseudo-Continuous ASL allows robust, non-invasive mapping of cerebral perfusion
(CBF) using standard MR hardware [408, 412]. In addition to being a suitable option
for basic brain research, pCASL CBF imaging has great potential to replace contrast-
enhanced methods in longitudinal studies as well as in the clinical practice [25, 77, 383],
specially in cases where the injection of Gd chelates for contrast-enhanced imaging is
contraindicated (e.g. patients with kidney conditions). Given these prospects, pCASL
has quickly become available in most clinical platforms and considerable efforts have
been made to standardize its sequence parameters and facilitate the comparison of re-
sults across multiple sites [7]. Regarding the reproducibility of its measures, it has been
estimated that repeated measures of CBF should vary by less than 5% [61] – compared
to other ASL strategies, pCASL affords the most reliable measure of CBF [113].
Pseudo-Continuous ASL has also been exploited in applications based on respira-
tory/blood gas manipulations [110, 379]. The study presented in Chapter 2 of this thesis
shows that pCASL performs better than PASL in measuring hypercapnically induced
CBF changes, but the degree of reproducibility of such measures remained to be deter-
mined. Clearly, the reproducibility of this type of measure hinges on the reproducibil-
ity of the gas manipulation [256]. Since the method used in that study (the Respiract
method) afforded reproducible gas changes, it would be a good candidate to help fur-
ther assessing pCASL’s reliability. Nonetheless, the study presented in Chapter 3 of
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this thesis suggests that, with small adjustments, fixed inspired (FI) methods can pro-
vide comparable results. In view of its simplicity, which is more likely to promote the
techniques under development, the study presented here investigates the degree of re-
producibility of pCASL measures that can be attained when the FI method is used to
modulate respiratory gas levels.
4.2 Refinements in the FI method
Reproducibility of blood gas manipulations using the FI method depends on precise
control over the doses that are administered for inhalation. In FI, gas mixtures are deliv-
ered via breathing apparatuses such as nasal cannulas, mouth pieces or face masks such
as used in clinical oxygen therapy or exercise physiology. The most common strategy
has been to administer gas mixtures through simple and inexpensive “Hudson masks”
[33]. This type of mask has a bag reservoir to optimize gas usage and increase dose
efficiency, but the breathing circuit design and material/geometry of the face mask are
impediments to a stringent control over the inspired doses. The gas mixtures adminis-
tered for inhalation are diluted by the entrainment of room air that leak in through the
edges of the mask or – due to poor performance of check valves – through the mask’s
exhaust vents 1. The degree of dilution is a function of the pressure inside the mask
chamber, which varies according to 1) the fit of the mask, 2) the flow rate of input gases
and 3) the subject’s inspired volume (Figure 2). One way to control for such variability
would be to have flow rates sufficiently high to keep a permanent positive pressure inside
the mask; another would be to seal the edges of the mask using adhesive tape. Nonethe-
less, whereas the first alternative causes subject discomfort and should be avoided 2, the
second alternative should be precluded because the complete sealing of a Hudson mask 3
creates the risk of asphyxia.
1. To avoid rebreathing of gases a unidirectional valve also separates the mask and bag reservoir.
Malfunction of this valve causes the mixing of administered and expired gases
2. Moreover, difficulty specifying the flow rates that are ‘sufficient’ to keep administered doses from
diluting is an obstacle for replicating experimental conditions.
3. Here we refer to Hudson masks with no safety vent(s)
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Next Figure shows respiratory traces of four different participants that underwent
a 10-min FI hypercapnic manipulation consisting of the administration of 5%CO2-air
mixtures for 2 minutes in two different instances. Medical air was administered during
baseline epochs. Subjects breathed the gas mixtures through a Hudson oxygen mask.
Minute volume has been controlled by pacing subjects’ breathing. A nasal cannula has
been used to sample respiratory PCO2 levels. Green traces represent the continuous
monitoring of PCO2; changes in inspired PCO2 are shown in black; changes in end-tidal
PCO2 are shown in yellow; and the blue traces represent the linear model of end-tidal
responses.
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Figure 4.1: Examples of FI manipulations using an oxygen mask.
In A, the loose fitting of the mask and/or malfunction of the valves hamper a good
correspondence between administered an inspired doses: the CO2 inspired dose does
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not reach 5% (i.e. PCO2 = 38 mmHg) during the hypercapnia induction. Case B is a
good example of how inspired doses are dependent on flow rates when using a poorly fit
oxygen mask. During a few seconds upon the transitions between air and CO2 adminis-
tration the operator increases the flow rate in an attempt to flush the gas lines and speed
up the transition in inspired doses; however what happens is that during such maneu-
ver the pressure inside the mask chamber raises, lessening the dilution of administered
doses and increasing inspired doses momentarily. In C we find an example where the
operator – realizing that the inspired dose did not reach its maximum – adjusts the flow
rate to keep the pressure inside the mask chamber sufficiently high to avoid entrainment
of room air and dilution of administered doses. In D, the mask is fit to the subject’s face
using adhesive tape to partially seal its upper edge and pads to fill the gap between the
bottom edge and the chin. In addition, the flow rate is sufficient to keep the CO2 mixture
from diluting. The trace of inspired doses do not show sharp step changes due to partial
mixing of administered gases in the breathing bag upon switching of CO2 doses.
In an attempt to refine the FI method I have designed a (MR compatible) breathing
circuit that can afford optimal dose efficiency in a safe and comfortable manner. The
mask that has been adopted in this circuit provides an excellent fit to a wide variety of
face sizes/geometries and can be easily put on and removed, which minimizes prepara-
tion time and subjects’ discomfort. A detailed report of this technical development has
been published in BMC Research Notes 4. The breathing circuit described next have
been deployed in the second study of this Chapter.
4. We recently became aware of a European distributor of medical respiratory support who markets a
similar circuit (not found in product catalogues.). The demonstration of improved inspired doses in our
paper remains an important contribution, and this distributor represents an additional potential source of a
high quality circuit
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A simple breathing circuit allowing precise control of inspiratory gases for experi-
mental respiratory manipulations
Authors: Felipe B. Tancredi, Isabelle Lajoie and Richard D. Hoge
Status: Published in BMC Research Notes vol. 7, p. 235-243, 2013. DOI:10.1186/1756-
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Respiratory manipulations modulating blood flow and oxygenation levels have become
an important component of modern functional MRI applications. Manipulations often
consist of temporarily switching inspired fractions of CO2 and O2; and have typically
been performed using simple oxygen masks intended for applications in respiratory ther-
apy. However, precise control of inspired gas composition is difficult using this type of
mask due to entrainment of room air and resultant dilution of inspired gases. We aimed
at developing a gas delivery apparatus allowing improved control over the fractional con-
centration of inspired gases, to be used in brain fMRI studies. The breathing circuit we
have conceived allowed well controlled step changes in FiO2 and FiCO2, at moderate
flow rates achievable on standard clinical flow regulators. In a two run test inside the
scanner we demonstrate that tightly controlled simple gas switching manipulations can
afford good intra-subject reproducibility of induced hyperoxia/hypercapnia responses.
Although our approach requires a non-vented mask fitting closely to the subject’s face,
the circuit ensures a continuous supply of breathable air even if the supply of medical
gases is interrupted, and is easily removable in case of an emergency. The apparatus
we propose is also compact and MRI compatible, allowing subject placement in con-
fined spaces such as an MRI scanner for brain examinations. We have reported a new
approach for the controlled administration of medical gases, and describe an implemen-
tation of the breathing circuit that is MRI compatible and uses commercially available
parts. The resultant apparatus allows simple, safe and precise manipulations of FiO2 and
FiCO2.
Key Words: Respiratory manipulation, functional MRI, Hypercapnia, Hyperoxia, Breath-
ing circuit
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INTRODUCTION
Respiratory manipulations modulating the fractional concentration of inspired O2
and CO2 (FiO2 and FiCO2) to induce hyperoxia/hypercapnia and modulate cerebral
blood flow and oxygenation have become an important component of fMRI studies mea-
suring the vascular as well as the metabolic function in the brain [9, 44, 106, 110, 253,
348, 418]. Methods using computerized systems to control modulations in inspired con-
centrations and target specific end-tidal levels have been proven successful in enabling
inter-subject reproducibility of hyperoxic/hypercapnic stimuli [18, 256, 315, 341, 398,
400] as well as in providing flexibility in the achievable gas mixtures [30, 81, 270] to
test different hypotheses. While individualized mixing of gas concentrations to achieve
prospective control of end-tidal levels is useful in certain situations, the requirements for
many applications are met by delivering predetermined concentrations of inspired gases,
so long as end-tidal values are recorded for retrospective normalization of the fMRI sig-
nal. The latter, simpler, approach thus continues to be widely adopted in quantitative
neuroimaging and other areas. A common practice has been to administer fixed frac-
tional concentrations of O2 and CO2 for inhalation [9, 106, 363, 418], delivering O2/CO2
enriched mixtures through low-cost nonrebreathing masks commonly used in clinical
oxygen therapy, which usually incorporate a reservoir bag to increase dosage efficiency
(the bag reservoir stores the gases delivered during expiration to make it available for
next inspiration(s), making better use of administered gases and alleviating dropouts in
FiO2 and FiCO2 during early phases of inspiration [33]). However, either due to varia-
tions in the shape of the subject’s face or to incomplete sealing of one-way valves used to
release excess gas flow, such oxygen masks are often very leaky [33], hampering precise
adjustments in fractional inspired concentrations and thus limiting the reproducibility
of the hyperoxic/ hypercapnic stimuli. One way around this limitation would be to en-
sure a tight seal of the face mask using surgical tape or other means. However, in a
closed circuit where the gas supply is directly connected to the mask, this creates a risk
of asphyxia in the event that the medical gas supply is interrupted, although this can be
mitigated through the incorporation of special safety measures. To improve control over
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inspired gases we have conceived a breathing circuit whose different compartments are
separated by high efficiency one-way valves and whose breathing chamber consists of
a non-vented mask providing a tight facial fit, but that can rapidly removed. To ensure
the safety of subjects, we have replaced the breathing bag found in oxygen masks by an
open reservoir, through which the subject breathes room air whenever the flow of ad-
ministered gases becomes insufficient. The resulting open breathing circuit (Figure 4.2)
represents an inherently safe design and allows precisely controlled step changes in the
fractional concentration of inspired gases, with moderate flow rates.
MATERIAL AND METHODS
The breathing circuit we describe below (Figure 4.3) has been implemented, using
commercially available components, to address three design criteria: MRI-compatibility,
accommodation within MRI radiofrequency coils enveloping the head for brain exams,
and sufficiently low cost to justify disposal after use to avoid transmission of airborne
or other pathogens. Parts were acquired from two different vendors: Intersurgical Inc
(NY, USA) and Teleflex Medical (NC, USA); which we will be referred to as IS and TM
respectively.
The circuit comprises a small non-vented face mask (IS # 7193) and a dual-limb air-
way that is appended to the mask’s frontal opening. An elbow (TM# 1632 or # 1624)
and a triple swivel wye-piece (IS # 1929) connect the limbs to the mask. A pair of valves
(TM # 1664/5) at the join of the limbs ensure that 1) inspired gases only come from the
incoming limb, consisting of a corrugated tube (2 TM # 1418 connected by TM # 1960)
that is preceded by a connector (TM # 1642); and 2) that expired gases only flow through
the outgoing limb, that can be a short corrugated tube (TM # 1410). These two limbs
have small outgoing limb serves as an exit for expired gases, the long incoming limb
serves as a gas reservoir, like the breathing bag of conventional oxygen masks. How-
ever, because of its geometry (we used ∼3.5 m of corrugated tube with 22 mm internal
diameter) and open end, the limb reservoir functions as a sequential container, where
administered gases are stacked as they arrive at the circuit and can be expected to mix
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Figure 4.2: New breathing circuit vs. a non-rebreathing oxygen mask. A typical oxygen
mask/circuit is shown on the top (A). The input gas may go straight to the mask or fill the
breathing bag when delivery rate exceeds uptake rate. Expired gases leave the mask through vents
controlled by valves. Gases inside the mask are often contaminated by air that leak in through the
edges of the mask and/or through the vents when valves are malfunctioning. This compromises
control over the inspiratory gases as well as the accurate monitoring of end-tidal values. To avoid
the latter concerns the new breathing circuit (B) uses a non-vented mask providing a sealed fit
to the subject’s face. The breathing bag is replaced by a long limb reservoir with an open end,
ensuring a constant supply of breathable air. Expired gases are exhausted through a second limb,
controlled by an efficient unidirectional valve. A sampling port adjoined to the mask to help the
respiratory monitoring. Vr = volume of the reservoir; Vd = dead space added by appending the
dual limb system to the mask.
less than in a bag type of reservoir. This way, during transitions between gas mixtures of
different concentrations, the new mixture becomes readily available for inspiration, al-
lowing sharp transitions in fractional concentration of inspired gases. Whereas the same
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Figure 4.3: Schematic of the circuit assembly. Gas mixtures are supplied through the barbed
inlet of the connector TM # 1642. The elbow can be of two different types, with a luer-lock or
barbed sampling port (TM # 1624 or # 1632 respectively). The limb reservoir is formed by two
corrugated tubings (TM # 1418) coupled by a connector (TM # 1960), which is not represented
here. The mask (IS # 7193) comes with a support (not represented) allowing to attach the harness
(TM # 15920).
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effect could be achieved without this long limb reservoir, that would require high flow
dosages to meet peak inspiratory rates.
The circuit was conceived to allow better isolation between circulating gases and
exterior, while ensuring a constant supply of breathable gas even in the event of an
interruption in the gas administration. The anesthetic mask we have adopted offers a
tight facial fit, drastically reducing entrainment of room air and resultant dilution of
inspired/expired gases (as can occur with Hudson-style oxygen masks) but can be very
easily removed in case of danger or discomfort. The mask does not need to be sealed
using adhesive tape [256] nor held to the head using restrictive harnesses that can be
difficult to remove in an emergency [47] (we have adopted the TM # 15920). More
importantly though, as mentioned above, the gas reservoir of our circuit has an open
end which protects the subject against disruptions in the gas supply. Whenever the gas
administration is insufficient to meet the subject’s ventilation the reservoir is replenished
with room air for inspiration, i.e. there is no special requirements to ensure a constant
supply of breathable air.
The proposed circuit is also equipped with a sampling port for the monitoring of
O2/CO2 and pressure wave inside the mask chamber, avoiding the use a nasal cannula
and potential discomfort associated with this. The sampling port is positioned at the
elbow that connects the mask to the circuit’s limbs and can be of two types, barbed
(elbow TM # 1632) or luer lock (elbow TM # 1624), depending on the tubing used for
the sampling line.
As a proof of concept of the improvement in respiratory manipulations attained with
the new circuit we have conducted two tests using both the new circuit and a non-vented
Hudson oxygen mask (# 1060) in a young healthy subject (female: 32y, 1.65 m, 60 kg).
In Test 1 the subject was given 100% O2 or 50% O2 balanced with air in two different
instances lasting 3 minutes each and 3 minutes apart. Medical air was administered
otherwise. Flow rates were 15 L/min during the whole manipulation. Test 2 followed
the same design as Test 1 but with different flow rates. Upon transitions in administered
concentrations, flow rates were increased to 30 L/min for 1 m:30s.
The new circuit has been deployed in multi-subject fMRI experiments conducted by
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our group, in which FiO2 and FiCO2 were modulated administering 100% O2 and 5%
CO2 according to the schedule proposed by Bulte et al [44]. The circuit has been used
in over 20 MRI sessions, with very consistent results. We will show here data obtained
from single representative participant who underwent two different runs of the above
protocol.
Respiratory gases were monitored using Biopac MP150 (Biopac Systems Inc., CA,
USA). Fractional concentrations of O2 and CO2 were analyzed and recorded at a 50 ms
sampling rate. The gas sampling line consisted of a long segment of rigid tubing per-
taining to the monitoring equipment (AFT31-XL) preceded by a disposable bacterial
filter (# 2200/01, Air Safety Medical Ltd,) and a short segment of oxygen tubing (#
2001, Salter Labs, CA, USA) to connect the filter to the sampling port of our breath-
ing circuit (built using a TM # 1632 elbow). We noted that, using the current setup,
accurate measures of fractional concentration were difficult to obtain when breathing
rates exceeded 10 breaths per minute. We believe this effect is mainly associated with
the limited rise/fall time of our gas analyzers and mixing of gases inside the sampling
line; but we have also observed that the bacterial filter placed in the sampling line con-
tributes to the problem, although we are not certain through which exact mechanisms.
In future experiments we intend to 1) replace the long segment of the sampling line by
a narrow-bore plastic tubing (then, to overcome the resistance it adds to the line, attach
an external sampling pump to Biopac) and 2) test other solutions to filter the sampling
gases. In the present study, however, to obtain crisp respiratory signal traces we have
instructed subjects to limit their respiratory rate to 10 breaths per minute. If the subject
breathes at a pace lower than usual there may be less contamination of inspired gases in
breathing circuit, which will result in better performance controlling for inspired doses
(even if the decrease in respiratory rate is just minor such as in the particular case of
the herein experiments). However, the same is true for the oxygen mask, i.e. a reduced
respiratory rate also lessens contamination of inspired gases and improves the mask’s
performance. Therefore we considered that the special requirement to cap respiratory
rate should not invalidate the comparison between performances of the two apparatuses.
On the contrary, we considered that it would help better illustrating the differences one
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should observe if using a robust sampling method.
The pressure wave at the end of the sampling line was monitored using an in-house
transducer that connected to one of Biopac’s analog channels. This signal helped identi-
fying the expired (i.e. end-tidal) points in the post processing of O2 and CO2 respiratory
traces.
Fractional concentrations were multiplied by 760 mmHg to be converted in approx-
imate partial pressure values. Baseline levels and changes in end-tidal partial pres-
sures were quantified using the approach described in ref [363]. The end-tidal sam-
pled points were fit to a linear model consisting of a third degree polynomial term plus
the CO2/O2 administration periods as the response regressors, which were shaped us-
ing bi-exponential functions to improve the contour of transitions. Baseline levels were
obtained from the regressors representing the offset term of the model; respiratory re-
sponses represented the effect size of fitted response regressors.
RESULTS
In Figure 4.4 we show results of Tests 1 and 2; tests with the oxygen mask are shown
on the left column whereas test with the new circuit on the right.
From the plots on the left column we note how different the composition of actual
inspired gases (FiO2) and the composition of administered gases (FA) can be when the
oxygen mask is used. Furthermore, in the second row we have a clear example of how
dependent the composition dosage – i.e. FiO2 – can be on the flow dosage – i.e. flow
rate (FR). The administration of 100% O2 at different FR’s induces different FiO2 inputs
(as well as end-tidal responses). This is related to the contamination of administered
gases by room air that leaks in to the mask: for lower FR’s the pressure inside the mask
is lower, which worsens the leak and reduces FiO2. Conversely, when fixed FR’s are
used (which is often the case) the degree of leak will vary according to the fit of the
oxygen mask to the subjects’ face. This compromises inter- but as well intra-subject
reproducibility of the FiO2 manipulations.
In the tests with the new circuit (right column) there was a very close correspondence
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Figure 4.4: Respiratory traces of hyperoxic manipulations using the new circuit (right)
vs. an oxygen mask (left). In the first row we show tests where 50% O2 and 100% O2 were
administered in two different instances and in which flow rate was 15 L/min during the entire
manipulation. In the second row we repeated the first experiments but increasing the flow rate to
30 L/min during 1m:30s after transitions. Fractional concentrations are given as partial pressure
with respect to an atmospheric pressure of 760 mmHg. FA = fractional concentration of admin-
istered O2; Fi = fractional concentration of inspired O2; ET model = model of the fractional
concentration of expired O2; FR = flow rate.
between FA and FiO2. In the test where FR was kept constant throughout the manipu-
lation (first row) we note that the transitions in FiO2 were not as sharp as the switching
of gases. This results from the small contamination of new input gases with gases that
remained in the limb reservoir from the preceding input phase. In the test where FR
is increased from 15 L/min to 30 L/min upon the switching of gases (second row) the
replacement of gases from the preceding input by the gases constituting the new FA in-
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put is faster, which results in FiO2 transitions that are sharper. Such maneuver can be
used in other experiments as a means to achieve squared step changes in inspired doses.
However, in this particular manipulation, the average FR was increased by 100% of the
regular flow rate – the limb reservoir being flooded with approximately 22 L of excess
gases during each of the 1m:30s transitional periods. To keep the average FR close to
normal levels and minimize gas usage, the flush procedure should be as fast as possible.
Ideally one would deliver a short bolus of the new FA input with the approximate vol-
ume of the limb reservoir. Nevertheless, the flush does not need to be well controlled and
in fact any increase in flow rate has the effect of accelerating the transitions in inspired
doses. For instance, if flow rates must be limited to a maximum of 20 L/min, keeping
FR at this level for 20-30 seconds will greatly improve transitions in the inspired doses.
Yet, in the many cases where traceability of flow rates is not a concern, the simplest ap-
proach to flush the limb reservoir would consist of opening the regulator’s valve widely
just before setting the flow rate to normal, traceable, levels.
In Figure 4.5 we show results from manipulations using the circuit in a fMRI exper-
iment for the non-invasive measurement of CMRO2 [106]. The 18-minute respiratory
schedule proposed by Bulte et al. [44], which includes interleaved stimuli of hyperoxia
and hypercapnia, was repeated twice. To accelerate transitions in inspired doses, we have
momentarily increased FR from 15 L/min to 60 L/min during 3 seconds upon each FA
transition, flooding the limb reservoir with 3 L boluses before resumption of the regular
flow rate. The change in gas flow during this flushing procedure is greatly attenuated
when gases reach the mask (due to dispersion in the long tubes), and is only marginally
perceptible to the subject.
The dosage efficiency was again high, as evidenced by the tight correspondence be-
tween the fractional composition of the administered mixtures and the fractional compo-
sition of the actual inspired gases. In the O2 monitoring signal we see the same squared
FiO2 contours as observed in Figure 3 when the 100% O2 is administered; all of which
have the same height as the FA of O2, i.e. 760 mmHg. In the CO2 monitoring signal, we
find blank, rectangular areas under the CO2 trace when the 5% CO2 mixture is admin-
istered. The height of these areas correspond well to the FA of CO2. Using moderate
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Figure 4.5: Reproducibility of O2 and CO2 manipulations using the new breathing circuit.
Manipulations consisted of two runs of the 18-minute schedule described in ref [44]. O2 (top) and
CO2 (bottom) respiratory traces (grey) were modeled as described in Material and Methods to
obtain end-tidal (ET) levels (black). Pure O2 was administered during 3 minutes in two different
instances, inducing an approximate 600 mmHg increase in the fractional concentration of ETO2.
A 5%CO2 mixture was also administered in two different instances, lasting 2 minutes each, which
induced an approximate 10 mmHg increase in the fractional concentration of ETCO2. We also
observed small changes in ETO2 and ETCO2 when CO2 and, respectively, O2 were administered.
When not breathing one of the above compositions, the subject breathed medical air.
rates and a simple flushing procedure, our respiratory circuit allowed sharp and precisely
controlled step changes in both FiO2 and FiCO2.
Our test results also demonstrate that end-tidal responses to controlled step changes
in inspired concentrations can be quite reproducible. In Figure 4 it can be seen that mod-
ulations in end-tidal gas levels are very similar both in terms of their qualitative shape
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and their amplitude. In each plot, the leftmost value represents the baseline end-tidal
level of the respective gas, whereas the 4 other values represent the responses associated
to the switching of administered/inspired compositions. Modeled increases in PET O2
and PET CO2 were both consistent: PET O2 increases varied by less than 10% relative to
the baseline levels whereas PET CO2 increases varied by less than 2%. Since the magni-
tude of elicited responses to a given challenge depend on the physiological status of the
individual, we note that it might not be possible to attain the same degree of intra-subject
reproducibility when subjects are scanned in multiple days.
A careful inspection of the O2 monitoring trace reveals a small negative FiO2 input
during the administration of CO2. This results from the slightly lower oxygen content in
the administered CO2 mixture which is composed of 5%CO2 and 95% of air. And we
also note that in this scheme 1) hyperoxic stimuli may not be isocapnic, i.e. when breath-
ing pure O22 the subject’s ETCO2 can be markedly depressed; 2) nor the hypercapnic
stimuli perfectly iso-oxic as ETO2 also changes when the CO2 mixture is administered
(although this may be less of a concern given the small, < 5%, relative changes in O2
levels and its respective impact on the MRI signal).
DISCUSSION
We have developed a simple breathing circuit allowing well controlled step changes
in the fractional concentration of inspired gases, to be used in applications such as in
MRI studies measuring the cerebrovascular responses to respiratory gases. In addition,
the circuit ensures uninterrupted availability of gas and operates at moderate flow rates
achievable with standard clinical flow regulators.
The type of mask and unidirectional valves we have employed in our circuit, which
prevent dilution of administered gases by room air (as can occur when using standard
clinical oxygen masks), are the features permitting the control over fractional inspired
concentrations. However, the key component of our circuit is the limb reservoir. While
optimizing gas consumption, it permits sharper transitions in the fractional inspired con-
centrations and, more importantly, endows the circuit with a fail-safe mechanism. It
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should be emphasized that for the proper operation of the circuit and its safety features,
the limb reservoir must be kept unobstructed at all times. To ensure total protection
of the subject additional safety measures should be included, such as the ongoing and
careful monitoring of both inspired and expired respiratory gases, as well as arterial O2
saturation.
Although the proposed circuit could also be used in applications entailing frequent
adjustments in inspired fractions (e.g. for feed-back control of end-tidal levels) that
would require high flow rates to permanently flush the limb reservoir with the right gas
composition for inhalation. To control of end-tidal levels at low flow rates alternative
methods are warranted [341]. Using the sequential gas delivery method introduced by
Banzet et al. [18] – which allows controlling for the effective volume of inspired mix-
tures – combined with a physiological model of the dependence of end-tidal responses
on inspired fractions it is possible to prospectively target end-tidal levels with minimal
gas usage (a feed-forward modeling method as opposed to feed-back control). This ap-
proach requires a computer controlled mixing system in addition to a specially designed
breathing circuit, which is normally taped on the subjects’ face and forms a closed loop
(in case of discomfort the subject can remove a safe plug positioned near the nose).
The prototype we have devised using commercially available parts has a dead space
that prevented us from having perfectly squared step changes in inspired concentrations.
As can be noticed in most transitions, inspired levels in the first breath right after the
switch of gases do not attain the administered concentrations. Ideally the circuit should
be fabricated using a non-vented and tightly-sealing mask with minimal-size chamber
and a gas input as close as possible to the subjects nose/ mouth to minimize the dead
space. Such a circuit, like the one presented here, should include sampling ports, to
avoid the use of nasal cannulas and the potential discomfort associated with these, and
be disposable.
In summary, the breathing circuit we have presented 1) allows control over fractional
inspired concentrations, 2) optimizes gas consumption in block design manipulations,
3) is simple, 4) safe and 5) comfortable.
END OF MANUSCRIPT 1
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4.4 Reproducibility of dual-echo pCASL
Other than providing a valuable index of cerebral vasculature function, CVR mea-
sures are an essential component of modern fMRI methods mapping brain metabolism,
or more precisely the cerebral metabolic rate of oxygen consumption (CMRO2) [9,
110, 157]. The cerebrovascular response to hypercapnia (increased PaCO2) yields a
global increase in cerebral perfusion (CBF) but also in blood oxygenation levels, which
is reflected in the fMRI signal dubbed BOLD – for blood oxygenation level depen-
dent. Blood oxygenation levels depend on the rate of oxygen delivery, which is deter-
mined by CBF, and the rate of oxygen extraction, which is determined by CMRO2. In
hypercapnically-induced hyperaemia, the BOLD signal increases because oxygen de-
livery exceeds the oxygen extraction. On the other hand, hyperoxia (increased PaO2)
causes an increase in oxygen delivery and in the BOLD signal, but with no significant
impact on CBF. It has been shown that using maps of CBF and BOLD changes to hyper-
capnia, a map of the BOLD change to hyperoxia, and a map of resting CBF, it is possible
to factor out the contribution of oxygen extraction to the baseline BOLD signal and, with
that, map resting CMRO2 [44, 106]. There has been great interest in the development
of this type of application and it was in this context that I have assessed reliability of
pCASL CVR measures.
A test-retest reproducibility study has been conducted using a FI manipulation to
induce hypercapnia and hyperoxia alternately; and pCASL to measure CBF and BOLD
simultaneously. For optimal contrast of these two signals, a pCASL implementation
allowing the acquisition of two series of EPI gradient echoes were adopted: proton den-
sity weighted images arising from the first train of echoes were used to compute the
ASL-subtraction perfusion series; BOLD series were obtained from the susceptibility
weighted images that derived from the second train of echoes. To ensure reproducibility
of the manipulation schedule, the mixing and switching of gases have been achieved
using an in-house computer controlled system. Gas mixtures were delivered using the
breathing circuit previously described. It has been found that pCASL measures of rest-
ing CBF in GM varied by less than 5%, in agreement with a previous report. More than
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95% of the GM voxels exhibited a significant baseline CBF signal. Measures of BOLD
and CBF responses were also robust (being detected in more than 85% of GM voxels)
and consistent, varying by less than 10% in the case of BOLD hypercapnic/hyperoxic
responses and by less than 20% in the case of CBF hypercapnic response (also known as
CVR). A detailed description of this study can be found in the manuscript that follows,
which has been accepted for publication in the Journal of Magnetic Resonance Imaging
as a full research article.
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4.5 Stuty manuscript 2
Test-retest reliability of CBF and BOLD responses to hypercapnia and hyperoxia
using dual-echo pCASL and step changes in the fractional composition of inspired
gases
Authors: Felipe B. Tancredi, Isabelle Lajoie and Richard D. Hoge
Status: Accepted for publication in the Journal of Magnetic Resonance Imaging (Feb/2015).
Purpose: To assess the reproducibility of BOLD/CBF responses to hypercapnia/hyper-
oxia using dual-echo pCASL and step changes in inspired doses. Material and Meth-
ods: Eight subjects were scanned twice, within 24h, using the same respiratory ma-
nipulation and imaging protocol. Imaging comprised a 5-min anatomical acquisition,
allowing segmentation of the grey-matter (GM) tissue for further analysis, and an 18-
min pCASL functional scan. Hypercapnia/hyperoxia were induced by increasing the
fraction of inspired CO2 to 5% and inspired O2 to 60%, alternately. Reproducibility
of BOLD and CBF pCASL measures was assessed by computing the inter-session co-
efficient of variation (CV) of the respective signals in GM. Results: BOLD and CBF
measures in GM were robust (with detection rates > 85%) and consistent, yielding CV
values below 10% for BOLD hypercapnic/hyperoxic responses and below 20% for the
CBF hypercapnic response. The CV for baseline CBF was 3.5%. Visual inspection
of baseline and response maps also revealed good reproducibility of anatomic features.
Conclusion: It is possible to attain reproducible and simultaneous measures of BOLD
and CBF responses to blood gases, within a reasonable scan time and with whole brain
coverage, using a simple respiratory manipulation and dual-echo pCASL.
Key Words: fMRI, BOLD, ASL, Hypercapnia, Hyperoxia, Cerebrovascular Reactivity
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INTRODUCTION
Functional MRI measures of the blood oxygenation (BOLD) and flow (CBF) re-
sponses to modulations in blood gases have been explored in studies of the vascular
reactivity and oxygen consumption in the brain. While some methods employ hypercap-
nia (increased arterial CO2 levels) to stimulate changes in CBF and BOLD [47, 64, 253,
257, 318, 348], others use hyperoxia (increase arterial O2) to induce changes in BOLD
with a weaker impact on CBF [64, 257]. More advanced methods estimating the contri-
bution of tissue oxygen consumption to the baseline BOLD signal rely on measures of
BOLD/CBF responses to both hypercapnia and hyperoxia stimulation [44, 106]. Clin-
ical studies often require repeating a scan before and after a therapeutic intervention
and results are only meaningful if imaging measures are reproducible in the absence of
physiological changes. Whereas the clinical adoption of the imaging techniques under
current development hinges on the robustness/reliability fMRI measures, it also does, to
some extent, on the availability (i.e. simplicity/compatibility) of related methods.
Modulations in blood gases are usually achieved, non-invasively, through breath-
ing maneuvers that induce changes in respiratory end-tidal (ET) levels [363], since these
reflect arterial blood gas content. Simple expedients such as hyperventilation and breath-
holding can induce changes in ET levels [39, 185, 187, 188, 269] and are widely avail-
able, but these methods do not allow independent modulation of CO2/O2 ET levels and
strongly rely on subject compliance, which compromises repeatability of the stimuli.
The preferred method for induction of hypercapnia and hyperoxia has been to admin-
ister air mixtures containing CO2 or supplemental O2 for inhalation [93]. Although
sophisticated strategies using computerized systems to deliver variable inspired concen-
trations and target ET levels [30, 377, 400] can afford respiratory stimulations that are
highly reproducible [398], the simpler approach of administering predetermined/fixed
concentrations for inhalation remains an attractive alternative for clinical applications
and continues to be widely adopted in quantitative neuroimaging [44, 53, 104, 107, 110,
129, 149, 245, 275, 320, 418].
A common way to induce hypercapnia and hyperoxia has been to administer CO2
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and O2 enriched air mixtures at a constant flow rate through standard clinical oxygen
masks used in respiratory therapy. A limitation of this method is the poor control over
the composition of gases actually inspired by the participant [33, 365], which hampers
reproducibility of the respiratory stimuli and related fMRI measures [256]. Alternatives
to improve control over inspired doses include partially sealing the edges of standard
oxygen masks with adhesive tape, or administering gas mixtures at high flow rates us-
ing apparatus such as t-valves, mouthpieces and nose clips in place of the oxygen mask.
However, these solutions can be uncomfortable for the subject. Our research group
has recently described a breathing circuit whose design intends to alleviate the latter
concerns [365]. The apparatus affords improved control over the inspired doses using a
comfortable mask that can be easily put on and removed. Additionally, the circuit design
allows uninterrupted breathing of ambient room air in the event that the flow of medical
gases is interrupted, providing a reliable fail-safe mechanism. This offers a good com-
promise between simplicity of the gas administration, reproducibility of inspired doses
and, equally important, subjects’ comfort to the procedure. It is still uncertain though to
which extent an improved fixed inspired manipulation impacts on the reproducibility of
ET and related fMRI responses.
Studies assessing the reactivity of cerebral vasculature to respiratory challenges have
employed either ASL [104, 274, 363], which provides a direct measurement of flow, or
BOLD imaging [30, 53, 245, 253, 374, 418], which allows monitoring of hemodynamic-
related oxygenation responses. Calibrated fMRI methods, on the other hand, require
both measures [44, 106, 108, 156]. Given that it might be difficult to reproduce the exact
same physiological condition in two different scans, it is desirable that BOLD and CBF
signals be acquired simultaneously, i.e. during the same manipulation. Since the BOLD
signal can be obtained from the ASL series [44, 403], this is less of a concern. Never-
theless, when extrapolating BOLD from a single echo time ASL series, this requires a
certain compromise between the two imaging contrasts. A dual-echo imaging scheme, at
the expense of minor protocol adaptations, optimizes imaging contrasts and can improve
the simultaneous measure of BOLD and flow signals [108].
Although continuous ASL (CASL) offers theoretical advantages over pulsed ASL
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(PASL), such as increased temporal SNR and implicit control over label delivery time
[384, 404], the predominant ASL technique has been the PASL type because of the
broader compatibility of clinical scanners with pulsed labeling schemes. Pseudo-CASL
(pCASL), in which a train of short pulses mimics CASL’s continuous irradiation, has
allowed researches to obtain CBF measures that are comparable to true CASL using
standard MRI hardware [61, 298]. It has already been employed in several studies mea-
suring respiratory-induced hemodynamic changes [44, 107, 108, 363] and a comparison
between pCASL vs. a typical implementation of PASL [364] indicated that 1) pCASL
is more sensitive in detecting respiratory-induced global CBF changes and 2) accuracy
of its measures less vulnerable to time-shift effects. A dual-echo version of pCASL
has great potential to promote new fMRI applications that are based on the simultane-
ous measure of respiratory-stimulated changes in BOLD and CBF; however, reliability
of such pCASL measures remains to be determined. To facilitate replication of results
and clinical translation of methods we considered that a reproducibility study should be
carried out using a broadly available stimulation method, such as a fixed inspired gas
manipulation.
The objective of this study was to assess the test-retest reproducibility of BOLD and
CBF hemodynamic responses to brief step changes in inspired O2 and CO2 levels, using
a dual-echo pCASL sequence to simultaneously image blood flow and oxygenation in a
small cohort of young healthy subjects.
MATERIAL AND METHODS
Eight healthy volunteers (ages between 22 and 40 years) were enrolled in this study.
They gave informed consent for their participation and experiments were conducted with
the approval of the Comité mixte d’éthique de la recherche du Regroupement Neuroim-
agerie/Québec. Experiments consisted of repeating an fMRI measurement in each sub-
ject in two separate scan sessions, which will be referred to as Tests A and B. The brain
imaging protocol included a brief 5-min anatomical acquisition and a 18-min functional
scan where BOLD and CBF signals were measured in the course of a respiratory manip-
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ulation combining hypercapnia and hyperoxia. Maximum interval between the two test
measurements was 24h; minimum 20 minutes.
Respiratory Manipulation
This manipulation consisted of interleaving two 2-min periods of hypercapnia induc-
tion with two 3-min periods of hyperoxia using fixed step changes in fractional concen-
tration of inspired O2 and CO2 (FiO2 and FiCO2) as in [44]. Controlled FiO2/FiCO2
changes have been achieved using the breathing circuit described in [365] to administer
the O2/CO2 enriched mixtures for inhalation (Figure 4.6). Using flow rates achievable
with clinical flow regulators this circuit affords a tight correspondence between the frac-
tional composition of administered gases and the actual dose inspired by the subject.
During the five baseline epochs of the manipulation, subjects were given air with at-
mospheric composition for inhalation. To induce hypercapnia, a gas mixture containing
5% of CO2 balanced with air has been administered, thus increasing subjects’ FiCO2
by about 5%. Hyperoxia was induced by having subjects breath a mixture composed
of 50% pure oxygen balanced with air, yielding an approximate three-fold increase in
subjects’ FiO2.
An automated system, fabricated in-house, was used for the switching and mixing
of gases to ensure reproducible timing of the gas administration schedule. Our system
comprises 3 electrically actuated flow controllers (SideTrakr 840, Sierra Instruments
L. Monterey, CA, USA) receiving medical air, oxygen and a 5%CO2-air mixture as gas
inputs; a 25 mL mixing chamber where the 3 output gases converge to prior to the final
delivery; and a computer controlled electronic box sending serial commands to the flow
controllers. The output of the mixing system connected to the breathing circuit through
∼10 m of oxygen plastic tubing. The system was programmed to 1) deliver medical
air during the baseline periods; 2) switch gas administration to the CO2 mixture during
the hypercapnic periods; and 3) flow equal amounts of O2 and medical air during the
hyperoxic periods. Gas mixtures were delivered at a flow rate of 20 L/min, except during
the first 5.4 seconds after each transition when flow rates were increased to 50 L/min to
accelerate the transition of inspired gases.
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Figure 4.6: Respiratory circuit. The breathing circuit we adopted in our study has been de-
scribed in Ref.[365]. It consists of a dual-limb circuit controlled by unidirectional valves, which
keeps administered (INPUT) gases from mixing with expired (OUTPUT) gases. The facial mask
incorporated in the circuit offers a tight fit which keeps INPUT/OUTPUT gases from diluting
by the entrainment of room air. INPUT gases are delivered in a limb reservoir, which can
be filled with room air in case the INPUT flow does not meet the subject’s minute volume.
INPUT/OUTPUT gases are monitored through a sampling port near the mask.
Respiratory gases were continuously monitored and recorded using a Biopac MP150
system (BIOPAC Systems Inc., CA, USA). The gas sampling line consisted of a 10 m
segment of rigid tubing (AFT31-XL, also from BIOPAC Systems Inc.) preceded by
an insufflation filter (# 2200/01, GVS filter technology, LA, UK) and a 1’ segment of
oxygen tubing to connect the filter to the sampling port of the breathing circuit. We
have also recorded the pressure wave at the end of the sampling line using an in-house
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transducer connected to one of Biopac’s analog channels. This signal was useful in the
post-processing of O2/CO2 traces as it helped identifying end-tidal (ET) points.
Imaging Protocol
Brain scans were acquired using a 3T scanner (Siemens TIM TRIO, Siemens Med-
ical Solutions, Erlangen, Germany) and the vendor’s 32-channel head coil. A mirror
affixed to the head coil, allowed subjects to view a projection screen situated in the back
of the scanner.
The breathing circuit we used in these experiments has an open limb through which
room air will enter whenever the flow of input gases are interrupted or becomes insuf-
ficient, i.e. there is no need to supply the subject with medical air to ensure a normal
breathing. However, this was treated as a fail safe mechanism and did supply subjects
with 15 L/min of medical air during the entire period they were fitted with the circuit
(clearly, during the manipulation, other medical gases have also been administered). Af-
ter setting the gas system to deliver medical air at 15 L/min subjects were fitted with
the breathing circuit and monitoring of respiratory traces started immediately thereafter.
Subjects were covered with a pair of blankets to maximize comfort and finally placed
head first in the scanner.
A T1-weighted anatomical acquisition (5 min MPRAGE at 1 mm3) followed a quick
localization scout. During this period a slide show with random pictures of nature was
projected onto the back screen. Respiratory traces during the anatomical acquisition
were recorded and kept in a separate file.
For the functional scan we have used a dual-echo version of pseudo-continuous ASL
(de-pCASL) to obtain simultaneous measures of BOLD and CBF. The pCASL [72] pa-
rameters were: label duration = 2 s (of Hanning shaped 500 µs pulses), post-label delay
= 0.9 s, labeling plane placed 10 cm below the centre of image slab, plane selection
gradient = 6 mT/m, TE1/TE2 = 8.4/30 ms and TR = 4.12 s. Readout consisted of a GRE-
EPI scheme (GRAPPA acceleration factor of 2 and 7/8 partial sampling of k-space)
imaging a total of 21 slices with 4.5 mm thickness, 10% gap and an in-plane resolution
of 4.5x4.5 mm2. With the above parameters, 131 ASL pairs have been collected along
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the 18 min respiratory protocol. Subjects were instructed to stay awake and breath com-
fortably. During this period a solid-grey background image with a small fixation marker
was projected onto the back screen.
Respiratory data Analysis
Continuous traces of respiratory O2 and CO2 were first multiplied by 760 mmHg,
to convert fractional concentrations in approximate partial pressure values. Next, we
have identified the late phases of expiration in the pressure wave signal. Based on the
time indexes of their respective occurrences, we have then extracted a vector of end-tidal
(ET) values from each of the O2 and CO2 continuous traces. Lastly, baseline levels and
changes in ET partial pressure were quantified as in [363]. ET sampled points were fit
to a model consisting of a third degree polynomial term plus four response regressors
representing the CO2/O2 administration periods (Figure 4.7, left).
Response regressors consisted of the paradigm block design whose transitions were
shaped using exponential functions to improve the contour of transitions and increase
statistical power of the fit. To compensate for delays in the respiratory recordings the
paradigm design has been shifted by 5-10 seconds on an individual basis. ET responses
to step decreases in inspired doses were analysed separately from the responses to step
increases, similar to the approach used in [304]. Due to small drifts in the recorded
values an extra exponential term has been added to the bi-exponential model proposed
in [363]. Time constants were optimized, for each subject, using a computer algorithm
based on least squares. While baseline ET levels were obtained from the offset term of
the model, ET responses were obtained from the effect size of fitted response regressors.
ET CO2 responses to the different periods of CO2 administration were averaged to syn-
thesize the hypercapnic response in a single value. The same procedure was applied to
the ET CO2 response to O2 administration, and ET O2 responses to both O2 and CO2
administration.
We also report the baseline ET levels recorded during the anatomical acquisition,
which we refer to as “resting levels,” to differentiate from the baseline levels encountered
during the respiratory maneuver (baseline ET levels may vary from the time the subject
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is placed in the scanner until the end of the experiment as a result of cardiovascular
adaptation to the supine position, small temperature/metabolic changes and the breathing
manipulation per se). Resting levels were computed by fitting the series of ET samples
with a constant function. Post-processing of respiratory data including extraction of ET
points and modeling of ET vectors were carried out using code we developed in MatLab
(MathWorks, Natick, MA, USA).
Average ET O2 and ET CO2 traces were computed after having resampled all indi-
vidual ET traces to the ASL series TR (4.12s) by linear interpolation.
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Figure 4.7: Respiratory and fMRI signal analysis. In this composite figure we show an illustrative example of how respiratory (left
panel) and fMRI (right panel) signals were analyzed to generate the parametric maps. End-tidal points (colored crosses) were identified
in the continuous traces (grey) and modeled (black) to estimate baseline and responses. Baseline values are indicated by a bar, magnitude
of responses are displayed close to the corresponding stimulation epochs. R2 for the end-tidal model fits in the test/retest scans are: O2 =
0.998/0.999 and CO2 = 0.959/0.957. BOLD and CBF signals were also linear modeled. Magnitude of responses are displayed close to the
corresponding stimulation epochs. R2 for the fMRI fits are: BOLD = 0.946/0.935 and CBF = 0.871/0.924. The signals we show correspond
to the average signal computed for the GM-ROI (drifts have been removed from the BOLD signal but not from CBF). Both CO2 and O2
stimulations yield positive BOLD responses whereas CBF responses are positive for CO2 and negative for O2. Data from this subject also
illustrates the strong dependence of fMRI signals on the respiratory ET levels. Variations in BOLD and CBF responses to the different
epochs of O2 and CO2 administrations were correlated with ET changes. Baseline CBF is higher in Test A (red) compared to Test B (blue)
probably because the baseline level of CO2 was 1.4 mmHg higher in Test A. CVR maps are shown in the next figure.
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Figure 4.8: Individual CVR maps. Illustrative example of CVR maps computed for the same
subject data in the preceding figure - BOLD/CBF response maps for each run were divided by
the respective increases in ET CO2 levels.
Imaging data Analysis
Anatomic images were segmented using FSL’s FAST tool [426] to generate a binary
mask of the brain and a grey-matter probability map for each individual subject. These
were resampled to the spatial resolution of fMRI scans.
Functional data was analyzed using NeuroLens2 (www.neurolens.org). Images were
first motion corrected. Tag and control series from both echoes were subtracted using
linear interpolation. ASL flow series were computed as the difference between control
scans and the mean value of neighboring tag scans in the first echo; BOLD as the sum of
tag and the mean value for adjacent control scans in the second echo. BOLD and ASL
series were modeled using a GLM consisting of 1 regressor for each of the 2 hypercap-
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nic/hyperoxic stimuli plus a 3rd degree polynomial to represent signal drift and baseline
offset (Figure 4.7 right).We used a gamma variate HRF function with 20s time-to-peak
and 40s width, which accurately modeled the relatively slow gas responses. Effect sizes
for hypercapnia and hyperoxia were respectively averaged to provide a single response
metric for each type of stimulus. BOLD responses were expressed as a percent change
of the baseline signal. ASL signals were converted to CBF in units of mL/100g/min as
in [386]. BOLD and CBF responses were expressed either in terms of the total change
to the different stimuli or normalized by the size of the stimuli, e.g. BOLD and CBF sig-
nal changes to hypercapnia have been divided by the ET CO2 increases yielding CVR
indexes of %∆BOLD/mmHg and ∆CBF/mmHg (Figure 4.8 shows an example of BOLD
and CBF reactivity maps obtained from the analysis of responses modeled in Figure 4.7).
The BOLD response to hyperoxia was normalized with respect to the increase in ET O2
and was expressed in units of ∆%BOLD/100mmHg.
Valid ASL measures can not be obtained in voxels for which a substantial volume
fraction is occupied by large veins or arteries. Idiosyncratic flow and BOLD responses
during hypercapnia and hyperoxia can be used to identify such voxels; for example very
large negative changes in apparent CBF during hyperoxia are likely due to T1 shortening
in arterial blood. Voxels presenting CBF responses lower than -50 mL/100g/min in hy-
peroxia or higher than 10% in hypercapnia were considered to be non-parenchymal and
were excluded from further analysis as in [106]. Voxels affected by the susceptibility
artifact related to the inhalation of enriched O2 mixtures were also excluded from the
analysis. An empirical threshold of -5% in BOLD responses was determined empiri-
cally, based on visual inspection of the various response maps and raw EPI scans. We
refer to all the above mentioned voxels as “non-parenchymal” voxels. We then reana-
lyzed the imaging data, this time applying spatial smoothing just after motion correction
(6 mm FWHM 3D Gaussian kernel) but excluding the non-parenchymal voxels and com-
pensating for downward bias introduced by their removal. This procedure consisted of
dividing the smoothed fMRI maps by a smoothed version of the brain mask from which
non-parenchymal voxels have also been removed.
To estimate the BOLD and CBF signal in grey-matter (GM) we have computed GM-
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weighted averages by averaging signals over the GM probability mask we obtained from
segmentation of the anatomical scan. These GM region-of-interests (ROIs) were thresh-
olded at 50% and had non-parenchymal voxels removed. Average BOLD traces for Tests
A and B, were computed by first removing signal drifts from individual traces. The lin-
ear modeling of CBF responses also included drift regressors to make it consistent with
the BOLD signal analysis. However, to permit visualization of perfusion drifts during
the manipulation, we display non-detrended CBF signals.
From the GLM analysis we also obtained parametric maps of the signal-to-noise
(SNR), contrast-to-noise ratio (CNR) and T-statistics of BOLD and CBF responses. The
T-maps were used to compute the detection rate in GM, i.e. the percent of GM voxels
exhibiting significant (P < 0.05 corrected) baseline CBF signal or increase in response
to hypercapnia/hyperoxia, which gives a measure of the technique’s sensitivity. The
grey-matter SNR and CNR were calculated by averaging their respective values over
the GM-ROI, as described above. While the detection rate provides an estimate of the
technique’s sensitivity, the CNR allows comparison of fMRI responses in terms of the
robustness of physical signals (BOLD vs. CBF) and responsiveness to the physiological
stimuli (hypercapnia vs. hyperoxia).
Lastly, we registered individual maps to the MNI 152 template using FSL FLIRT
tool [180] and computed group-average maps for the different scan session, i.e. average
maps for Tests A and B.
Reproducibility Analysis
As a measure of the reproducibility of our respiratory manipulations and fMRI mea-
sures in GM we have computed the inter-session coefficient of variation (CV) for these
variables as in [61]. First, a CV between Tests A and B was computed, for each
individual subject, as the percent of variability with respect to the mean value, i.e.
100∗(SD/MEAN). The overall CV was then computed by averaging the squared CV
values and taking the square root. Test measurements A and B were also compared
voxel wisely. Individual CV maps were generated by computing the CVs for all voxels
in the individual parametric maps A and B (registered onto the MNI space). Overall CV
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maps were obtained by averaging the squared CV maps and then taking the square root.
RESULTS
All participants tolerated the manipulation well. One subject reported having falling
asleep during both test measurements, which reflected in respiratory traces that were less
uniform than those measured in other participants. Modeled ET levels are reported in
Table 4.I.
[mmHg] End-tidal O2 levels End-tidal CO2 levels
Rest Baseline ∆ to O2 ∆ to CO2 Rest Baseline ∆ to CO2 ∆ to O2
A
B
%CV
113 ± 5 118 ± 3 281 ± 3 6 ± 2 40 ± 2 39 ± 1 11.8 ± 0.8 -1.1 ± 0.3
113 ± 5 117 ± 4 285 ± 4 3 ± 2 42 ± 2 40 ± 1 12.1 ± 0.8 -0.6 ± 0.2
17.0 4.2 3.8 150 13.5 5.5 13.2 155
Table 4.I: Respiratory manipulation. ET O2 and ET CO2 values are given in mmHg. Rest =
baseline ET levels measured during the anatomical acquisition; BSL = baseline levels measured
during the manipulation; ∆ to CO2 = average change in the respective ET levels during the CO2
administration; ∆ to CO2 = average change during the O2 administration. CV% = coefficient of
variation (percent of variation with respect to the mean) between test measurements A and B.
The small but significant (t-student paired test, P < 0.02) reduction in ET CO2 and in-
crease in ET O2 from resting to baseline result from a subtle increase in subjects’ minute
volume during the functional scan. When the comparison was between Tests A and B,
baseline and resting values did not differed significantly (P > 0.2). End-Tidal changes
observed in both tests were also reproducible, though the CV for CO2-induced hyper-
capnic responses was more than 3 times higher than the CV for O2-induced hyperoxia
(13.2% vs. 3.8%), which probably stems from the lower ratio between the magnitude
of the increases and baseline levels. The hyperoxic stimulus increased ET O2 levels by
almost 285 mmHg (from a baseline of 118 mmHg to 401 mmHg at the end of the O2
administration) whereas the hypercapnia stimulus induced an approximate 12 mmHg in-
crease in ET CO2 levels (from 39 mmHg to 51 mmHg). Due to a hypercapnically-driven
increase in minute volume ventilation ET O2 levels increased by ≈5 mmHg during the
CO2 administration, in spite of the lower O2 fraction in the CO2 mixture compared to
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the medical air inhaled during baseline period. Conversely, during the O2 administration
ET CO2 decreased by ≈1 mmHg as a result of a paradoxical increase in minute volume
provoked by hyperoxia [169, 247].
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Figure 4.9: Average manipulation and fMRI signals in the GM-ROI. Results from Test A are
shown in red and from Test B in blue. BOLD signal increases to both hypercapnia and hyperoxia
stimulation while the pCASL flow signal (CBF) increases during hypercapnia and decreases
during hyperoxia.
The average ET traces in Tests A and B are shown in the left column of Figure 4.9.
Temporal evolution of ET O2 levels in response to the manipulation were highly re-
producible as indicated by the almost complete overlap of Test A and B average traces
(Pearson’s r = 0.9994) and small error bars. ET CO2 traces were also fairly reproducible
(r = 0.9662) but we note that in Test B the average ET trace exhibits a drift that is not ev-
ident in Test A (first test). In Test B subjects tended to begin the manipulation at a higher
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level compared to Test A (about 3 mmHg higher) and, along the scan, experienced a
progressive decline in ET levels, which, towards the end of the manipulation, fell below
the levels observed in Test A. Given that we have modeled ET traces incorporating drift
regressors, and that the two traces intersect nearly halfway the manipulation, the baseline
levels computed for both manipulations were almost equivalent: 39±1 mmHg in Test A
vs. 40±1 mmHg in Test B.
Right column of Figure 4.9 shows the GM BOLD and CBF signals that were mea-
sured in Tests A and B. Signals are very similar both in terms of temporal evolution
and magnitude of the peak responses (r = 0.9365/0.8454). Respiratory stimuli yield
consistent changes in BOLD and CBF signals along the manipulation as well as across
subjects. BOLD signal increased in average 1.9±0.2% during the hypercapnic stimuli
and 1.14±0.04% in response to hyperoxia in both Tests A and B. As to the pCASL flow
signal, we observe small diminutions during hyperoxic epochs and marked increases
during the CO2 administration, indicating an average increase of 53±3% in CBF levels
in response to hypercapnia. The drift we observe in ET CO2 levels of Test B is not as
evident in the CBF related measure, although we note that the flow signal in Test B starts
at a slightly higher level (5 to 10 mL/100g/min).
Table 4.II shows a summary of modeled fMRI signals in the GM ROI. The CV for
baseline CBF was 3.4%, comparable to that found by Chen et al. Measures of the CBF
response to hypercapnia showed a variance of 16.3% between Tests A and B. When
these measures were normalized by the ET CO2 increases to compute cerebrovascular
reactivity (CVR), contrary to what we expected, CV tended to increase, reaching 19.8%.
The relative increase in CBF per mmHg increase in ET CO2 was 4.6±0.5%, with a
20.3% variance between tests. Reproducibility of BOLD signals were greater. The CV
of BOLD hypercapnic response was 6.8%. When the responses were normalized by
the magnitude of ET CO2 increases, we obtained the same trend observed for CBF, CV
tended to increase, reaching 8.8%. While the magnitude of hyperoxic BOLD responses
was lower compared to that found for hypercapnia (1.14±0.04% vs. 1.9±0.2%), the CV
of hyperoxic BOLD was slightly greater than the CV of hypercapnic BOLD: 8.4% vs.
6.8%. When hyperoxic responses were normalized by the magnitude of ET O2 stimulus,
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CV increased to 10% – the same trend observed for the other fMRI responses, and also
reported by Goode et al [128].
fMRI measures
CBF BOLD
BSL ∆ to CO2 ∆/∆CO2 %∆/∆CO2 %∆ to CO2 %∆/∆CO2 %∆ to O2 %∆/∆O2
mL/100g/min mL/100g/min mL/100g/min/mmHg %/mmHg % %/mmHg % %/100mmHg
A
B
%CV
67 ± 3 37 ± 3 3.3 ± 0.3 4.9 ± 0.5 1.9 ± 0.2 0.17 ± 0.02 1.16 ± 0.04 0.41 ± 0.01
67 ± 3 33 ± 3 2.8 ± 0.3 4.3 ± 0.5 1.9 ± 0.2 0.17 ± 0.02 1.12 ± 0.03 0.39 ± 0.01
3.4 16.3 19,8 20.3 6.8 8.8 8.4 10.0
CNR of fMRI signals and detection rate in GM
CBF BOLD
BSL ∆ to CO2 BSL ∆ to CO2 ∆ to O2
SNR   /  %GM CNR   /  %GM SNR CNR   /  %GM CNR   /  %GM
A
B
%CV
2.6 ± 0.2 / 96.3 ± 0.7 1.4 ± 0.08 / 88 ± 1 226 ± 15 3.9 ± 0.4 / 89 ± 2 2.4 ± 0.1 / 89 ± 1
2.5 ± 0.2 / 96.5 ± 0.7 1.2 ± 0.1 / 85 ± 3 222 ± 12 3.9 ± 0.4 / 88 ± 2 2.3 ± 0.2 / 88 ± 1
7.9 / 0.8 15.1 / 6.8 4.8 6.6 / 2.0 10.0 / 1.6
Table 4.II: Functional MRI signals in the GM-ROI. BSL = Baseline; ∆ to CO2 = average
signal change during hypercapnia; ∆/CO2 = average signal change during hypercapnia normal-
ized by the increase in CO2; ∆%/∆CO2 = average percent signal change during hypercapnia
normalized by the increase in CO2; ∆%/CO2 = average percent signal change during hypercap-
nia; ∆%/∆CO2 = average percent signal change during hypercapnia normalized by the increase
in CO2; ∆%/O2 = average percent signal change during hyperoxia; ∆%/∆O2 = average percent
signal change during hyperoxia normalized by the increase in O2; %CV = coefficient of variance
between Tests A and B (as a percent of the average signal).
fMRI measures
CBF BOLD
BSL ∆ to CO2 ∆/∆CO2 %∆/∆CO2 %∆ to CO2 %∆/∆CO2 %∆ to O2 ∆/∆O2
mL/100g/min mL/100g/min mL/100g/min/mmHg %/mmH % %/mmHg % %/100mmHg
A
B
%CV
67 ± 3 37 ± 3 3.3 ± 0.3 4.9 ± 0.5 1.9 ± 0.2 0.17 ± 0.02 1.16 ± 0.04 0.41 ± 0.01
67 ± 3 33 ± 3 2.8 ± 0.3 4.3 ± 0.5 1.9 ± 0.2 0.17 ± 0.02 1.12 ± 0.03 0.39 ± 0.01
3.4 16.3 19,8 20.3 6.8 8.8 8.4 10.0
CNR of fMRI signals and detection rate in GM
CBF BOLD
BSL ∆ to CO2 BSL ∆ to CO2 ∆ to O2
SNR   /  %GM CNR   /  %GM SNR CNR   /  %GM CNR   /  %GM
A
B
%CV
2.6 ± 0.2 / 96.3 ± 0.7 1.4 ± 0.08 / 88 ± 1 226 ± 15 3.9 ± 0.4 / 89 ± 2 2.4 ± 0.1 / 89 ± 1
2.5 ± 0.2 / 96.5 ± 0.7 1.2 ± 0.1 / 85 ± 3 222 ± 12 3.9 ± 0.4 / 88 ± 2 2.3 ± 0.2 / 88 ± 1
7.9 / 0.8 15.1 / 6.8 4.8 6.6 / 2.0 10.0 / 1.6
Table 4.III: Signal quality and detection in GM. NR = Contrast-to-noise ratio; %GM = percent
of GM voxels significantly (P < 0.05, corrected) responding to the stimulus. Metrics concern the
measurement of baseline (BSL) flow signal, BOLD/CBF changes during hypercapnia (∆ to CO2)
and BOLD changes during hyperoxia (∆ to O2).
In Table 4.III we report metrics that permit assessing the quality of the fMRI signals
measured in the GM ROI, namely: signal-to-noise ratio (SNR) of the BOLD and CBF
signals, contrast-to-noise ratio (CNR) of hypercapnic/hyperoxic fMRI responses and de-
tection rate of baseline CBF (CBF0) and gas responses. We have found that detection
rates were above 85% for all measured quantities. On average, 96.4±0.7% of GM vox-
els showed significant CBF0 signal (P < 0.05, corrected). The detection rate of BOLD
and CBF responses to hypercapnia were 88±2% vs. 87±2%, respectively; detection rate
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of BOLD hyperoxic response was 88±1%. The average CNR of BOLD hypercapnic
responses were 3 times greater than the CNR of CBF responses, 3.9±0.3 vs. 1.32±0.06,
which reflects the higher temporal stability of the BOLD signal. The CNR of BOLD
hyperoxic responses were 2.4±0.1, lower than the CNR for the hypercapnia responses,
although we note that a different scenario could have been observed if the magnitude of
CO2 and O2 increases were other (e.g. ET CO2 increases of 5 mmHg combined with ET
O2 increases of 600 mmHg). The BOLD SNR, as expected, was conspicuously higher
than the SNR of ASL subtracted series (i.e. CBF): average values were, respectively,
224±9 and 2.5±0.1.
In Figure 4.10, we show BOLD and CBF group maps for 3 different axial slices of
the MNI 152 template (slices 66, 81 and 96). BOLD maps are shown in the 3 columns on
the left while CBF maps in the 3 columns on the right. Each set of 3 rows shows results
pertaining to Test A, Test B and the respective coefficient (CV) of variation between the
two measurements.
As expected, overall, functional maps exhibit a distinct grey-matter / white-matter
contrast, in keeping with the notion that the prominent neural/vascular density of grey-
matter tissue (GM) engenders BOLD/CBF signals that are higher than those observed in
white-matter (WM). The window level of CV maps are all the same, namely 0-200%.
At these levels, the transition from violet to blue indicates the passage from 20% to
30%, the approximate fiducial limit of CV. Qualitatively, CV maps show, overall, low
variability (<30%) in the GM region. The high CV values forming a blue rim around the
cortex of virtually all CV maps result from the misalignment of individual maps and can
be considered artifactual.
BOLD SNR-CV maps (rows 1 and 2, left) are remarkably homogeneous, revealing
CVs in WM comparable to the CV in GM. On the other hand, the BOLD (and also CBF)
CVR-CV maps indicate that CVR measures in WM are much more difficult to repro-
duce (rows 4, 5 and 6). Regional variability of HOR-CV (last row) tend to be lower than
the CVR-CV; however, HOR measures near the nasal cavity can be severely compro-
mised by the susceptibility effect of inspired O2, creating a region of high variability in
proximal slice(s).
103
BOLD CBF
SNR
CVR
HOR
CBF0
CVR
%CVR
slice 66 slice 81 slice 96
A
B
CV
A
B
CV
A
B
CV
slice 66 slice 81 slice 96
m
L / 100g / m
in
m
L / 100g / m
in / m
m
Hg
%
 / m
m
Hg
%
 / 
m
m
Hg
%
 / 
10
0m
m
Hg
[a
.u
.]
%
%
%
%
%
%
500
0
200
0
200
0
200
0
200
0
100
0
5
0
8
0
0.28
0
0.7
0
200
0
200
0
Figure 4.10: Functional MRI maps. BOLD parametric maps are shown in the 3 columns on
the left, CBF maps in the 3 columns on the right. Each set of 3 rows show results pertaining to
Test A, Test B and the computed coefficient of variance between the two tests. SNR = Signal to
Noise Ratio; CBF0 = baseline CBF; CVR = CerebroVascular Reactivity to CO2; %CVR = CBF
CerebroVascular Reactivity expressed as a percent of the CBF baseline signal; HOR = HyperOxic
Response (expressed as a percent change in the BOLD signal per 100 mmHg increase in ET O2).
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Baseline CBF maps indicate a 3-fold higher CBF signal in GM compared to WM
(rows 1 and 2, right), but reproducibility of the CBF0 signal is uniform across the brain,
as indicated by the relatively flat CV maps (3rd row). When computed as the absolute in-
crease in CBF per mmHg of CO2, the CBF-CVR maps (rows 4 and 5), display the same
GM-WM contrast as observed in the CBF0 maps. Reproducibility of CVR measures is,
however, lower than the reproducibility of CBF0; and spatially dependent (6th row). Vari-
ability of CVR measures in WM can be an order of magnitude higher than in GM (CVs
in deep WM may reach 200%). When the hypercapnic response is expressed as a percent
increase in CBF with respect to its baseline levels, the CVR maps no longer show a clear
contrast between GM and WM tissues (rows 7 and 8). In WM and in the posterior cor-
tex (regions where longer arrival times [103, 249, 282, 375] and delayed CO2 responses
[30, 367] render ASL measures challenging) the CBF percent changes are much higher
(>10%/mmHg) compared to the overall response in GM (around 4%/mmHg).
DISCUSSION
We have evaluated reproducibility of dual-echo pCASL measures of BOLD and CBF
responses to blood gases by having 8 healthy subjects scanned twice within a 24h inter-
val and using a simple respiratory manipulation to induce changes in blood gases. The
breathing paradigm we have adopted comprised changes in end-tidal levels of both O2
and CO2. Although these were manipulated in the same scan, we would expect repro-
ducibility of pCASL measures to be the same in paradigms in which only one of them
(e.g. CO2) is manipulated.
The BOLD and CBF signals measured in both tests were robust and consistent.
BOLD and CBF signals were significantly higher than noise levels in more than 85%
of the voxels of our GM mask. In agreement with a previous report [61], pCASL mea-
sures of baseline CBF differed by less than 5% of the mean value between scans. As
to the reproducibility of evoked responses, we found that while increases in CBF signal
(which was expected to have a lower SNR) differed by less than 20%, BOLD responses
differed by less than 10%
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Here we report a direct estimate of the reproducibility of BOLD signal changes to
hyperoxia. Goodwin et al. [129] have previously reported reproducibility of the calibra-
tion parameter M, which is computed from BOLD hyperoxic responses but also depends
on other measured quantities. Reproducibility of BOLD and CBF responses to hyper-
capnia, on the other hand, have been more widely studied, both in humans and animals,
though estimates were obtained using other imaging and respiratory methods.
Using a computer controlled system to prospectively target end-tidal levels, Kassner
et al. [183] have measured BOLD-CVR in 19 subjects, and found that, between days,
CVR in GM varied by 6.8% of the mean value. This is equivalent to what we have
obtained for the BOLD responses before these were normalized by the magnitude of
the CO2 increase to compute CVR. Winter et al. [398] used the same method to study
cerebrovascular reactivity in juvenile swine and obtained BOLD measures that were
highly reproducible – CV in GM-containing structures were found to range between
4.4% and 9.0%. If we consider that these values were obtained with a BOLD dedicated
imaging method and in animals that were under anesthesia (mechanically ventilated),
the CV of 8.8% we report for the CVR in the whole GM in awake humans is promising.
A different study reported reproducibility of BOLD and CBF responses to hypercap-
nia in humans though in a small area restricted to the visual cortex. Using a PASL tech-
nique, Leontiev and Buxton [225] measured percent BOLD and CBF responses whose
inter-session CV were more than two-fold higher than ours: 26.1% and 40.6% vs. 6.8%
and 18.8%. An interesting finding in their study, which we expected to have replicated
in ours, was that reproducibility of CO2-normalized CBF responses were remarkably
higher than the non-normalized ones (CV decreased from 40.6% to 23.7%), suggesting
that a significant part of the variability observed in this type of measurement stems from
inconsistencies in the hypercapnic manipulation. Our results, however, showed an oppo-
site trend: when the BOLD and CBF responses were normalized by the magnitude of the
stimuli, CV values tended to increase. Goode et al. [128] also observed this effect: nor-
malization of BOLD responses degraded their inter-subject reproducibility. Most likely
these findings are just artifactual, but given that our subjects underwent consistent respi-
ratory manipulations and that BOLD/CBF responses were lower in the second scan, it is
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also possible that our measurements indicate an habituation effect.
In a recent study examining the accuracy and precision of pCASL CBF measures,
Heijtel et al. [149]) showed that pCASL measures were reproducible and consistent
with PET 15O-H2O measures, regardless of blood CO2 conditions. Aside from nuances
related to the imaging methods, a comparison between these two measures is problem-
atic mostly due to relevant differences in the manipulation methods. It is also difficult
to compare the degree of reproducibility achieved in that study with ours because 1)
CBF/CVR were measured with up to 7 days difference between scans and 2) the authors
report an index for repeatability/variability that is slightly different than our computed
CV. In spite of the different methodologies adopted, both studies add evidence support-
ing pCASL as a technique with potential to replace standard invasive measures and able
to provide reliable measures of CBF and CVR. We thus feel that our reproducibility
study is complementary to the study of Heijtel et al.
Despite the small drift we observed in the ET CO2 traces of the re-test experiment,
ET modulations were consistent. Since the dependence of BOLD susceptibility sig-
nal on ET O2 is the relatively small (less than 0.005%/mmHg), the spurious effects of
small (≈5 mmHg) O2 increases during CO2 administration are less of a problem for the
accuracy of BOLD/CBF measures during hypercapnia. On the other hand, the small
(≈1 mmHg) reduction in ET CO2 during the O2 administration is somewhat a concern.
As Iscoe and Fisher pointed out [169] it is important to appreciate the hyperoxic-
associated hypocapnic effects because they can cause a significant decline in CBF. Even
though the spurious effect of hyperoxygenation on blood/tissue T1 renders CBF quan-
tification challenging [46, 425], we did model the CBF responses to O2 inhalation and
our estimates indicate a 7.1±0.9% reduction in baseline CBF levels associated to the
hyperoxic-hypocapnia. Assuming that CBF has been measured in the linear region
of the CO2 dose-response curve and – as our hypercapnic experiments indicate – that
CBF changes 4-5% per mmHg change in CO2, the 7% reduction in CBF in response
to hyperoxic-hypocapnia is not only related to the CO2 effect. Such measure does have
a component associated to the effect of O2; which can influence CBF directly through
vasoconstriction or indirectly by accelerating blood longitudinal relaxation (T1 shorten-
107
ing) [296]. A discussion about the accuracy of CBF measures in hyperoxia and disen-
tanglement of the different effects contributing to it are, however, beyond the scope of
this paper.
The O2-induced hypocapnia might, likewise, have impacted on the BOLD signal,
causing BOLD hyperoxic responses to be underestimate. In an eucapnic 283 mmHg
hyperoxic stimulation, where CBF should stay constant, one would measure BOLD re-
sponses higher than what we measured, with CBF levels depressed. Thus, in studies
involving hyperoxic induction without control for hypocapnia, the quantification of re-
lated BOLD hyperoxic responses should be judicious.
Although reproducibility of the respiratory stimuli using the adopted method did not
match those obtained using a system for prospective end-tidal targeting [398], the sim-
plicity of the manipulation and degree of reproducibility of related fMRI measures that
can be achieved with it, still make the fixed inspired methods attractive for clinical ap-
plications. As the magnitude of respiratory responses are greatly determined by inspired
doses, reproducibility of fractional inspired concentrations is an asset in fixed inspired
based methods. The breathing circuit we have used for gas delivery ensures a tight cor-
respondence between administered doses and the actual doses inhaled by the subject,
thus affording step changes in FiO2 and FiCO2 that were highly reproducible. When
the only breathing apparatus available is a standard oxygen face mask, a better control
over inspired doses is desirable to improve reproducibility of the stimulus. This can be
achieved by partial sealing the edges of the mask using use adhesive tape; and increasing
the flow rate of administered gases.
The pCASL imaging protocol we report here was tailored to the 18-min respiratory
protocol and had labeling/readout parameters adjusted to meet criteria such as whole
brain imaging with minimal gap and detection rate of CBF responses in GM above 80%.
The post-label delay (PLD) of 900 ms we have adopted is somewhat shorter than the
values generally reported, which are >1 s. In 3D acquisitions where there is a single
PLD for the whole imaged volume, PLD can be as long as 2 s. In spite of that, according
to Asllani et al. [15], the delivery times at proximal slices of the brain can be as low as
400 ms, which is more than twice as short as the PLD in the first slice of our 2D acqui-
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sition (the nominal PLD, 900 ms). The effective PLD in the last slice of our imaging
slab is 2.0 s, which is also much longer than the delivery time Asllani et al. found in
upper parts of the brain ( 1.1 s). This means that our 2D-imaging protocol satisfies the
condition of PLD > delivery time, per slice. The recent study of Donahue et al. lends
support to that showing tag delivery times of less than 1.0 s in central slices [80].
It has been assumed that in a cohort of young, normal and cooperative subjects, and
within a 24h maximum interval between scan sessions, both test measurements should
yield the exact same result, i.e. that any difference in observations should be attributed
to limitations of the measuring/stimulation method rather than to physiological changes.
However, CBF can change in the course of the day, so our results manifest a combination
of experimental error and physiological shifts. The degree of reproducibility we reported
here is probably close to the maximum degree one can be achieved using the proposed
method, but different results could be obtained with a shorter interval between scans
and a larger sample could be used to confirm our findings. The reliability of reported
measures in clinical populations also remains to be evaluated.
Small minute minute volume fluctuations (regarded as high frequency components
of the respiratory manipulation) are reflected in fMRI signals as (physiological) noise,
which decreases the statistical power of response estimates. ET-related noise should not
have a significant impact on the accuracy of response amplitude estimates (i.e. CVR
maps) because the linear modeling of fMRI signal acts as a low pass filter. However,
in some clinical populations this can be otherwise. The control for ET spontaneous
fluctuations is possible using other breathing circuits and/or computer controlled gas
mixing systems [18, 341, 400]
Although we have not applied physiological de-noising (e.g. RETROICOR [122,
409]), nor partial volume correction [14], or even corrections for hemodynamic re-
sponse delays [30], these post-processing strategies might certainly help improving re-
producibility/reliability of pCASL dynamic measures and should be incorporated in fu-
ture studies. Other improvements necessitating ancillary MRI acquisitions would in-
clude corrections for regional differences in arrival times [80, 102, 249] and for drops in
label efficiency [13, 175, 410]. Last, but no less importantly, readout related implemen-
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tations such as 3D-imaging [137], background suppression [105, 115, 417], multi-band
excitation [90], etc, might also contribute to a better and more reliable pCASL signal.
In conclusion, the use of simple respiratory manipulations to induce blood gas changes
and pCASL to measure associated BOLD/CBF responses is a promising avenue for the
translational research on neurovascular function imaging methods.
CHAPTER 5
PHYSIOLOGICAL MODELING OF CVR
The objective of this study was to formulate a CVR model that accounted for osmotic
forces and could explain the ASL experimental data.
]
5.1 Cerebral perfusion pressure
The cerebral vasculature consists of the vessels downstream from the internal carotids
and vertebral arteries that either feed or drain the brain plus cerebral capillaries [268].
While arteries and veins are self-contained vessels, capillaries are muscleless, single-
layered, minute size vessels that rest embedded within the organ tissue. Capillaries form
a vast fractal array of tubes that pervade the organ giving it porosity [56, 63, 127, 237].
Given their ubiquity, they are generally considered an indissociable constituent of the
tissue. It is at the capillary level that blood, penetrating the intimacies of cerebral tissue,
exchanges with the surrounding extravascular tissue. The brain has an extremely high
metabolic activity per unit mass and approximately 15% of the cardiac output is required
to keep its homeostasis [66, 260]. This highly metabolic and highly perfused organ is
also a key component for the survival of the body, and as such it counts on a stringently
auto-regulated vascular system [165, 173, 289, 397].
It has been shown that cerebral blood flow (CBF) remains fairly constant for a wide
range of systemic arterial pressure (MAP) values, indicating that cerebral vasculature re-
sistance is tightly adjusted to compensate for pressure changes upstream (Figure 5.1A)
[207, 218, 356]. On the other hand it has also been observed that cerebral perfusion
pressure (CPP) remains constant for a wide variety of perfusion regimens (Figure 5.1B)
[134, 142, 314]. For instance, upon a drop in resistance downstream, caused by any
given vasodilatatory stimulus (e.g. hypercapnia), the main arteries feeding the brain will
be found to offer less resistance and let more blood to flow in [193, 223]. Such flow
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changes would require, however, accompanying central changes in the cardiac output
[196]. At the main entrance of blood in to the brain, i.e. at the origin of the internal
carotids, the carotid sinuses function as physiological pressure sensors, that, signaling
to the autonomic centers in the brainstem, provide input to feed-back pressure control
mechanisms regulating the cardiac output 1 [300].
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Figure 5.1: Relationship between Pressure, Resistance and Flow. This Figure shows a simpli-
fied description of auto-regulatory flow-pressure mechanisms. In the auto-regulatory zone, cere-
bral blood flow (CBF) remains constant for a range of different systemic pressure (A) (Adapted
with permission from Lippincott Williams and Wilkins/Wolters Kluwer Health: Samuel Lucas
et al., Influence of Changes in Blood Pressure on Cerebral Perfusion and Oxygenation, [240],
2010). This occurs because cerebrovascular resistance adjusts in accordance to the upstream
pressure (MAP): increases in pressure yields increases in downstream resistance to flow. When a
given dilatory stimulus, such as hypercapnia, decreases resistance downstream, upstream adjust-
ments are necessary to allow blood flow to increase and keep cerebral perfusion pressure (CPP)
constant (B).
The above observations imply the existence of multi-level neuro-muscular reflex
mechanisms involving tonus changes and central adjustments in cardiac output that are
intended to ensure 1) cerebral perfusion immunity to changes in hydrostatic pressure
1. Cerebral vasculature provides two out of the three pressure inputs used in such regulatory circuitry.
The other input comes from similar baroreceptors lying on the aortic arch, which senses and signals global
changes in the systemic pressure.
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upstream and 2) cerebral perfusion pressure immunity to changes in resistance down-
stream; thus allowing a condition where perfusion levels are ultimately determined by
the resistance of downstream vessels [54, 197].
The brain displays a unique compartmentalization of its functions and cerebral vas-
culature provides control over the resistance of its vessels at a remarkably low level
which allows supporting its metabolic demands with proportional hyperaemic responses
that are temporally and locally coupled with the changes in metabolism. It has been ob-
served that local hyperaemic responses evoked by neuronal stimulation can occur within
milliseconds [70] and be constrained to volumes as minimal as 1 mm3 [125, 148], a
phenomenon that implies resistance adjustments at the level of arterioles and capillaries.
Although extensively exploited in – and actually forming the basis of – modern imaging
techniques for mapping the cerebral function [235, 380], the nature of such fine control
over cerebral perfusion has been elusive [141, 222, 291, 324].
With recent and more convincing observations of capillary dilation arising from ei-
ther neuronal or vascular stimulation (including hypercapnia) [16, 82, 354, 381], the
view that capillaries are mere “rigid tubes immersed in gel” seems to have been aban-
doned 2. The exact mechanisms underlying the changes in capillary resistance, as well
as the contribution of capillary reactivity to the cerebral hyperaemic responses, are, yet,
a matter of debate [92, 173, 236, 292, 326]. It is natural to speculate whether capillaries
could play an active role in hyperaemic responses [58], participating as the main deter-
minant of cerebral perfusion levels – this would provide ultimate specificity to tissue
perfusion control [236]. However, since capillary vessels are still commonly regarded
as passive elements of the cerebrovascular circuitry, the current understanding is that
tissue hyperaemia is a phenomenon originating within arterioles. According to the latter
views, the capillary dilation that occurs during hyperaemia is the effect accompanying,
i.e. caused by / controlled by, arteriole vasodilation [209, 254]. Albeit widely accepted,
this cause-effect rationale implies a breakdown of the general pattern of cerebral vascular
resistance control. According to what has hitherto been exposed, if, by any reason, arte-
2. Capillaries are more easily compared to a elongated and distensible “soap bubbles” immersed in
liquid
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riolar resistance drops prior to capillary resistance, thus increasing the perfusion pressure
exerted upon capillaries, we should expect an increase in capillaries resistance in order
to preserve perfusion against upstream changes [210, 323, 352], not the opposite. That
is to say, if auto-regulation of perfusion pressure is to conform in the whole cerebral
vasculature, in hyperaemic responses the capillary resistance changes should precede
and be the cause, rather than the effect of arteriolar adjustments. Furthermore, capillar-
ies are highly permeable to water, i.e. water does not exert a significant force upon its
walls. According to the Starling’s hypothesis [200], an increase in capillary intravascular
hydrostatic pressure favours the movement of water to the extravascular compartment,
causing brain oedema [309] rather than a capillary volume gain.
Although the idea of a feed-forward control of capillary resistance continues to be
explored in models of metabolic-induced hyperaemia, no in vivo evidence has been pro-
duced to support this hypothesis. Conversely, at least one study in muscle [21] and one
in the brain [58] report measures of metabolically induced vascular changes that suggest
capillaries dilate prior to upstream vessels.
The next Figure shows an electrical circuit analogy of CPP control during hyper-
aemia according to the latter view. The upper diagram represents the vascular system
supplying the brain. The different segments of the vascular system, from the heart/aorta
to the venular tree, are depicted from left to right. The cardiac output is the circuit ele-
ment raising the potential of venous blood and propelling it to the brain as arterial blood,
with high pressure and velocity. The arterial side of cerebral vasculature, i.e. Main ar-
teries, Arteries, Small arteries and Arterioles, are represented as resistor/capacitor ele-
ments. As they increase in number, the per element resistance/capacitance progressively
decreases. Capillaries are shown as a myriad of pores permeating an object, i.e. the
cerebral tissue. The venular tree is represented as a pool of blood with low and steady
hydrostatic pressure [261], i.e. “ground level of the vascular circuitry.”
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Figure 5.2: Electrical circuit analogy of CPP control during hyperaemia.
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As it has been Generally observed CO2-induced hyperaemia is caused by relaxation
of the downstream vessels (1) of the cerebral vasculature, not by an increase in cerebral
perfusion pressure (as described in Figure 3B, perfusion pressure remains fairly con-
stant during the CO2 response). A decrease in resistance (⇓R) of downstream vessels
yield a pressure (P) reflex of upstream vessels (2) that cause a retro-propagation of rapid
adjustments in the resistance of upstream vessels to re-establish perfusion pressure (3).
According to an Upstream model of tissue hyperaemia control, capillary reactivity is
regulated by arterioles. The first thing to occur in CO2-hyperaemia would be a drop
in arterioles’ resistance (1). The consequence of that would be a forwardly propagated
increase in capillary hydrostatic pressure (2), which in turn would yield capillary dila-
tion (3). Re-establishment of perfusion pressure would stem from the retro-propagated
resistance adjustments above mentioned, but which would be triggered by a combined
decrease in arterioles and capillaries resistances (4). In a Downstream model of tissue
perfusion regulation the first thing to happen would be a drop in capillary resistance (1).
This would cause a drop in perfusion pressure that is is further re-established by retro-
propagated decreases in arterial resistances (3). In such a model of perfusion pressure
compensation during CO2-hyperaemia there is only retro-propagation of resistance ad-
justments. Although a Downstream model conforms better with a general understanding
of resistance/pressure regulation, Upstream models are still the dominant view because
capillaries are considered passive elements of the vascular circuitry.
To summarize, the raison d’être of cerebral vasculature auto-regulatory mechanisms
is to ensure proper perfusion of the brain, permitting adjustments according to the or-
gan’s demands. And it is reasonable to suppose that cerebral hyperaemic responses is
a phenomenon originating at the tissue level. If the arterial side of cerebral vasculature
can considered a hydraulic control system existing to preserve the perfusion pressure ex-
erted upon the cerebral tissue, capillary resistance would be the key factor determining
the rate of tissue perfusion. To put it differently, the prime duty of cerebral vasculature
may be to grant spongey brain an adequate flux of blood to keep the hydrostatic tone of
its pores, irrespective of their aperture. That would require, though, a rationale for the
phenomenon of intrinsic porosity changes.
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5.2 Blood osmotic pressure
The intravascular content of capillaries are separated from the rest of the brain tissue
by what is known as the Blood-Brain-Barrier (BBB) [35, 287]. The BBB is formed by
the single layer of tightly interconnected endothelial cells that defines capillary bound-
aries, an adjacent matrix of glycoproteins (glycocalyx), surrounding glial cells (e.g.
perycites) and cell processes (astrocytes end-feet). While severely limiting the diffusion
of most of the solutes present in the blood and brain tissue, such barrier offers virtually
no resistance to the passage (of gases) and water. The BBB can thus be regarded as the
ideal semi-permeable barrier, causing the brain to function as an osmometer (Ref [344]
page 67). Whereas protected against hydrostatic pressure variations, the cerebral perfu-
sion is extremely susceptible to changes in blood osmotic pressure. This fact has been
exploited in the treatment of intracranial hypertension [78, 97] where hypertonic solu-
tions are administered to promote a decrease in cerebral water content, i.e. shrinkage of
brain volume [378]. The use of hypertonic solutions may also help in ischemic stroke,
by promoting the re-perfusion of affected areas [362]. Like hypercapnia, hypertonic so-
lutions reduce vascular resistance (presumably by causing a blood volume increase [312]
in the first place) and allow perfusion to increase [182].
To date no one has speculated whether, analogously to the administration of hyper-
tonic solutions, vasculature resistance changes to CO2 can be related to changes in the
blood osmotic pressure.
While gaseous CO2 is not osmotically active per se, the products of its dissolution
(H+ and HCO−3 ) are. It has been shown that blood osmolarity is indeed affected by the
relative amount, or partial pressure, of CO2. According to Boning et al. [32] a 10 mmHg
increase in PaCO2 raises blood osmolarity by 3.7 mOsm, which corresponds to an os-
motic pressure increase of approximately 65 mmHg. This is about half the hydrostatic
pressure of blood in the aorta; and more than 10 times larger than the estimated increase
(5mmHg) producing capillary volume changes in upstream models [209]. It is worth
noting that the net transfer of water across the BBB is largely governed by the balance of
osmotic pressure between intra and extra vascular compartments. These may be as high
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as 5,500 mmHg in each of the compartments, almost 200 times higher than hydrostatic
pressures.
5.3 CVR model based on osmotic forces
The CBF changes induced by CO2 manipulations are usually estimated by linear fit-
ting a response regressor to the measured data. Response regressors can consist of the
monitored changes in respiratory CO2, for instance, or any approximate model of the
associated hemodynamic responses. In Chapter 2 and 4 of this thesis, CBF measured
responses were fit with a model generated from the convolution of the paradigm de-
sign (the schedule representing the periods of normocapnia/hypercapnia) with a gamma
variate function, the hemodynamic response function (HRF) that is commonly used in
fMRI signal analysis. Given the differences in magnitude and time courses of PET CO2
changes, the parameters defining the HRFs were adapted for each case: in Chapter 4
the time to peak and width defining the gamma function were three time as large as
in Chapter 2. In Chapter 3, the response regressors consisted of the modeled PET CO2
responses (similar to using PET CO2 monitored values). Though such statistical proce-
dures can afford robust estimates of CBF responses, they do not provide a rationale for
the phenomenon underlying the vascular reactivity to blood CO2 – fitting of the data with
PET CO2 traces or any empirical HRF can only attribute a magnitude for the observed
responses.
Amongst the few mathematical models describing the vascular reactivity to CO2,
only one [130] attempts to explain the complete chain of physiological events that would
lead to a change in vessels’ resistance and hence blood flow 3. This model incorporates
38 parameters, several of which are estimated from in vitro experiments and which in
general were allowed to vary over a range of accepted values (sometimes over orders
of magnitude). The CBF responses predicted by this model were slower than the ex-
perimentally observed data and the authors concluded that a more rapid mechanism of
vascular resistance control was necessary to accurately explain the in vivo data. Osmotic
3. In the referred model, CPP is considered to be unaltered during flow changes so that perfusion
becomes a function of downstream vessels’ resistance
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forces have not been contemplated in such model.
Vascular reactivity to experimental manipulations in blood osmotic pressure has been
observed in the brain as well as in other vascular territories [112, 140, 146, 243]. How-
ever, similarly to the cerebral reactivity to blood CO2, the phenomenon is not completely
understood. There seems to be no consensus about the physiological mechanisms in-
volved nor a mathematical model relating blood osmolarity to perfusion changes. How-
ever, given that osmotic manipulations imply the transfer of water between compart-
ments and that tissue hyperaemia implicates an increase in capillary blood volume, I
reason that the simplest way to model the physiology of osmotically-induced hyper-
aemia is to associate it to an osmotically-induced blood volume gain.
The model of cerebrovascular reactivity to CO2 that I propose is grounded in 3 corol-
laries: 1) during a brief episode of hypercapnia most of the CO2 remains intravascular,
in the form of HCO−3 [338], functioning as a hypertonic manipulation; 2) in normal con-
ditions (and assuming an ideal control of capillary perfusion pressure [262]) perfusion
can be made a function of capillary resistance only; and 3) blood and the surrounding tis-
sue are two tightly coupled compartments that exhibit complementary volume changes,
respecting the Monro-Kellie doctrine of a constant total volume (e.g. dehydration of the
extravascular compartment issuing from an increase in blood osmotic pressure is equiv-
alent to the blood volume/capillary size gains).
This CVR model uses a dynamic version of the Starling filtration equation allowing a
temporally varying blood osmolarity input. By converting blood CO2 in to blood osmo-
larity changes it is possible to use the model to compute the perfusion changes induced
by any given hypercapnic manipulation. Apart from the CO2 variable input, the model’s
output depends on two other physiological quantities, namely the capillary/BBB perme-
ability (or more precisely, the water conductivity) and baseline vasodilation (VASO0).
Figure 5.3 shows the schematics of how to compute the flow changes from CO2 changes
according to the new proposition.
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Figure 5.3: Modeling the role of blood osmolarity in CVR. In the proposed model, the perfu-
sion responses (∆CBF) observed during hypercapnia (∆CO2) would be the result of vascular oc-
cupancy changes (∆VASO) that occur due to CO2-induced changes in blood osmolarity (∆Osm).
∆Osm can be computed from ∆CO2 using the relationship reported by Boning et al. Using a tem-
poral version of the Starling equation it is possible to compute the ∆VASO dynamic responses
associated to a given ∆CO2/∆Osm change. This equation takes BBB permeability and initial
VASO (VASO0) as fixed parameters. ∆CBF can be computed from ∆VASO using the Grubb’s
formula.
Alluding to Figure 4, the model suggests that capillaries are supplied by a battery-like
pressure source and regulate tissue perfusion by acting as a "lumped Starling resistor";
and that osmosis is the driving force of capillary reactivity.
Validity of this model has been assessed by comparing its numerical predictions
with real experimental data measured with pseudo-continuous ASL. To generate the
predicted responses the model has been fed with monitored values of PET CO2 (a surro-
gate for arterial CO2) and BBB permeability reported in the specialized literature. ASL
hemodynamic data have been fit with the new CO2-HRF model by allowing VASO0 to
vary, yielding best estimates for this parameter. Estimated VASO0 values ranged from
4.8% to 8.5%, in agreement with literature estimates of VASO0 [120, 135] and blood-
to-tissue water partition coefficient (another parameter estimating the contribution of the
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blood/vascular compartment to the imaged volume) [7, 153, 423]. The model predicts
that the magnitude of CBF responses are inversely related to VASO0, which is in keeping
with other experimental observations. More importantly, the fitting of CBF data using
this CO2-HRF afforded a physiological rationale for the differences in the amplitude of
measured CVRs; and in timing as well. In an additional test, to gauge the impact of per-
meability on the time course of predicted CBF changes, VASO0 was fixed and BBB was
allowed to vary. Results from this test suggest that BBB permeability is a critical phys-
iological quantity affecting the promptness of cerebral vasculature to respond to blood
CO2 changes. In conclusion, the model explains CVR differences in terms of physiology
and succeeds predicting in vivo hemodynamic data using parameter values that are fairly
well established. A detailed account of the mathematical development and model’s val-
idation is found in the manuscript that follows, which has been submitted to Medical
Hypotheses as a full research article (it has been provisionally accepted for publication
in Jan 2015, with minor revisions pending). A brief report on these observations has
been communicated in the 2014 annual meeting of the Organization for Human Brain
Mapping.
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5.4 Stuty manuscript
Modeling the role of osmotic forces in the cerebrovascular response to CO2
Authors: Felipe B. Tancredi, Hèléne Girouard and Richard D. Hoge
Status: Provisionally accepted for publication in the journal Medical Hypothesis 4.
Increases in blood osmolarity have been shown to exert a vasodilatory effect on cere-
bral and other vasculature, with accompanying increases in blood flow. It has also been
shown that, through an influence on blood concentration of the bicarbonate ion and pH,
changes in blood levels of CO2 can alter blood osmolarity sufficiently to have an im-
pact on vessel diameter. We propose here that this phenomenon plays a previously
unappreciated role in CO2-mediated vasodilation, and present a biophysical model of
osmotically driven vasodilation. Our model, which is based on literature data describ-
ing CO2-dependent changes in blood osmolarity and hydraulic conductivity (Lp) of the
blood-brain barrier, is used to predict the change in cerebral blood flow (CBF) associated
with osmotic forces arising from a specific hypercapnic challenge. Modeled changes
were then compared with actual CBF changes determined using arterial spin-labeling
(ASL) MRI. For changes in the arterial partial pressure of CO2 (PaCO2) of 20 mmHg,
our model predicted increases of 80% from baseline CBF with a temporal evolution that
was comparable to the measured hemodynamic responses. Our modeling results suggest
that osmotic forces could play a significant role in the cerebrovascular response to CO2.
Key Words: Arterial Spin Labeling, Blood Osmolarity, Cerebral Blood Flow, Cerebral
Blood Volume, Hypercapnia, Neuroimaging, Physiological Modeling, Cerebrovascular
Reactivity
4. In between the initial deposit of this thesis and the oral examination the manuscript in this Chapter
has been accepted for publication – it has been online since 25 March 2015. The manuscript has been
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INTRODUCTION
Carbon dioxide (CO2), a byproduct of oxidative metabolism and the most abundant
constituent of blood after water and NaCl, is also a potent vasoactive agent. Increased
levels of CO2 in the blood, a condition termed hypercapnia, cause cerebral vasculature to
dilate, decreasing vascular resistance and increasing cerebral blood flow [134, 162, 193,
195, 314, 332, 363]. Although CO2 has long been recognized as an important regulator
of the vascular tone and blood flow in the brain, the exact mechanisms of such control
have been uncertain [38, 419].
The current understanding is that the effect of CO2 on cerebral vasculature is medi-
ated by additive effects of acidosis and bicarbonate ion [370]. These, in turn, will activate
KATP and BKCa channels [71, 388]; Na+-H+ exchangers [370], Na+ pump [370] as
well as nitric oxide (NO) [230, 231] and cyclo-oxygenase-1 pathways [273] induce va-
sodilation through inhibition of voltage-dependent Ca2+ channels (VDCC) [393]. Since
parenchymal arterioles account for about 40% of total cerebral vascular resistance [88],
hypercapnic effects had been attributed to the vasoreactivity of these arterial segments.
However, it has also been recognized that capillaries, the vessels mostly exchanging with
the tissue, have an important participation in the cerebrovascular response to hypercap-
nia [16, 82, 381], and some evidence suggests that the CO2-response could be driven
at the level of such small vessels. For example, a higher percentage change in diame-
ter in response to mild hypercapnia had been observed in the smallest capillaries [163].
The reactivity of brain capillaries to neuronal activation may involve the participation
of pericytes [292] - though it has also been demonstrated that capillaries can dilate in
the absence of pericyte activity [92]. Capillary vessels contain blood within the tissue,
separating it from the other brain compartments, all of which have water contents – i.e.
their volumes – intimately related [124, 200, 226]. Thereby, modulation in water trans-
port gradients is another possible mechanism contributing to transient capillary blood
volume changes [311] such as those occurring in response to CO2 [82].
As Yoon et al. have recently pointed out [419], it is possible that the cerebrovascular
response to hypercapnia includes a component associated to changes occurring within
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the blood compartment. The cerebral vasculature, as well as that of other organs, is
very responsive to changes in blood osmolarity. Administration of hypertonic solutions,
which increases blood osmolarity, yields a decrease in vascular resistance with an ac-
companying hyperperfusion of the tissue [112, 140, 182, 243, 244, 312, 362]. When
dissolved in plasma, CO2 alters blood pH and bicarbonate levels, thence influencing
blood osmolarity [31, 32, 150, 264] and possibly disturbing the water transport gradient
between blood and parenchyma. Despite the impact of CO2 on blood osmolarity, there
has been little attention to the potential role of blood osmolarity and capillary water
transfer mechanisms in the vasodilatory response to hypercapnia.
Infusion of sodium bicarbonate solutions has been shown to cause blood osmolarity
to increase [420] and yield dose-dependent increases in CBF [43]. While such manip-
ulations cause blood volume to increase, they also cause the water content of the brain
tissue to decrease. This is consistent with the Monro-Kellie hypothesis [203, 309], which
states that, under normal conditions, volume increases in one compartment of the brain
(e.g. blood), must be accompanied by volume reduction in another (e.g. extravascular).
Similarly, while inducing increases in cerebral blood volume and flow, hypercapnia is
also associated with increases in blood bicarbonate content and shrinkage of extravas-
cular compartments of the cerebral tissue. Lu et al. [238] measured that a moderate 10-
15 mmHg increase in PaCO2 yields an approximate 1-2% reduction of the extravascular
space to accommodate a fractional blood volume occupation that increases from 5% to
6-7%. It is conceivable that such hypercapnically-induced volume exchange is related to
an osmotically-driven transfer of water between intra- and extravascular compartments,
i.e. that during hypercapnia the extravascular space loses water to blood because, due
to an increased CO2-bicarbonate activity, blood is rendered hypertonic. According to
Boning et al. [32] a 10-15 mmHg increase in PaCO2 raises blood osmolarity by approxi-
mately 1-2% of its nominal value, a figure that is comparable to the extravascular volume
reduction measured by Lu et al.
We hypothesize that the phenomenon of cerebrovascular response to CO2 includes
a contribution associated with the emer- gence of an osmotic gradient across the blood
brain barrier (BBB) that causes the volume of the blood compartment to change.
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HYPOTHESIS
Theory
Metabolically-generated CO2 is washed out by arterial blood that enters the cerebral
tissue with lower amounts of CO2 and leaves the brain as venous blood, with higher
PCO2, higher [HCO−3 ] and lower pH [202, 322]. There is a permanent passive flux of
CO2 from brain to blood because there exists a gradient of PCO2 between parenchyma
and blood [119, 301] and because the BBB is permeable to CO2 in its gaseous form [283,
316]. Yet, the presence of carbonic anhydrase (CA) enzymes residing in the luminal face
of the BBB and erythrocytes accelerates hydration of CO2 to be carried by blood in the
form of H+ and HCO−3 thus greatly contributing to the tissue-to-blood flux of CO2 [114,
151]. It seems that, paralleling the role of hemoglobin that gives blood a high capacity
for carrying and rapidly loading/unloading oxygen, a high activity of CA enzymes in the
blood compartment endows blood with an efficient mechanism for transporting CO2.
Nevertheless, while advantageous in the blood, a high catalytic activity of CA en-
zymes in the parenchyma would be an enemy of the tissue [322]. Not only because CO2
needs to quickly cross lipid barriers and reach the blood stream to be washed out – which
would be hampered should this gas be readily dissolved in the parenchyma – but also
because tissue homeostasis would be too susceptible to normally occurring transients in
blood PCO2 levels. A lower CA activity in the parenchyma implies that CO2 would be
converted into H+/HCO−3 less efficiently in this compartment than in the blood com-
partment [41, 316, 337, 338]. Accordingly, although parenchymal PCO2 can increase
during a brief episode of hypercapnia – because an increase in blood PCO2 will reduce
the tissue CO2 washout – this increase would represent a much smaller total amount of
dissolved CO2 than that necessary to increase PCO2 in the blood. Albeit there is no
direct empirical evidence of this phenomenon, the rationale finds support in different
studies on the buffer capacities of the different body storages of CO2 [62, 89]. While it
has been shown that it may take more than 1 h for all the fluids in the body to equilibrate
with alveolar/arterial PCO2 [335, 376] some studies show that blood PCO2 increases in
the feeding arteries are closely followed by PCO2 increases in the jugular vein [37, 193].
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Altogether this indicates that despite its higher volume compared to the blood compart-
ment and higher total capacity to store CO2, extravascular compartments dissolve CO2
at a much slower rate than blood.
In conclusion, if we observe that the blood brain barrier (BBB) is relatively imper-
meable to the products of CO2 dissolution in plasma and that the parenchyma dissolves
CO2 at a much lower rate than blood, we can assume that the surplus of CO2 perfusing
the tissue during a brief hypercapnic stimulus (∼2 min) will remain mostly intravascular,
in the form of H+/HCO−3 , functioning as a hypertonic manipulation and giving rise to
an osmotic gradient across the BBB. This will result in a water volume transfer between
BBB’s adjacent compartments that increases the volume of the blood compartment and
decreases the tissue resistance to perfusion. Hyperaemia of the cerebral tissue will follow
as long as upstream vessels respond synergistically, also decreasing resistance, to allow
more blood to flow in. That is to say, the driving forces of cerebral vascular reactivity
to CO2 might be viewed as being, at least in part, of an osmotic nature, and originating
at the capillary level [58, 350], as opposed to being regulated by pre-capillary arteriolar
tone [173].
To assess the potential impact of this mechanism, we have devised a simple bio-
physical model allowing quantification of tissue perfusion changes associated with CO2-
related changes in blood osmolarity.
Conceptual model
We have developed a two compartment model, in which the intravascular (blood)
and extravascular (EVC) compartments of the brain tissue have their volumes coupled
according to the doctrine of Monro-Kellie (as in refs. [309] and [209]. Increases in vas-
cular space occupancy (VASO), i.e. blood volume, are accompanied by equivalent losses
in EVC; and vice-versa. When blood osmolarity increases, the EVC loses water to the
blood stream until the osmotic gradient across the BBB separating the two compart-
ments is eliminated. If we respect the Monro-Kellie principle, when the equilibrium is
reestablished, the blood compartment occupies a larger volume (Figure 5.4).
In our model, we assume that such volumetric changes occur under conditions of
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1) At stead-state, Starling forces (osmotic + hydrostatic pressure gradients 
across BBB) are in equilibrium and the net transfer of water between 
the two compartments, EVC and blood, is null; 
2) During hypercapnia when blood becomes hyperosmotic with respect to 
EVC, an osmotic gradient across the BBB arises and the net transfer of 
water between EVC and blood is no longer zero; 
3)  EVC loses water to the blood and shrinks, while blood volume 
increases resulting in dilation of the exchanging vessel. The volume 
exchange reaches steady-state when EVC has lost enough water to re-
equalize the Starling forces between the two compartments. The 
perfusion increase is a function of the osmotic increase, and fractional 
contributions of the EVC and blood compartments to the total volume.
Figure 5.4: Osmotic driven increase in the blood volume and flow: conceptual model. EVC
= Extravascular compartments; EVCV = EVC Volume; d = diameter.
normal vascular autoregulation [181, 218], so that perfusion pressure is considered to
remain constant for different values of vascular resistance. This allowed us to state flow
as a function of resistance only [254] and to employ Grubb’s formula [134] to compute
the changes in blood flow from changes in blood volume (according to Poiseuille’s law,
and assuming laminar flow, flow changes can be expressed as a power function of volume
changes using an exponent of 2.0; Grubb’s empirical law uses an exponent of 2.63 to
relate the two quantities).
To relate CO2 levels to blood osmolarity changes, we use the relationship reported
127
by Boning et al [32]. These authors found that in hypercapnia, when blood pH is lower
and [HCO−3 ] higher, blood osmolarity increases by 0.37 mmol/L per mmHg increase in
PCO2; and that in hypocapnia, when pH is higher and [HCO−3 ] lower, blood osmolarity
decreases by 0.22 mmol/L per mmHg decrease in PCO2. In our computations, monitored
samples of end tidal PCO2 (PET CO2) were considered to be accurate reflections of PCO2
in arterial blood and were used as a surrogate of the latter quantity.
To summarize, tissue perfusion rates can be modeled as a function of CO2 levels in
the following manner: 1) changes in local CO2 levels result in blood osmotic changes
that can be computed using Boning’s ratios; 2) these osmotic changes are used to com-
pute the shrinkage of the EVC, which in turn determines the complementary increase in
blood volume; 3) last, the resultant change in cerebral blood flow is predicted based on
the latter volume change using Grubb’s relation.
For the steady-state solution of the system, which is independent of the rate of wa-
ter/volume exchange between compartments, the changes in volume occupancy of both
intra and extra vascular compartments can be readily computed. The dynamic solution
of the problem, on the other hand, depends on the hydraulic conductivity (Lp) of BBB
and requires a more complex model to account for the rate of water exchange between
the two compartments. A solution for the dynamics of volume exchange between blood
and EVC during the changes in blood osmolarity is possible using a dynamic version of
Starling filtration equation and numerical integration. The BBB is modeled as an ideal
semi-permeable membrane [309] – at least within the boundaries of a short lasting vas-
cular stimulus – and we have adopted the Lp value of 40.8×10−9 cm/s/cmH2O [201].
Due to the lack of an established value for the elastic force exerted by the BBB, as well
as to the uncertainty regarding changes in elastic force due to blood volume changes (i.e.
whether one should observe Laplace’s law for instance), we have not considered elastic
forces in our model.
Since the mean transit times in the brain are extremely short (in the order of 1-
10 seconds [50, 167]), for the sake of simplicity, two final assumptions were made: 1)
that the segment of vasculature exchanging with tissue experience the same changes in
blood osmolarity; and 2) that these changes are not influenced by the dilution due to
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volume exchange because blood is rapidly renewed through bulk flow, washing out the
portion that has been altered by the water transfer. We also did not take into account
the effect of the flow changes on the metabolically generated CO2 that is continuously
deposited in the blood stream.
Model equations
The blood/vascular and extravascular compartments are considered to have tubular
geometry and to be concentric. The diameter of the blood/vascular compartment will
be denoted by db and the total (vascular + extravascular compartments) diameter by dT .
We will be using an initial value of 5 µm for db, the approximate size of brain capillary
vessel.
Next, we develop a mathematical equation where the volume of vascular compart-
ment, or its radius, becomes a temporal function of blood osmolarity. Total radius,
rT , is obtained from the initial vascular occupancy, VASO0, and initial radius of the
blood/vascular compartment, rb:
rT =
rb√
VASO0
(5.1)
The Starling equation [217] states that the rate of water exchange between vascular
and extravascular compartments is determined by the balance of hydrostatic and osmotic
forces across capillary membrane, times the membrane’s hydraulic conductivity:
Jv = Lp×A× [∆P−∆Π] (5.2)
Where Jv is the net volume of water filtration across the capillary membrane, Lp the
membrane’s hydraulic conductivity, expressed as flux per unit area per unit pressure and
A the membrane’s surface area. ∆Π and ∆P are, respectively, the gradients of osmotic
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and hydrostatic pressure across the membrane, and are commonly termed Starling forces.
During equilibrium the net flux of water across the BBB is null because Starling forces
are balanced, i.e. [∆P−∆Π] = 0.
For clarity, Equation 5.2 is rewritten expanding the difference terms:
Jv = Lp×A× [Pe−Pb−Πe+Πb] (5.3)
Where the subscripts b and e stand for blood/vascular and extravascular (EVC) com-
partments respectively. In this equation, the Jv vector points to the vascular compartment.
During an initial state of equilibrium, the osmotic pressure in EVC is computed as:
Πe =Πb−∆Pb|e (5.4)
Osmotic pressure is defined as:
Π= ∑
n j.σ j
V
.RT (5.5)
Where n j is the number of osmolytes and σ j the membrane’s reflection coefficient
regarding the particular osmolyte j, R the gas constant, T absolute temperature, and V
the solution’s volume.
If we assume that the amount of osmolytes in EVC remains unchanged during the
CO2-induced CBF changes, osmotic pressure in EVC during hypercapnia can be ex-
pressed as:
Πe(t) =
c1
Ve(t)
.RT (5.6)
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The constant c1, which reflects the weighted sum of osmolytes’ osmotic activity, can
be obtained using equation 4, after having defined the initial conditions for blood osmo-
larity, fractional compartment occupancies and gradient of hydrostatic pressure across
BBB.
Considering the Monro-Kellie doctrine (i.e. that the vascular+EVC total volume is
kept constant during the exchange of water between the two compartments) we can then
express Ve(t) as a function of vascular radius:
Ve(t) = pi.l.
(
r2T − [rb(t)]2
)
(5.7)
Where l is the depth (or length) of the tubular blood/vascular compartment and will
be assumed constant and having unit value for the sake of simplicity.
The derivative of EVC volume change is expressed as:
dVe(t)
dt
=−2pi.l.rb(t).drb(t)dt (5.8)
The changes in surface area of the barrier separating the two compartments can also
be expressed in terms of the changes in its vascular radius:
A(t) = 2.pi.l.rb(t) (5.9)
We then re-write Equation 5.3 as function of time:
dVe(t)
dt
= Lp.A(t).
[
Πe(t)−Πb(t)+∆Pb|e
]
(5.10)
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Where ∆Pb|e and Lp are assumed to be constant.
The osmotic pressure in the blood compartment can be expressed in terms of blood
osmolarity (BO) as:
Πb(t) = BO(t).RT (5.11)
With:
BO(t) =
BO(0)+0.37 ·∆PETCO2(t), ∆PETCO2(t)≥ 0BO(0)+0.22 ·∆PETCO2(t), ∆PETCO2(t)< 0 (5.12)
Using equations 5.6-5.9 and 5.11, equation 5.10 can be rewritten as:
drb(t)
dt
=−Lp ·
[[(
c1
pi · l · (r2T − [rb(t)]2)
)
−BO(t)
]
·RT +∆Pb|e
]
(5.13)
In this equation vascular radius (rb) and blood osmolarity (BO) are temporally cou-
pled. Vascular dimension – radius, area or volume – changes because there is a transfer
of water volume between the vascular and the EVC compartments. All constants are
known except rT , that reflects VASO0 (equation 5.1). This parameter is optimized in the
fit of the model to experimental data.
By using Grub’s relation we can compute the change in blood flow as:
CBF
CBF0
=
(
CBV
CBV0
)α
=
(
rb(t)
rb(t = 0)
)2·α
(5.14)
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Where alpha is the inverse of the Grubb’s constant for total blood volume (i.e. 1/0.38).
For other parameters, we have adopted the following literature values: baseline/initial
blood osmolarity of 300 mmol/L [79] ; ∆Pb|e=30 mmHg [200] ; Lp=40.8x10−9 cm/s/cmH2O
[201] ; and T=310K. During optimization of the model, we have allowed VASO0 to vary
from 1% to 25%.
HYPOTHESIS EVALUATION
General and simple relation between VASO0 osmotic increases and ∆CBF
Assuming the grey matter tissue to have a 5% vascular occupancy (VASO0) [239,
284] and that Grubb’s relation describes the coupling between blood flow and volume
[134], the typical ASL measurements of 20-60% flow increase induced by a 5-10 mmHg
hypercapnic challenge [47, 59, 274, 275] corresponds to a ∼10-20% increase in blood
volume, meaning that VASO increases from 5% to 5.5-6%. According to our proposi-
tion, a 5-10 mmHg increase in PCO2 corresponds to an approximate 0.5-1% increase
in blood osmolarity. This, in turn, induces a 0.5-1% decrease in EVC volume with an
accompanying increase in VASO. If VASO0 = 5%, it increases to ∼5.5-6%, which cor-
responds to a 10-20% increase in blood volume and a 20-60% increase in flow. The
%∆CBF output of our model is thus in general agreement with literature values for this
type of experiments.
Modeling the dose response curve of CO2 cerebrovascular reactivity
We have used the model to fit CBF data from a previous study by our group in
which CBF was measured, in different circumstances, over a broad range of different
PET CO2 values (details can be found in ref. [363]. Approximately 80 PET CO2:∆%CBF
pairs were collected for each individual subject. CBF measures were acquired in a 3T
MRI scanner (SIEMENS Tim Trio), using the perfusion imaging technique of pseudo-
continuous Arterial Spin Labeling (ASL) [72, 364]. The ASL flow signal was averaged
over grey matter as described in [363]. For each subject, VASO0, that determines the ex-
ponential growth of the modeled dose-response curve, was optimized by minimizing the
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mean square of the model residuals. Given that CBF was measured under both hypo and
hypercapnia regimens, the fitting shows an inflection point, which results from the use
of the different CO2:Osmolarity ratios reported by Boning et al. (see Theory section). In
each case, the PET CO2 value at the inflection point corresponds to the subject’s resting
levels of PET CO2. As the above described procedure consisted of fitting non-temporally
related data, the modeled dose-response curves are considered the steady state solution
of the model.
Figure 5.5 shows the modeled dose-response curves and VASO0 estimates for 9 dif-
ferent young healthy subjects. We have found estimates of VASO0 that ranged from
6-11%, with a mean value of 8.0±0.4%. Although higher than the literature estimate
we have mentioned above (5%), it is still within the limits of what is considered to
be the blood-to-tissue water partition coefficient (10%) [153], a parameter indicating the
fractional occupancy of the brain vascular compartment with respect to its water content.
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Figure 5.5: Modeled CO2 vs. CBF dose-response curves. Fitting of the CO2 vs. CBF dose
response curve in 9 different subjects gave an average VASO0 of 8.0±0.4%.
Modeling the dynamics of CO2 cerebrovascular reactivity
We have also evaluated the hemodynamic solution of the model by fitting it to time
series of CO2-induced CBF changes. In this procedure, the PET CO2 values recorded
during the respiratory manipulation were used as a temporally varying input to the os-
motic model. As previously mentioned we have used a Lp of 40.8×10−9 cm/s/cmH2O,
the mean value measured by Kimura et al. at 37◦C [201]. To investigate the impact of Lp
on the modeled responses we have conducted additional fits in one of the data sets us-
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ing four other values (in cm/s/cmH2O) reported by those authors: the mean and median
measured at room temperature, i.e. 5.9×10−9 and 13.2×10−9 ; the median measured at
37◦C, i.e. 27.4×10−9 ; and 120×10−9 , the approximate maximum value. Care was also
taken to consider hypo and hypercapnic regimens separately.
Figure 5.6 shows four representative examples of the dynamic changes in PET CO2
and ASL flow signal during a hypercapnic experiment using the administration of an
air mixture mildly enriched with CO2; and the model’s predicted responses in red. The
dashed lines represent the responses predicted by the model when the literature VASO0
value of 5% [238] is adopted. The red solid lines represent the model’s predicted re-
sponses when using VASO0 estimates that best fitted the model to the flow data.
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Figure 5.6: Modeled hemodynamic responses to CO2. In each of the 4 composites the bottom
graph shows the trace of monitored PET CO2. Subjects breathed at a constant rate (16 breaths
per minute) during the entire period. Hypercapnia was induced by administering air mixture
containing 5% CO2 in two different instances, as indicated by the segments of solid line in the
bottom of the same graph. The top graph shows the Model’s predicted responses (in red) overlaid
on the ASL flow signal in GM (grey). The red dashed line represents the responses using the
literature VASO0 value of 5% while the red solid line represents the responses using the VASO0
values that best fit the model to the data. VASO0 estimates are indicated in the legend boxes
(upper left in each plot).
The hemodynamic responses computed by our model fitted the ASL data with opti-
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mal VASO0 values of: 4.8, 5.6, 5.6 and 8.4%. Figure 5.7 shows a comparison between
model fits using five different values of Lp, each represented in a different color (the red
solid line corresponds to the model fit using the same Lp value as in the previous fits).
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Figure 5.7: The impact of BBB hydraulic conductivity Lp for the hemodynamic response
to CO2. The osmotic model is fit to the ASL-CBF signal (grey line) using different values of Lp
(in units of 10−9 cm/s/cmH2O). The red solid line represents the model fit using a Lp of 40.8,
which is the same value used in models shown in Figure 4. The purple, orange, green and blue
dashed lines represent model fits using Lp values of 120, 27.4, 13.2 and 5.9, respectively. The
VASO0 fit values ranged between 4.7% and 4.9%.
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DISCUSSION
Quantification and general agreement with experimental data
A mathematical model describing the coupling between CO2 and CBF has been pre-
viously proposed by Greenberg et al [130]. In their model, reactivity of the cerebral
vasculature to hypercapnia is mediated by the surplus of CO2 that has been carried by
the blood and diffused to extravascular compartments. The possible influence of CO2 on
the blood osmotic pressure is disregarded. When tested against experimentally acquired
data, their model, which comprises 38 different parameters, most of which unknown,
failed to accurately predict the CO2-induced flow changes. The model computed flow
responses that were slower than what was suggested by the experimental data, probably
due to the several diffusion limiting processes involved in its quantitative formulation.
The authors concluded that a more rapid control mechanism should exist to account for
the coupling phenomenon.
The physiological model we have devised, which depends on 9 parameters, most of
which are reasonably well established, accurately predicted the percent change in CBF
during hypercapnia.
Our model is also in agreement with experimental observations that vascular reactiv-
ity to CO2 depends upon initial levels of both CBF and CO2, i.e. it satisfies the condition
that cerebral vascular reactivity be steeper in hypercapnia than in hypocapnia [60, 332,
363, 390] and lower for higher values of initial vasodilation [163, 171, 280, 353].
When adopting the typical value of VASO0 = 5% our model accurately described
literature reported values on CO2-induced CBF increases.
When fitting the model to a large data set representing the CO2 dose-response curves
of 9 subjects (Figure 5.4) we have found an average VASO0 that was somewhat higher
than the above value: 8% vs. 5%. This difference could reflect the misuse of the literature
term VASO to express the fractional occupancy of vascular water. The brain’s blood-to-
tissue water partition coefficient, which is an estimate of the blood water occupancy, is
usually assumed to be 10%, closer to the fractional occupancy the model computed for
the data set. Yet, such difference could also be a result of bias due to: 1) issues with
139
the ASL measurement (decreases in labeling efficiency, thus sensitivity of the method
[13]); or 2) the broad range of CO2 levels explored (the model may fail to predict CBF
reactivity outside a given range).
Given the strong non-linearity of the relation between the CBF responses and CO2
dose [144, 313, 363], VASO0 estimates will vary depending on the range of manipulated
levels of CO2. If we consider that the model predicts an exponential like dose-response
curve, whose concavity is inversely related to VASO0, and that the true/measured re-
sponse is sigmoidal, the fit of the model to a wide range of CO2-CBF values (as we
did) might result in an overestimated value of VASO0 . Additionally, some of the meth-
ods used to collect the fitted data, did not control for changes in partial pressure of O2
(PET O2), which consists a confounding factor for the CO2 reactivity measurement and
impacts in the accuracy of the VASO0 estimates.
The fitting of the model to ASL time series representing the CBF changes during
hypercapnic manipulations, where PET TCO2 changes were limited to about±10 mmHg
and PET O2 has been controlled, gave a mean VASO0 of 6% (Figure 5.6). Since the
CBF series were normalized by its initial value (rather than by an independent mea-
sure/estimate of baseline flow) the VASO0 estimates represent the vascular occupancy
at the beginning of the manipulation, when subjects were hypocapnic and brain vessels
were constricted. However, in three subjects, VASO increased from an initial value of
∼5.0% to ∼7.0% at the peak of the hypercapnia; any intermediate value representing
the true VASO0 for these subjects, i.e. their VASO modeled at normocapnia, will still
better correlate with literature VASO0 than with the water partition coefficient. In one
subject VASO0 was notably higher (8.4%). We wonder whether the difference could be
reflecting a transitory physiological status (higher vasodilation due to migraine or medi-
cation for instance) or an anatomical idiosyncrasy of the subject (such as higher capillary
density of his GM tissue).
Another explanation for the possible overestimation of VASO would be the exclusion
of the tissue tension of CO2 from our computations. Albeit largely governed by arterial
CO2, the CO2 level in the blood compartment is also a function of extravascular PCO2; or
more precisely, on the balance between the rate of deposition and wash-out of the gas. If
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CBF increases and the metabolic rate of CO2 production remains constant, the washout
of CO2 will exceed the rate of its deposition, resulting in the dilution of the deposited
fraction of blood CO2. Such phenomenon would tend to reduce the flow response to the
hypercapnic stimulus. The consequence of that in our model would be overestimation of
VASO.
Impact of hydrostatic pressures on the volume coupling
The influence of hydrostatic pressure on the volume coupling phenomenon described
by the model, expressed through the term ∆Pb|e of our equations, is negligible due to its
minor contribution compared to osmotic forces involved in the balance of Starling forces,
which may be as high as 5,500 mmHg in the blood compartment during hypercapnia –
according to our hypothesis, about 100 mmHg higher than in EVC. The forces driving
water volume exchange between intra and extra vascular compartments are thus largely
determined by the osmotic balance across BBB.
The impact of Lp
The hydraulic conductivity of the BBB is critical for the speed of the volume ex-
change process. Given the lack of an established value for capillary Lp in humans, we
have adopted in our model the mean value reported by Kimura et al. who measured Lp
in rat arterioles [201]. In a recent modeling paper, Li et al. [227] suggested that capil-
lary/BBB water conductivities in humans would be on the same order of magnitude as
those measured by Kimura and colleagues (between 1-100×10−9 cm/s/cmH2O). Given
that a broad range of possible Lp values have been reported [201] we have also com-
puted CBF as a function of time over a similarly broad range of Lp values in one of our
data sets (Figure 5.7) to verify whether the behavior described by our model would be
conserved for the different reported values. Simulations with extremely low values of Lp
demonstrate that, even under these exaggerated conditions, osmotic effects can account
for significant increases in CBF that occur on similar time scale to observations made
using MRI.
Most studies assessing the CBF responses to the administration of hypertonic solu-
tions measure CBF at a low sampling rate (usually 1 min) which makes it difficult to
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appreciate how fast transients in CBF elicited by this mechanism can be. Hardebo et
al. [140] provide a good example of rapid, osmotically-induced changes in blood flow.
Lundvall experiments in salivary gland [243] also supports the concept of a fast vascular
reactivity to blood osmotic challenges.
It is also worth noting that the idea of a quick shrinkage of EVC concurrent with
hyperaemia is not novel [209]occupancy. In fact, the phenomenon has been exploited in
modern functional imaging techniques for the indirect assessment of blood flow-volume
during hypercapnia and neuronal stimulation [238].
Capillary reactivity and a downstream regulation of CBF
Despite growing evidence that capillaries, the vessels mostly exchanging with tissue,
are very responsive to either hypercapnia [16, 82] or neuronal stimulation [354], hyper-
capnic effects on cerebral perfusion have been generally attributed to the vasoreactivity
of pre-capillary arterioles – probably because this arterial segment accounts for about
40% of total cerebral vascular resistance [88] and because capillaries are commonly
viewed as passive elements of the vascular circuitry. According to upstream models of
CBF regulation [254], in hyperaemic responses arterioles provoke capillary dilation by
relaxing and letting capillary perfusion pressure increase.
Recently, however, it has been speculated whether the control of tissue perfusion
could in fact occur downstream, at the capillary level [21, 71, 292, 326]. In the brain,
possibly aided by vascular cells such as pericytes [292] but not necessarily [92]. A
downstream regulation of cerebral blood flow would not only be more specific than an
upstream control [236] but also better conform with general observations on the autoreg-
ulation of vascular resistances.
It has been widely reported that vascular resistances change in response to a change
in perfusion pressure [134, 161, 182, 314, 371]: increases in hydrostatic pressure are
accompanied by an increase in downstream vessels resistance, whereas decreases in
pressure are accompanied by decreases in resistance. This ensures stability of tissue
perfusion conditions within a certain range of arterial pressure values, termed the au-
toregulatory zone. Also, during flow increases that occur within the autoregulatory zone,
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when the downstream resistance drops, upstream vessels need to decrease resistance to
keep perfusion pressure constant. It is conceivable that such phenomena of pressure-
resistance control be present in all levels of the vascular systems. From this perspective,
if the resistance of arterioles drops, thus increasing the hydrostatic pressure exerted upon
capillary vessels downstream, capillaries should increase resistance, i.e. shrink [352], not
dilate as implied in upstream models. From this same perspective, during CO2-induced
CBF changes, capillary resistance changes downstream should precede arteriolar adjust-
ments upstream [197]. We note that while there is no clear evidence of an upstream
regulation of capillary resistance, at least one study in brain [58] and one in striate mus-
cle [21] show capillary dilatation preceding the dilation of upstream vessels.
Also, brain capillaries, although not fenestrated, are considerably permeable to water,
to the point that, for practical purposes such as in the theory of ASL, it is often assumed
that intravascular water instantly mixes with the surrounding tissue upon its arrival at the
capillary bed. Being so, water should not exert a significant force upon capillaries’ walls,
but, rather, across them. An increase in capillary intravascular hydrostatic pressure,
according to Starling’s hypothesis, favours the movement of fluid to the extravascular
compartment [65, 309], which would lead to capillary volume shrinkage, /textiti.e. [352]
an increase in capillary resistance, an outcome that concurs with a downstream model of
flow control.
In our opinion, as paramount to the brain’s homeostasis as the renewal of its capillar-
ies’ contents (i.e. tissue perfusion) is the maintenance of capillary hydrostatic pressure
[96, 177, 178, 181, 369]. And we believe that the perfusion change in response to CO2
is a phenomenon originating in the capillary level, where the exchange between blood
and parenchyma is greatest.
We consider the phenomenon of vascular auto-regulation by assuming that perfusion
pressure is kept constant at the capillary level, i.e. that the arterial side of cerebral vas-
culature is a hydraulic system [10] existing to ensure stability of capillary intravascular
pressure, which allows one to predict increases in capillary flow based on its resistance
changes. This is equivalent to say that the cerebral vasculature bears a feedback type of
pressure control system whose propagated response (upstream) begins with changes in
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capillary tone (downstream) [173, 197] and that flow is ultimately a function of capillary
resistance.
The remaining question would be: how capillaries change their resistance to control
the blood flow levels? And, supposing the capillary response to hypercapnia [163] occurs
due to changes in blood properties [419] what is there about plasma that is important
for normal autoregulation? [352]. According to our hypothesis, the answer would be:
blood osmolarity. Capillaries are vessels particularly sensitive to blood osmotic changes
[310] and it is conceivable that capillary resistance responds to CO2 driven shifts in
blood osmolarity [32]; which, under conditions of constant perfusion pressure, could be
a key factor determining the rate of tissue perfusion.
We would like to emphasize that for an optimal perfusion, the dilation of capillar-
ies must be associated with dilation of upstream resistance arteries and arterioles [197].
We expect all mechanisms controlling the resistance artery tone to act in series with
osmolarity-dependent mechanisms so that our hypothesis does not exclude the partic-
ipation and importance of these mechanisms in the CBF response to CO2, but rather
propose an obligatory role of resistance artery adjustments in response to the capillary
tone. Put differently, we advocate that factors having an influence in the muscle tone
of arteries/arterioles (phenomena involving more complex molecular/cellular processes)
have an impact on the vascular response to CO2 because they affect the maintenance of
capillary tone during osmotically-driven blood volume changes.
Implications and future directions
The autoregulation of cerebral vasculature is known to occur within certain bound-
aries, i.e. cerebral perfusion pressure (CPP) is constant for a limited range of vascular
resistances [142]. If the auto-regulatory function of the cerebral arterial tree exceeds a
certain limit, capillary hydrostatic pressure will drop, and CBF will no longer be able to
increase according to the exponential fashion described by our model. This would result
in a CBF vs. CO2 curve that is sigmoidal in shape, as has been observed experimen-
tally [20, 314]. The incorporation of CPP as an additional variable would allow a more
comprehensive version of the model, that could help predict CBF-CO2 coupling over a
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broader range of conditions.
The proposed model could also provide a rationale for the response of cerebral vas-
culature to changes in blood O2 tension [45, 85, 401]. It is possible that the reactiv-
ity of the cerebral vasculature to O2 is mediated by CO2 through the Haldane effect
[117, 169, 234], i.e. that hypoxia might cause vasodilation because it increases the blood
buffer capacity to CO2 and, with that, blood osmolarity, blood volume and flow. If that is
the case, the osmotic model could provide a unified description of the vascular response
to both of the gases involved in the oxidative metabolism of brain cells. Further exten-
sions of our model could include the computation of the total dissolved CO2 – and thus
blood osmolarity – from partial pressures of both CO2 and O2.
Initially, it would be desirable to further investigate if the CBF response to hypercap-
nia is in fact mediated by CO2-induced changes in blood osmolarity, i.e. test our primary
hypothesis using dedicated experiments, in animal models.
The first experiment we propose would consist of manipulating blood PCO2 levels
while keeping pH and HCO−3 /osmolarity constant. This could be achieved using a simi-
lar approach as used by Hardebo and Nilsson [140] and employing intracarotid injections
with blood substitute that has been previously manipulated. Injections would contain
blood with different PCO2 and CA inhibitors to keep CO2 mostly in its gaseous state.
If the CBF response to CO2 depends on the osmolarity changes induced by this gas, the
intracarotid injections should result in equivalent CBF changes, despite the differences
in PCO2. The second complementary experiment we propose would consist of adminis-
tering intracarotid injections with the same PCO2 and pH but different total amounts of
dissolved CO2 and, thus, osmolarity. The expected outcome of this experiment would be
a suppressed CBF response to PCO2 for the injection in which CA activity is blocked,
as in the study of Hauge and colleagues [147].
It is worth noting that while manipulations of arterial blood osmolarity using hy-
pertonic solutions can induce vascular relaxation and perfusion increases in different
vascular territories [112, 140]. Lundvall et al. have observed that in muscle and salivary
gland the osmolarity of venous blood increases with metabolically-induced hyperaemia
[243, 244]. These results suggest that blood osmolarity could also be among the regula-
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tory factors mediating functional hyperaemia in different tissues. It would be desirable
to reproduce the same experiments of Lundvall et al. and measure the time courses of
osmolarity in both blood and EVC compartments to verify if, at the onset of induced
flow increase, an osmotic gradient across capillary walls is formed. Another ambitious,
though no less valuable, endeavor would be to try replicating Lundvall’s experiments in
the brain to see if focal neuronal activation increases osmolarity of the venous effluent
draining that particular region. Such experiments would help elucidating the participa-
tion of blood/tissue osmolarity and water transfer mechanisms in the normal control of
tissue perfusion.
Conclusion
Although several factors have been shown to modulate the CBF response to CO2, the
exact mechanisms and mediators are still a subject of debate [419]. Based on the idea
of a volumetric coupling between the cerebral parenchyma and its exchanging vessels,
we propose a new model of cerebral blood flow (CBF) regulation by CO2: during hy-
percapnia, when blood osmolarity increases with respect to parenchyma, the diameter
of exchanging vessels increases, which decreases vascular resistance and allows CBF
to increase; when diminished (i.e. in hypocapnia), the converse occurs, with a net re-
duction in vessels’ diameter and decrease in CBF. From this notion, we have devised a
simple biophysical model relating CBF and CO2, whose predicted values agreed well
with experimental measurements using the imaging technique of ASL to measure CBF.
Our modelling results suggest that osmotic forces could be among the set of regula-
tory mechanisms modulating blood flow under hypercapnic conditions, thus revealing a
previously unappreciated factor in the CBF response to CO2.
Furthermore, to the best of our knowledge there exists no model explaining the rapid
flow responses to osmotic manipulations as those observed by Hardebo and Nilsson
[140]. Our model provides a unifying framework that can account for CBF responses
to both the direct osmotic manipulations and hypercapnia induction. We thus feel our
study also extends previous work on osmotic manipulations of the blood brain barrier
with new experimental data.
CHAPTER 6
FINAL REMARKS
6.1 Arterial Spin Labeling
Earlier techniques for measuring brain perfusion were based on the inhalation or in-
jection of exogenous tracers [84, 192, 218, 272, 278, 290, 307, 331, 371]. The idea of
measuring perfusion responses to manipulations in blood CO2 levels (aka CVR) has been
introduced by Kety and Schmidt in seminal papers from late 1940’s [191, 193]. Since
then there has been increasing interest in this type of measure and other less invasive,
contrast-free, techniques estimating cerebral perfusion and CVR have been exploited,
namely: doppler ultrasonography of flow velocity in carotids/mean cerebral arteries
[132, 267, 325, 372, 394], phase contrast angiography (PCA) [1, 20, 28, 29, 349, 391]
and BOLD/ASL based fMRI [22, 183, 256, 297]. Whereas sonography of flow veloc-
ity in large caliber arteries can afford robust estimates of the total blood perfusing the
brain, the technique suffers from limited spatial localization and bias related to changes
in vessels’ size (which are assumed to remain constant during CO2-induced perfusion
changes). PCA is another technique allowing a measure of flow velocity in cerebral arter-
ies, but that can be calibrated by its complementary measure of vessels’ cross-sectional
area, thus affording more reliable estimates of total flow changes. However, PCA suffers
from limited temporal resolution and – similarly to sonography – limited spatial local-
ization. BOLD imaging, on the other hand, offers high temporal and spatial resolution,
permitting an in-depth characterization of vascular dynamics; but the technique lacks
from specificity – the BOLD signal depends on several physiological parameters and
thus provides an indirect measure of perfusion. The non-invasive technique allowing a
specific and quantitative measure of cerebral perfusion and mapping of CVR is Arterial
Spin Labeling.
Amidst the various Arterial Spin Labeling schemes, pseudo-Continuous ASL emerges
as the most robust and reliable method, with potential to substitute standard contrast-
147
enhanced techniques in the clinical practice [7] and, as I expect to have demonstrated in
this thesis, to promote applications based on blood gas manipulations. Future improve-
ments in pCASL image SNR would certainly be advantageous as it should allow higher
image resolution and, with that, a more in depth characterization of CVR. Refinements
in perfusion quantification, i.e. improvements in the accuracy of pCASL CVR measures,
would also be desirable. Whereas pCASL should benefit from general enhancements in
image readout, sensitivity and accuracy of CVR measures can be boosted by 1) correct-
ing for spin labeling imperfections [13, 175], 2) removing physiological noise from the
perfusion signal [26, 122], 3) compensating for partial volume/flow effects [14, 229] and
4) response time variability [347, 367] – most of which can be achieved using available
methods and simple ancillary acquisitions. It would also be recommendable to vali-
date/correct single-TI pCASL CVR measures using multi-TI ASL and kinetic modeling
of the tag dynamics during CO2 changes [15].
In this thesis I have emphasized the compatibility of the pCASL method with stan-
dard MRI hardware and its potential to foster new perfusion-based applications. The
pCASL CVR measures presented here were acquired in a clinical 3T, utilizing the scan-
ner’s RF (body) coil to generate the labeling pulses. However, the energy deposition
implicated in such irradiation scheme becomes an obstacle as we move towards higher
field strengths (≥7 T) [126, 366]. In ultra-high field MRI systems the labeling by pseudo-
continuous RF might only be feasible using a dual-coil approach to constrain energy de-
position to the tag region. Besides, given that field-inhomogeneities are more prominent
in those systems, it might become indispensable to correct for labeling efficiency in an
individual basis. Multi-TI PASL techniques, which are much less energy demanding
than any continuous approach, will certainly continue to play an important role in the
development of CVR methods. However, I suspect that with limited applicability, as
they do not afford dynamic measures of tissue perfusion like single-TI pCASL.
To summarize, single-TI pCASL imaging allows a non-invasive, robust and reliable
measure of CO2-induced hemodynamic changes using standard clinical MRI hardware.
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6.2 Respiratory manipulations
As I also hope to have demonstrated in this thesis, it is possible to acquire robust
pCASL CVR measures exploiting simple and widely available methods to manipulate
blood CO2 levels, such as breath hold or inhalation of CO2 mixtures with fixed com-
positions. The fixed-inspired (FI) method is less dependent on subjects’ cooperation
and more flexible if compared to breath-hold; besides, respiratory responses associated
with FI are more easily quantified. Last but not least, with the technical developments
that have been presented here, reproducible FI manipulations can be conducted in a safe
manner with minimal setup time. All features that are desirable in a clinical environment
and should thence help promoting the broader adoption of CVR measures.
Although constituting an excellent option for simple measures of CVR, the FI method
might not be suitable for studies of cerebrovascular regulation requiring rigid control
over respiratory gases. In these cases, more sophisticated methods like the Respiract are
warranted.
However, in my opinion there are concerns related to its operation that need to be
addressed for it to gain a broader interest. The Respiract method controls respiratory
responses using a physiology-based feed-forward approach with no input from feed-back
monitoring data ,which makes the control system cumbersome and operator-dependent.
I noticed that for a successful manipulation the RespirAct invariably requires the ongoing
monitoring of PET CO2 traces and frequent interventions to correct for drifts. As a future
development I propose three modifications that should render the method more attractive.
1) According to my experience, the end-tidal CO2 response to a step change in inspired
concentration can be described by an exponential growth and a decay of 2 phases each 1,
i.e. it is possible to model the respiratory physiology in this type of experiment using just
4 constants. Therefore, rather than forcing respiratory responses based on a theoretical
model of its physiological underpinnings and several physical/physiological inputs, the
feed-forward control could be achieved using a prediction of 4 unnamed exponential
processes. 2) The method should incorporate a preliminary self-calibration run providing
1. Poulin and colleagues have used a similar approach to model ventilatory and flow-velocity
responses[303–305]
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a direct measure of the 4 above mentioned processes/constants. 3) The system should
also count of feed-back data to permanently recalibrate its model (in other words it would
consist of an adaptive feed-forward control system).
CVR measures are usually obtained using a given change in end-tidal CO2; and com-
pared in terms of the amplitude of associated perfusion changes, i.e. as to the slope of
measured CO2:perfusion responses. In Chapter 3 I stressed the importance of measur-
ing CVR in the linear range of the CO2 dose-response curve so that results could be
more reliably compared. However, I have also suggested that it might be possible to
fully characterize the non-linear CO2 dose-response. By measuring cerebral perfusion
under many different PaCO2 levels one may obtain a more comprehensive picture of
cerebrovascular function [20, 22, 314]. If the CO2:perfusion data is fitted with a logistic
function, CVR measures can be compared in terms of various descriptors such as: co-
ordinates/derivative at the inflection point, distances from the inflection point to upper
and lower plateaus, distance between plateaus, and so forth. Some groups have been
developing this nice idea; however the BOLD signal has been used as a surrogate of per-
fusion [22]. It has been suggested that the height between upper and lower plateaus of
the BOLD-CO2 curve represents the cerebral vascular reserve. It should be noted that,
strictly speaking, that the BOLD signal difference reflects the “oxygenation reserve”
of the cerebral tissue. Whereas corresponding closely to perfusion, blood oxygenation
level follows its own saturation curve (during CO2 increases the BOLD signal saturates
much faster than the ASL signal). A more accurate estimate of the cerebral vascular
reserve can be obtained using a direct measure of cerebral perfusion. Thus far my group
has been the only having used a quantitative perfusion imaging technique (ASL) to por-
tray the CO2 dose-response function of cerebral vasculature in humans. In future work
I intend to implement ASL protocols allowing robust parametric mapping of the CVR
dose-response function descriptors.
In Chapter 3 I also have proposed a new approach to quantify end-tidal gas levels
during experimental manipulations. The procedure consists of modeling end-tidal moni-
tored samples using baseline, response and drift regressors – similarly to what is custom-
arily done in fMRI signal analysis. However, unlike hemodynamic response functions
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(HRF), the respiratory response functions (RRF) are optimized in the statistical fit, i.e.
the procedure also estimates the (four) descriptors of a fundamental RRF. That is to say,
other than affording robust estimates of end-tidal changes to any given respiratory ma-
nipulation, the procedure outputs the subject’s RRF. If used in the reverse sense, this RRF
allows predicting the inspired doses that are necessary to give rise to a desirable end-tidal
response. In future work I intend to exploit the algorithm that I have developed for the
post-processing of respiratory signals, in a respiratory control system for the prospec-
tive targeting of end-tidal O2/CO2 levels. Moreover, in Chapter 4 I have shown why
the robust estimates of end-tidal changes using this approach may be an asset in experi-
ments involving hyperoxic calibration of the BOLD signal [44, 108, 109, 257, 402, 411].
During hyperoxic induction, there might be a subtle decrease in CO2 levels [95, 169],
which confounds O2-induced BOLD measures 2. By modeling CO2 levels it is possible
to precisely quantify the changes in end-tidal CO2 induced by hyperoxia, and with that
estimate the BOLD response purely associated with O2.
6.3 Physiological modeling
Using basic assumptions and a few constants that are reasonably well accepted, the
quantitative model [330] of cerebral vascular reactivity that has been proposed succeeded
explaining the hemodynamic changes measured by pCASL. Although pCASL afforded
robust measures of cerebral perfusion and permitted validating the model’s predicted
outputs, the physiological foundations of such model remains to be confirmed. However,
it should be noted that, other than describing the temporal relationship between perfusion
and CO2, this is the first time a CVR model aspire to establish a direct physical link
between the two quantities.
The model is also original inasmuch it incorporates a previously unappreciated phe-
nomenon in the CVR phenomenon, viz. the changes of blood osmotic pressure induced
by the products of CO2 dissolution. The possibility of CO2 acting on the cerebral vas-
2. More than the O2 changes occurring during hypercapnia might confound CVR measures. The
BOLD responses elicited by a 1 mmHg increase in CO2 are about 30x higher than the responses elicited
by an 1 mmHg increase in O2.
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culature through blood bicarbonate has never been considered. Furthermore, it consti-
tutes the first downstream model of vascular control. According to the proposition, the
CVR phenomenon originates at the capillary level; vascular adjustments upstream are
considered to have a secondary, supportive, participation. The phenomenon of capillary
reactivity, which has gained increasing interest [145, 173, 213, 232, 354], is still not fully
understood. There have been speculations whether capillary resistance could be regu-
lated by pericytes [292] or whether it could be related to blood volume gains stemming
from fluid exchange between brain compartments [209]. The herein proposed model em-
braces the latter notion, but it proposes that the fluid exchange emanates from transients
in blood osmotic pressure, rather than hydrostatic pressure. One of the assumptions of
this model is that cerebral perfusion pressure is regulated at the tissue level. According
to this model, as paramount for the brain survival as the renewal of capillary contents is
the maintenance of its hydrostatic pressure.
While the assumption of a constant capillary perfusion pressure is a simplification
that is more easily endorsed (after all, other models have used the concept of vascular
auto-regulation to postulate a constant pressure at the level of arterioles, just one level
above capillaries), the other assumption supporting the model is subjected to debate.
The model assumes that because the activity of carbonic anhydrase enzyme is higher
in the blood than in the extravascular compartment [114, 322] and because the BBB
is impermeable to HCO−3 [283], the surplus of HCO
−
3 produced during a brief episode
of hypercapnia remains mostly intravascular, thus functioning as a hypertonic vascular
stimulation. Although there are no direct evidence of what is suggested, the proposition
does not violate the common understanding that, while being fairly permeable to water,
the BBB has very limited permeability to blood solutes. Blood solutes may take several
hours to passively cross the BBB; therefore, in the time frame of a 2 min manipulation,
the BBB could indeed be considered the ideal semi-permeable membrane. Secondly,
the concept of a differential activity of CA has not been candidly expressed, but CO2 is
diluted in different compartments of the body with different time constants 3 [89]. Last
3. CA is a very primitive family of enzymes, ubiquitous in living organisms, much more than the
hemoglobin complex, which is exclusive of more complex animals. It has been suggested that CA plays
a crucial role in circulation of vascular plants [160]. What determines the rate of CO2/water exchange
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but not least, the teleological argument that CO2 ought to dissolve faster in blood than in
extravascular compartments to facilitate its transport is far from nonsense.
The manuscript of Chapter 5 had been appraised by several experts in the field before
it has been submitted to scientific periodicals for publication. The manuscript has been
submitted to three different journals of physiology dedicated to or with sections dedi-
cated to theory/hypothesis or mathematical/computer modeling. In the two first attempts,
I and co-authors had feed-back from a total of 6 reviewers, who manifested a broad spec-
trum of opinions, ranging from “extremely interesting”, “intriguing and provocative”,
“merits considerable attention”; to “severely flawed”, “pure speculation”, “science fic-
tion.” Amidst the more objective criticism on methodology, we had comments regarding
the corollary of BBB’s impermeability to HCO−3 (which I have addressed above) and the
adopted value for BBB’s permeability to water (Lp).
The first Lp value we have adopted was derived from a theoretical paper published
in one of Nature’s journals [209]. Later, as advised by one of the reviewers, we have
adopted a value that had been determined experimentally (in an animal model) about
3 times lower than the original one [201]. We have demonstrated that the output of
the model was not severely impacted because the value was still above a threshold of
functionality; and included a new figure illustrating the impact of Lp values on the
model’s predicted responses (Figure 4 in that manuscript). Surprisingly, in the sec-
ond submission, one of the reviewers repudiated the use of the new Lp value arguing
that it had been measured under non-ideal circumstances – a clear evidence that experts
are far from having reached a consensus on the right value of BBB’s Lp nor the best
method to evaluate it (e.g. while Fenstermacher and Johnson measured a capillary Lp of
3.2x10−10 cm/s/cmH2O in the rabbit [91], Coulter measured 10.3x10−8 in the cat [68]).
The Lp value that have been proposed this time was 1-3 orders of magnitude lower
than the one previously suggested. A reviewer pointed specifically to an in vivo study
between the plant and its environment, the velocity of sap within its vessels, and the rate of photosynthesis,
is the opening of small pores in the plant’s leaves, known as stomates. Stomates opening is regulated by the
volume of its guard cells, a pair of structures that are responsive to changes in osmotic pressure. It seems
that the volume regulation of guard cells relies on the differential activity of CA in different compartments
of the stomates.
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where Lp was extrapolated from the PS (permeability-surface) product [288] saying that
that values was “probably the most reliable, and... ...very close to values obtained in the
frog”. However, to compute Lp from the PS product one needs an estimate of the total
surface area of capillary walls (ref [36] page 35), which, as far as I know, has not been
established – so far, the S of the product is a estimate per se and if overestimated, Lp
is underestimated. Interestingly, in the referred study, the author shows tracer dilution
kinetics that are suggestive of a fast water exchange between blood and extravascular
compartments.
The water extraction fraction is indeed limited and dependent on blood transit time
[339, 423]. However, in the rat, for flow rates lower than 200 mL/100g/min, the fraction
is close to unit. And it has been shown that such approximation is valid in humans as
well. In fact, virtually all ASL techniques assume perfect mixing of labeled water upon
its arrival at the capillary bed [55, 423] – it has been said that water function as a “freely
diffusible tracer.” In other words, when quantifying perfusion from ASL signal one is
assuming Lp has infinite value.
While nearly impossible to precisely measure the permeability of fragile structures
such as capillaries, particularly in vivo, the lack of a consensus on the exact Lp value has
been virtually the only point impeding the manuscript’s publication. And it is unfortu-
nate that the authors were not given the chance to counter the reviewers’ objections, for
our manuscript has been peremptorily rejected.
In sum, the proposed model is simple, does capture the dynamics of CBF changes
associated to blood CO2, brings a previously unappreciated effect of CO2 in to attention,
may also be able to explain the vascular effect associated to blood O2 [83, 162, 333,
334, 391, 411, 413] and has the potential to extend knowledge on hypertonic manipu-
lations [43, 288, 362]. Experiments for further validation of the model have also been
proposed in the manuscript. Given that the basis for having been refuted are doubts re-
lated to one of its adopted constants, which, while supported by specialized literature,
is not completely established, I see no reason why the model should be discarded as
a hypothesis. In my opinion, it should merit publication in the appropriate vehicles of
scientific communication. The manuscript has been submitted to the journal of Medi-
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cal Hypotheses and, recently, accepted for publication with minor revisions pending the
editor’s approval.
As a further development I intend to incorporate cerebral perfusion pressure (CPP)
as an extra variable to the model and account for the influence of metabolically deposited
CO2, which have not been considered. This should permit modelling CBF in a broader
variety of conditions, more accurately. A possible avenue to explore the relationship
between CPP, CBV and CBF [163, 199, 295, 321] would be to combine fMRI measures
weighted on perfusion (with ASL) and CBV (with the VASO technique for instance).
The way to assess the contribution of the rate of CO2 deposition to CVR is to acquire
fMRI data during challenges that combine blood CO2 manipulations and neuronal stim-
ulation [157].
Until it is subjected to validation, the proposed mechanism of cerebrovascular reac-
tivity to CO2 remains as a peculiar hypothesis. However, a new idea should stand as a
conceivable hypothesis only if its supporting corollaries and ensuing consequences can
harmonize with generally observed phenomena. The concepts that have been integrated
in the model, such as osmotically induced fluid exchange, are present in phenomena
other than CVR. In Appendix II I discuss the possible implications of the proposed
model for the general understanding of tissue perfusion, its limitations, and point out a
couple of experiments that could shed some light on the matter.
6.4 In conclusion
I hope that with this thesis I have been able to fulfil the requirements for the obtain-
ment of the degree of Doctor Philosophiæ – that I have been able to thorough examine a
scientific problem, adequately use the scientific method, communicate my findings in a
clear and objective manner, and that I have made an original and relevant contribution to
knowledge. As an biomedical engineer and very pragmatic person I hope that the small
developments I have made will find a direct applicability in the clinical practice; as a
theorist, passionate about imagination, I hope that the model of perfusion control I have
proposed can nurture stimulating debates.
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Appendix I
PICORE PASL tag width
Among the positive feed-back that unfolded from the work presented in Chapter 2,
there has been some criticism regarding the labeling parameters chosen for the compar-
ison. It is certainly true that in comparing measures obtained with two ASL schemes
the choice of labeling parameters is critical. Ideally one would compare pCASL and
PASL using an assortment of labeling parameters. However, with the cohort size (10
subjects) and functional scan time (10 min) I and co-authors considered could offer a re-
liable comparison between CVR measures, that would not have been feasible. We were
constrained to a fixed set of parameters and have adopted those we deemed suitable for
an honest comparison.
In that work we have used PICORE Q2TIPS with standard gap size and inversion
times. The labeling pulse was applied to a 160 mm tag width, which we considered
to offer a good compromise between the volume of labeled blood and immunity of the
image region to spurious influence from the label pulse. The 160 mm width was 60%
higher than the 100 mm recommended in the initial implementation of the sequence for
measuring baseline flow; and close to the average value other groups had been using to
measure CO2-induced changes (see Table 1 of this thesis). To compare PASL with the
continuous approach, we have used a pCASL sequence that was in its earliest stage of
development 1, with parameters also tailored for measuring baseline flow; therefore, no
special advantage has been given to pCASL.
Anyhow, as part of a broader investigation on the effects of PASL labeling parameters
for the accuracy of CVR measures (that is not included in this thesis), I have conducted
an additional head-to-head comparison between the performances of pCASL and PASL
PICORE Q2TIPS in measuring CO2-induced flow changes, this time using different PI-
CORE tag widths 2. Whereas the respiratory challenge and pCASL sequence parameters
1. An almost out-of-the-box sequence that had been provided by our collaborator and co-author; actu-
ally the person who has conceived/programmed the first implementation of pseudo-continuous ASL
2. The two most critical parameters for the accuracy of Q2TIPS CVR measures are tag width and TI1.
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were the same of those we had used in the study of Chapter 2, the cohort was just half the
size (5 subjects). PASL parameters were also the same, except for tag widths, that were
100 mm (the customary value used in several resting CBF measures) and 200 mm (the
highest value found in Table 1). Results are shown in the next figures. To facilitate the
comparison, ASL signals were not converted into physiological units of perfusion and
were left in arbitrary units, i.e. signals here reveal the magnitude of the control-label raw
signal obtained with each labeling scheme. Signal intensities during normocapnia are
shown in Figure I.1; signal changes induced by hypercapnia are shown in Figure I.2. In
each figure, results from the 3 ASL sequences are shown in different rows (the number
after ‘PASL’ identifies the PICORE tag width in mm).
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Figure I.1: The control-label ASL signals measured during normocapnia. Comparison of
pCASL, PICORE Q2TIPS PASL using tag widths of 100 mm (PASL-100) and 200 mm (PASL-
200), in 5 different subjects. ASL flow signal strength of pCASL and PASL-200 are comparable
and greater than PASL-100.
Q2TIPS may lose control over label duration if TI1 is too long or the tag width is too narrow. Shortening
TI1 reduces the amount of tag that is delivered to the tissue, and with that perfusion SNR, so we did not
consider that an option.
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Figure I.2: Hypercapnically-induced ASL signal differences. A comparison between the ASL
signal differences induced by a 5 mmHg hypercapnic challenge reveal that pCASL is more robust
detecting global flow changes. PASL-200 and PASL-100 measures are probably underestimated,
implying that control over label duration is rendered ineffective.
In baseline normocapnia, pCASL and PASL-200 flow signals are comparable and
higher than the PASL-100 signal. The hypercapnically-induced signal changes measured
by pCASL are markedly higher than the changes measured by the two PASL versions,
with PASL-100 yielding the lowest signal changes. If on one hand these results confirm
that the use of a wider tag width is able to alleviate the difference between pulsed and
continuous ASL performances in measuring global flow changes, on the other hand they
confirm our suspicion that, when large shifts in blood velocity are concerned, saturation
pulses can miss the trailing edge of the tag bolus and become unable to control for its
duration, even using a thick 200 mm tag width. I note that these experiments were per-
formed using a mild hypercapnic challenge (5 mmHg increase in PET CO2) to induce
flow changes. The difference in performance should likely become more apparent in
hypercapnic challenges inducing greater flow increases (e.g. the 12 mmHg PET CO2 in-
creases engendered in the second study of Chapter 4). An unexpected finding in this
xx
short experiment was that baseline/normocapnic PASL-100 signal was lower than the
PASL-200 signal. Since saturation pulses were applied exactly after the same delay time
(TI1) from the the label pulse, the tag volume – thus measured flow signal – should also
have been the same. Such signal loss in PASL-100 is probably related to an ineffective
control over the bolus duration, and I suspect this is due to some degree of hypercapnia
that is induced during the baseline periods of the CO2 manipulation (i.e. baseline is not
really normocapnia). As in the comparison of Chapter 2 study, to produce controlled
PET CO2 changes we have employed RespirAct, which (as noted later, in Chapter 3) is a
system relying on partial rebreathing and thus prone to altering normal CO2 levels.
Appendix II
CO2, osmosis and perfusion control
If water is life’s most essential substance, osmotic pressure is probably the most ubiq-
uitous physical force in living organisms. Organism can be defined as a self-organized
vat of water containing a metabolic machinery that is able to replicate itself. An organ-
ism is permanently manipulating its interior solutes with the aid of enzymes and to keep
its state - i.e. its homeostasis 1 – it needs to counter effect, relentlessly, the tendency of
water to cross its boundaries – i.e. osmotic pressure.
The very existence of a cell – life’s minimal entity – relies on the active regulation
of its intracellular osmotic pressure, which is accomplished by the continuing transport
of ions by transmembrane carriers such as the sodium potassium pump [12], present in
all animals’ cells. If this ion pump is impeded to work – by the lack of energy or drug
action[11, 216] – the volume homeostasis of the cell is disrupted, which results in cell
swelling and possibly death by lysis 2.
An organ is defined as a a self-contained collection of cellular tissues that are bound
together to serve a specific function in an organism of higher complexity. Tissues, in
turn, are composed from a myriad of interconnected an interdependent cells, which,
when functioning together, modify their common environment. The homeostasis of an
organ depends on the adequate perfusion of its tissues to keep the extracellular milieu.
In animals of closed circulation, blood is the fabric interlacing with all organs of the
body; it is the fluid tissue that supplies and washes the other connecting tissues. As such,
blood has a fundamental role in the body’s homeostasis. The osmolarity and volume of
blood and its perfused organs are affected by many processes of water exchange between
the body and exterior; namely: absorption in the digestive tract, kidney filtration, tran-
spiration and respiration. In situations when the osmolarity of arterial blood perfusing an
organ is depressed, that organ gradually absorbs water and swell [136, 286, 355, 357].
1. From the greek, the permanence of its state/equilibrium
2. Defined as the breakage of the shell separating the intracellular space from its environment. When
losing its individuality and merging with the outer world, the cell dies.
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If dilution of the organ’s solutes is too severe it eventually ends in the organ’s failure
by water poisoning [233]. Conversely, if osmolarity of arterial blood is augmented, the
organ gradually loses water [136, 286, 357], eventually culminating in its failure by de-
hydration 3 [189, 358].
As previously mentioned, there is ample evidence that experimental manipulations
inducing blood hyperosmolarity elicit vasodilation and tissue hyperaemia in different
vascular beds [112, 362]. If the blood hyperosmolarity yields tissue dehydration and
blood volume increases, it suggests that vasoreactivity to blood osmolarity might be re-
lated to an osmotically-induced water exchange between blood and tissues (as postulated
in the CVR model presented in Chapter 5). In addition, it has also been demonstrated,
in two vascular beds [243, 244], that the osmolarity of the venous output increases with
metabolic activity, i.e. while metabolism elicits an increase in tissue perfusion it also
increases the osmotic arterio-venous difference (a-vdi f f ). Similar patterns of perfusion
responses were observed for equivalent changes in arterial (manipulated) and venous
(evoked) osmolarity [243]. These findings together suggest that osmotic forces and vol-
ume regulation of tissues are related to the normal control of tissue perfusion.
One of the most recognized mechanisms of the human body homeostasis is the con-
trol of arterial blood pressure [279]. Other than increasing the risk of rupture in arteries,
hypertension disrupts the water homeostasis of the body and may result in vasogenic
oedema [309], i.e. swelling of organs. The natural response to an increase in blood hy-
drostatic pressure is a tendency of arteries to constrict, refraining blood expansion. Upon
a sudden increase in blood pressure, brain arteries constrict to prevent propagation of
hydrostatic pressure and preserve the cerebral tissue [133]. If submitted to hypertension
for prolonged periods, arterial walls may undergo irreversible morphological changes,
becoming rigid, frail and prone to inflammatory processes – which can culminate in
arteriosclerosis [3], a major threat to the proper circulation of the body and its home-
ostasis. Arteriosclerosis reduces the functional capacity of cerebral vasculature and is
related to different processes of dementia [179, 342]. On the other end, when hypoten-
3. Thirst, a behavior phenomenon that drives animals to seek for water replenishment, primordial for
animal’s survival, is triggered by blood hyperosmolarity [368].
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sion is concerned, it has been observed that blood volume increases [263] as a means to
compensate for the lack of turgidity in the vascular tree, which occurs at the expense of
organs’ shrinkage.
Evidence for the (partial) maintenance of cerebral perfusion pressure (CPP) abounds
[356, 397]. Whether the hydrostatic pressure is preserved at the level of the arterioles
or capillaries is, though, a matter of debate. Most models of perfusion control advocate
that CPP is constant at the levels of arterioles and that these vessels are responsible
for regulating cerebral perfusion through an active regulation of the hydrostatic pressure
that is propagated to the tissue [209], i.e. arterioles dilation promote hyperemia through a
feed-forward control of tissue-CPP so to say. Since regulation of tissue perfusion would
stem from the vasomotion of arterioles – vessels that are located upstream the capillary
bed, the actual site of perfusion – propositions of cerebral perfusion control based on
this notion are collectively known as upstream models.
As has been previously argued, such rationale finds difficulty conforming with gen-
eral observations of vascular functioning. Many in vivo studies suggest that the con-
stancy of hydrostatic pressure exerted on capillary beds is secured with the aid of arteri-
olar vasomotion [177]. As August Krogh 4 has once highlighted, capillary opening and
tissue hyperaemia might not be related to arteriolar dilation [212]. There is evidence
that arterioles and capillaries vasomotion go in opposite directions, i.e. that arteriolar di-
lation causes capillaries do shrink [210, 352], and that, in hyperaemia, capillary dilation
precedes arteriolar dilation [21, 58]. That is to say, arterioles might respond and be a
consequence of capillary dilation, not the cause, as proposed in upstream models. It is
worth repeating that capillaries are not self-contained vessels of water; they are more
like a cell-type of vessels that rest embedded in a matrix of interconnected cells and
their conjunctive fluid; and whose contents are at the imminence of blending with the
extravascular environment. Capillary blood is separated from the parenchyma by thin
boundaries that are very permeable to water 5, thus representing a fluid compartment
4. Laureate with the Nobel Prize for his work on physiology of capillary perfusion
5. In the case of BBB, where capillaries are not fenestrated and have surrounding structures that limit
the diffusion of substances from blood to parenchyma, including water [204]. However, brain capillaries
are also unique in the sense that they count on specific water channels known as aquaporins [101, 271]
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within the various tissues. As such, capillary volume regulation should obey the laws
governing water exchange across physiological barriers, i.e. comply with the Starling
hypothesis.
The feed-back downstream model proposed in Chapter 5 of this thesis may go against
upstream models, but its corollaries conform with generally observed phenomena. The
model of perfusion control based on capillary reactivity and osmotic forces constitutes an
attempt to reconcile concepts such as tissue pressure auto-regulation, capillary reactivity
and the Starling hypothesis. As have been discussed, the model assumes CPP constant
at the tissue level and makes tissue perfusion (i.e. the rate of tissue content renewal) a
function of capillary resistance. In such model, vasomotion of capillaries would occur
due to physical forces emanating from solute gradients, i.e. from osmotic rather than
hydrostatic forces – a simple mechanism of perfusion auto-regulation that would be
inherited from primitive organisms of open circulation, devoid of a propelling pump
to force tissue perfusion.
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The next point that deserves examination is the intertwined effects of respiration,
metabolism and blood osmolarity in tissue perfusion.
Venous blood is hypercapnic and also hypertonic compared to arterial blood. That
means, the blood flowing through the systemic circulation reaches the different organs
(like the brain) with a certain osmotic pressure and, after exchanges with surrounding
tissues, leaves the organ with a higher osmotic pressure. Implications of this dynamic
process are two fold: 1) there is a tendency of the cellular respiration/metabolism to
increase the osmotic pressure in the brain and 2) there is an ongoing dilution of the brain.
The osmotic a-vdi f f of the brain (and perhaps also of other organs) is thus determined
by the balance between its perfusion and metabolic rates.
On the other hand, the re-arterialization of venous blood that takes place in the lungs
is a process that implies the restoration of blood osmotic pressure. Other than being
involved in water homeostasis because of breathed out vapor, systemic respiration re-
stores the concentration of blood gases, among which CO2 [202], a substance that is
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known to alter blood osmolarity [32]. After having renewed its gas composition, the
blood leaving the lungs is hypocapnic and hypotonic compared to the blood that flew
in through the pulmonary arteries. Worth to note that such respiratory induced changes
in blood osmolarity are substantially faster than other osmotic adaptations such as those
related to kidney filtration. The blockage of CA enzyme(s), which hampers the proper
re-arterialization of venous blood 6 [24, 255], increases arterial HCO−3 and affects the
CO2/pH/osmotic homeostasis in the blood and body 7. It takes ours for the kidneys to
re-establish blood homeostasis.
The resemblance between the dynamics of CO2 and osmotic arterio-venous differ-
ences is, in my opinion, striking; and indicates that the two quantities are indissocia-
ble 8. It is unfortunate that studies measuring metabolically-induced changes in per-
fusion and osmotic a-vdi f f have not included the analysis of blood gases [243, 244];
and, conversely, that studies measuring metabolically-induced changes in perfusion and
gas/metabolites/pH a-vdii f have not included analysis of blood osmolarity [19, 351]. It
would be quite important to determine the exact participation of ions, CO2 and other
metabolic residues in the normal modulation of venous blood osmolarity.
I also find remarkable that, while responding with vigour to changes in blood CO2
and water/osmolarity 9 [362], the byproducts of oxidative metabolism, the cerebral vas-
culature is relatively insensitive to changes in blood O2 [411] and glucose [281], the
fuels of oxidative metabolism.
Other than affecting cerebrovascular resistance, CO2 is also the main substance
buffering body’s pH, which is fundamental for the proper functioning of virtually all
organs of the body. Prolonged periods of hypercapnia (or a buildup of metabolic waste)
yields acidosis, which may culminate in comma and eventually death [86, 328]. This is
6. By blocking/inhibiting CA activity, the rate of CO2 hydration/dehydration is diminished, which
hampers the elimination of CO2 through the lungs.
7. Acetazolamide, which uses this pharmacological principle, has been administered to increase cere-
bral perfusion, correct for blood pH, reduce glaucoma and oedema, increase diuresis and hypertension
control (among others)
8. I considered beyond the scope of this thesis to discuss the arterio-venous temperature differences.
It is possible that temperature changes might also participate in the control of perfusion through thermo-
osmosis
9. CO2 reactivity seems to be preserved even when the brain is injured [327]
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why blood CO2 is also one of the key messengers of respiratory drive, the prime behavior
of survival [302, 304]. Oxygen, is indeed paramount for cellular functioning, however
the body seems to have been designed to respond to the excess of carbon dioxide with
much more alertness than to the lack of oxygen [20, 222, 359]. As long as CO2 is prop-
erly eliminated, one can die from anoxia without barely noticing it – for instance, by
inhaling pure Helium, one of the risks associated to the MRI environment.
It is reasonable to think that an organ’s perfusion is determined by its necessity to
dispose of its metabolic byproducts to keep its homeostasis (including CO2, the residue
of cellular respiration) 10. From this perspective, during functionally-evoked hyperaemia
capillaries would dilate and cerebral perfusion would increase according to a tendency
of the organ to become hypercapnic and hypertonic. Since capillaries are able to quickly
sequestrate CO2, and react to its intravascular increase, metabolic waste would be prop-
erly washed [322]. Now, it is important to note that if blood CO2 and osmolarity are to
control tissue perfusion, these two quantities cannot be found decreased with the issuing
hyperaemia; otherwise they would counteract the hyperaemic effect. The degree of cere-
bral hyperaemia should be determined by a balance between the tendency of the organ
to increase CO2/osmolarity and the tendency of blood stream to keep its resting home-
ostasis. Thence, both CO2 and osmolarity should be found slightly increased during
functional hyperaemia.
To sum what has been said, if perfusion is to be controlled by the chemical residues
of its metabolism [218], when metabolism is momentarily elevated in a particular region
of the brain, the blood compartment and venous drain of that area should be found hyper-
capnic compared to its normal state. This might be true in some tissues, and the osmotic
model proposed in Chapter 5 could find applicability explaining functional hyperaemia
in the respective vascular beds.
I reiterate that it has been observed, in different vascular beds, that CO2 and osmolar-
ity in the venous output is increased during metabolically-induced hyperaemia. In mus-
cles, either a localized [351] or a more general measure [73] will reveal that metabolic
10. When Roy and Sherrington first described the phenomenon of functional hyperaemia in the brain,
it had been indeed the first thought that sparked [323]. This theory of metabolic regulation of cerebral
perfusion has been proposed by others [218, 352]
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stress increases venous blood CO2, acidity and osmolarity; and that respective arterio-
venous differences increase with the workload [170, 360, 415]. Therefore, a model of
perfusion control by CO2/osmolarity would be applicable in this case.
The coupling between metabolism and hyperaemic responses in the brain (or neu-
rovascular coupling, NVC) has, though, been a matter of intense debate [94, 98, 143,
164, 214, 222, 252, 317, 427]; and it is also here – exactly in the brain – that an osmotic
model of functional hyperaemia has difficulty integrating with current views. Perhaps
because there is still no consilience.
When the NVC phenomenon has been first described by Roy and Sherrington in
1880, the authors speculated, indeed, that the observed hyperaemia would be mediated
by the chemical products of metabolism [323]. Later (dating from the 60’s), Wilder
Penfield, an acclaimed neurosurgeon from Montreal, reported ictal-induced hyperaemia
[291], but during which he eventually observed redness of pial veins. His observations
were the first to suggest that functional hyperaemia yielded a dilution of deoxygenated
hemoglobin in the venous blood, i.e. that venous blood becomes arterialized during
hyperaemic responses, at least from the standpoint of O2. The notion of a functionally-
induced dilution of the cerebral tissue rivalled the idea of a NVC mechanism based on
metabolic products.
With the development of functional imaging techniques it has been possible to esti-
mate cerebral metabolism and perfusion less invasively. The work of Fox and Raichle
using PET imaging, in 1986, has inaugurated a whole new era of brain function as-
sessment [99]. In their seminal paper, those authors have showed maps of perfusion
and metabolism portraying hyperaemic responses that were hugely disproportionate to
the amount of O2 consumed (which would have caused the dilution of deoxygenated
Hb and the venous blood redness described by Penfield years earlier). However, it was
not until the 90’s that the field of brain functional imaging would experience its major
boost. Seiji Ogawa and colleagues at the Bell laboratories were the first to demonstrate
that it was possible to generate a MRI signal whose contrast reflected the blood O2 levels
[276]; or more precisely, the level of deoxy-Hb dilution. The signal has been coined with
the acronym BOLD, for Blood Oxygenation Level Dependent, and has been used ever
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since as the primary means to localize metabolic changes in the brain (and elsewhere)
non-invasively.
The above observations suggested that the brain could resort to anaerobic metabolism
to support its bouts of energy demand [100]. Late in the 90’s Rick Hoge and colleagues,
from the same institution of Penfield, in Montreal, have provided an elegant demonstra-
tion that the brain does in fact increase oxygen consumption during enhanced activity
and its associated hyperaemia [158]. Using BOLD imaging combined with ASL-CVR
measures those authors have shown that the relationship between perfusion and deoxy-
Hb dilution was dependent on the intensity of sensorily-evoked responses. That is to say,
if there would not be oxygen consumption during activation, the BOLD signal would
have to be higher than the actual measures. Brain metabolism depleted some of the extra
available oxy-Hb thus reducing the observed BOLD-oxygenation signal. The proportion
between the supply and consumption of oxygen during functional hyperaemia have been
estimated to be about 2:1.
The notion of an hyperaemic related venous blood arterialization and the current
view that the brain is essentially an oxidative organ, might probably explain the many
models of NVC based on an upstream control of perfusion [173]. Since neither O2
nor the metabolic byproducts of oxidative metabolism could account for the perfusion
control (O2 because it is disproportionally high and metabolic byproducts because they
should be washed), the search for the underlying mechanisms of NVC has invariably
led to more complex rationales 11. A recent computer modeling paper incorporates the
postulate of a CO2 washout, and suggests that this potent vasoactive agent should exert a
vasoconstrictor effect in NVC and oppose functional hyperaemia [422]. Clearly, a model
11. It should be noted that a state of luxuriant perfusion (arterialization of venous blood) is also a sign
of brain death [174, 194, 221, 266, 329]. A measure of O2 a-vdi f f , or simply jugular O2, might be
used as a surrogate of irreversible damage of the brain tissue and support the diagnosis of brain death
of someone who had been comatose. Now, imagine a comatose patient that is submitted to an fMRI
scan and that suddenly arises from a deep coma but gets stuck in a locked-in condition [219, 220], where
he regains conscience but is unable to communicate with the experimenter. When his brain metabolism
is re-established, the O2 a-vdi f f increases, which causes a global reduction in the BOLD signal. Will
the experimenter realize the patient has awaken or would he conclude that the patient has passed? This
thought experiment shows how the interpretation of the BOLD signal can be paradoxical; or just of limited
application. It is also intriguing that the cerebrovascular reactivity to CO2 can be preserved in coma [70].
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of NVC based on CO2/osmolarity is in disagreement with this view.
A CO2/osmotic model of NVC can only be valid if during functional hyperaemia the
venous blood becomes more venous-like from the standpoint of CO2 and osmolarity. If
we embrace the notion that the increase in perfusion is disproportional to the increase
in O2 consumption and that venous-blood is arterialized from the standpoint of O2, an
osmotic model implies that the respiratory coefficient during periods of enhanced activity
exceeds unit value, i.e. that oxidative metabolism would be close to saturation during
normal activity and that the organ would heavily resort to anaerobic pathways to meet
the energy demands evoked by additional stimulation. Therefore, either the CO2 model
may change the current understanding, reintroducing old ideas of brain functioning and
perfusion control, or it will be proven flawed to explain the NVC.
Nevertheless, I insist that a model of NVC based on osmotic forces should still stand
as a hypothesis, for it has not yet been ruled out. There is no experimental data showing
that venous blood osmolarity nor CO2 decreases with metabolic activity. On the con-
trary, recent data using novel fMRI strategies, shows that pH decreases during the bouts
of brain activity 12 [152, 251], which strongly indicates an accumulation of metabolic
residues in the tissue and venous drain. Furthermore, it has also been reported that during
global stimulated hyperaemia the respiratory coefficient exceeds unit value. Brodersen
and colleagues have measured lactate, O2 and CO2 in the jugular veins of patients treated
with electro-convulso-therapy and showed that although venous blood is more arterial-
ized from the standpoint of O2, it carries more CO2 and lactate [42]. Using the Xenon
method, Madsen and colleagues have also measured an increased lactate output during
mental activity [250]. 13. Lastly, I have also been intrigued with a short communication
presented at the last annual meeting of the International Society for Magnetic Resonance
in Medicine, on BOLD fMRI signal [2]: it has been suggested that, in muscles (where
oxygen is known to be decreased during moderate functional hyperaemia) pH decreases
12. Using micropipettes to measure pH, Kraig and colleagues also observed stimulus dependent acidi-
fication of the cerebral tissue in the rat [208].
13. Worth to note that pH and blood CO2 levels are associated with BBB lactate permeability. It has
been reported that lactate transport across the BBB can be twice as fast when blood is hypercapnic/acid
[205]. Such phenomenon could be interpreted as a mechanism facilitating the disposal of non-oxidative
wastes in to the blood stream during increased activity.
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were correlated with BOLD increases. Acquisitions were all non-invasive, based on
MRI techniques, and measures of CO2/osmolarity were not available; yet, the authors
speculated whether the functional signal could be impacted by osmotic effects 14. Ani-
mal models and more invasive measures of brain solutes and perfusion during metabolic
stress are clearly warranted.
I can think of three unexplored avenues of investigation that should lead to a better
understanding of the phenomena underlying auto-regulation of cerebral perfusion. First,
as mentioned in Chapter 5, it would be essential to verify whether CO2 in fact acts on
the cerebral vasculature through blood bicarbonate. An experiment manipulating total
dissolved CO2 independently from PaCO2 should be carefully devised 15. Second, a dy-
namic measure of BBB’s osmotic gradient during both hypercapnic and hypertonic ma-
nipulations should help determining whether capillary reactivity is in fact a phenomenon
ruled by osmotic forces. Third, a direct measure of O2/CO2/osmolarity arterio-venous
differences during metabolically-evoked hyperaemia should suffice to unveil whether
CO2/osmolarity have any participation in the neurovascular coupling. This would con-
sist, in essence, of repeating Lundvall’s experiments [243] 16 in a particular area of the
brain, this time measuring venous CO2 , HCO−3 and lactate.
It is worth to note that if CO2 is found to play a role in the neurovascular coupling,
CVR measures might gain a different status. In hypercapnic manipulations, the manip-
ulated blood perfusing the brain increases CO2 in the whole blood compartment and
venous drainage of the organ, which could be mimicking a condition of global increase
in cerebral metabolism. I am suggesting that, more than a mere vaso-motor reflex, CVR
measures could be capturing – in fine details – the most innate function of cerebral vas-
culature, i.e. its ability to properly washout the byproducts of cerebral metabolism and
manage the brain’s homeostasis.
14. Relaxometry of blood with different amounts of dissolved CO2 could be useful to determine any
eventual contribution of blood osmolarity to the BOLD fMRI signal
15. The experiments of Hauge et al. [147] already constitutes good evidence for the role of bicarbonate
in the CO2 vascular response.
16. The authors of this study have measured blood osmolarity changes in the venous effluent of muscles
and salivary gland during functional hyperaemia and observed increases in venous osmolarity in the order
of 1-30 mmolar.
